CN102711645A - Systems, apparatuses, and methods for treating tissue and controlling stenosis - Google Patents
Systems, apparatuses, and methods for treating tissue and controlling stenosis Download PDFInfo
- Publication number
- CN102711645A CN102711645A CN2010800606276A CN201080060627A CN102711645A CN 102711645 A CN102711645 A CN 102711645A CN 2010800606276 A CN2010800606276 A CN 2010800606276A CN 201080060627 A CN201080060627 A CN 201080060627A CN 102711645 A CN102711645 A CN 102711645A
- Authority
- CN
- China
- Prior art keywords
- damage
- air flue
- electrode
- energy
- tissue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B18/1477—Needle-like probes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B18/1492—Probes or electrodes therefor having a flexible, catheter-like structure, e.g. for heart ablation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00005—Cooling or heating of the probe or tissue immediately surrounding the probe
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00005—Cooling or heating of the probe or tissue immediately surrounding the probe
- A61B2018/00011—Cooling or heating of the probe or tissue immediately surrounding the probe with fluids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/0016—Energy applicators arranged in a two- or three dimensional array
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00184—Moving parts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00214—Expandable means emitting energy, e.g. by elements carried thereon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00214—Expandable means emitting energy, e.g. by elements carried thereon
- A61B2018/0022—Balloons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00214—Expandable means emitting energy, e.g. by elements carried thereon
- A61B2018/00267—Expandable means emitting energy, e.g. by elements carried thereon having a basket shaped structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00434—Neural system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00541—Lung or bronchi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B2018/1405—Electrodes having a specific shape
- A61B2018/1435—Spiral
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B2018/1467—Probes or electrodes therefor using more than two electrodes on a single probe
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B2018/1475—Electrodes retractable in or deployable from a housing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N7/00—Ultrasound therapy
- A61N2007/0004—Applications of ultrasound therapy
- A61N2007/0021—Neural system treatment
- A61N2007/003—Destruction of nerve tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N7/00—Ultrasound therapy
- A61N7/02—Localised ultrasound hyperthermia
- A61N7/022—Localised ultrasound hyperthermia intracavitary
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Plasma & Fusion (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Heart & Thoracic Surgery (AREA)
- Otolaryngology (AREA)
- Physics & Mathematics (AREA)
- Cardiology (AREA)
- Radiology & Medical Imaging (AREA)
- Surgical Instruments (AREA)
Abstract
Systems, delivery devices, and methods to treat to ablate, damage, or otherwise affect tissue. The treatment systems are capable of delivering a coolable ablation assembly that ablates targeted tissue without damaging non-targeted tissue. The coolable ablation assembly damages nerve tissue to temporarily or permanently decrease nervous system input. The system, delivery devices, and methods can damage tissue and manage scarring and stenosis.
Description
Quoting of related application
The rights and interests that No. the 61/260th, 349, the U.S. Provisional Patent Application that the application requires to submit on November 11st, 2009 according to 35 U.S.C. § 119 (e).Incorporate this piece provisional application into this paper in full by reference.
Background
Technical field
The present invention relates generally to the system, the apparatus and method that are used to handle tissue, more specifically, the present invention relates to be used to cause required reaction and control narrow system, apparatus and method simultaneously.
Description of related art
Pneumonopathy possibly cause many problems that lung functions is caused adverse effect.Pneumonopathy such as asthma and chronic obstructive pulmonary disease (" COPD ") may cause the gas-flow resistance of pulmonary to increase.The mortality rate that causes by pneumonopathy, all be considerable with healthy relevant cost and population size with adverse effect.These diseases often cause adverse effect to quality of life.Symptom is diversified, but generally includes cough, dyspnea and asthma.For example, in COPD,, may observe dyspnea when carrying out to a certain degree aggravating activities when (as running, jog, hurry up etc.).Along with advancing of disease, carry out such as the walking non-aggravating activities the time also may observe dyspnea.As time goes on, the symptom of COPD may take place during more and more littler activity, exist up to these symptoms always, thereby seriously limit the ability that the people accomplishes normal activity.
The common characteristics of pneumonopathy are airway obstruction, it stops up with the air flue chamber, airway walls thickens, in the airway walls or the change of structure on every side or above combination relevant.Airway obstruction can significantly reduce the gas exchange amount of pulmonary, thereby causes dyspnea.The obstruction in air flue chamber can be caused by too much intracavity mucus or edema fluid do or both.Airway walls thickens and can be caused by airway smooth muscle excess shrinkage, airway smooth muscle hypertrophy, mucous gland hypertrophy, inflammation, edema or above combination.The variation of air flue surrounding structure (the for example destruction of lung tissue itself) can cause the radially forfeiture of traction of airway walls and airway constriction subsequently.
The characteristic of asthma can be shunk for airway smooth muscle, smooth muscle is loose, mucus produces too much, the inflammation and the swelling of mucous gland hypertrophy and/or air flue.These are stimulus object (for example cold air, smog, anaphylactogen or other chemical substance), the systemic hormone (chemical substance of blood of local inflammation cytokine (by being arranged in the chemical substance that airway walls or near immunocyte discharge in the part), suction unusually; Like antiinflammatory hydrocortisone and analeptic epinephrine), the complicated interactional result of local nerve system input (be completely contained in the neurocyte in the airway walls, its local reflex that can produce smooth muscle cell and mucous gland stimulates) and central nervous system's input (being transmitted to the nervous system signal of smooth muscle cell and mucous gland from brain through vagus nerve).These conditions tend to cause provisional widely change in organization and initial reversibility airflow obstruction, and these finally possibly cause permanent change in organization and permanent airflow obstruction, and this makes the asthmatic patient dyspnea.Asthma may further include through the hyperergy airway smooth muscle that can significantly increase gas-flow resistance shrinks acute attack or the attack that the air flue cause further narrows down.SOA comprises repeatedly dyspnea (for example, breathe hard or out of breath), asthma, the uncomfortable in chest and cough of outbreak.
Emphysema are types of COPD, it is characterized by around pulmonary's air flue or the change of contiguous lung tissue.Emphysema can relate to the destruction of lung tissue (for example alveolar tissue, such as alveolar sac), and this causes the minimizing of gas exchange and lung tissue radially reducing of traction that airway walls is applied on every side.The destruction of alveolar tissue stays the emphysema lung areas with excessive space, its lack alveolar wall and alveolar blood capillary and so when gas exchange inefficiency.Air " stranded " is in these bigger spaces.The air of this " stranded " may cause the excessive expansion of lung, and in the scope of breast, has limited the interior stream of rich oxygen containing air and than the normal function of health tissues.This has caused significant dyspnea, and possibly cause hypoxia level and high carbon dioxide level in the blood.Even in healthy individuals, such lung tissue destruction is also taken place as the part of usual aging process.Unfortunately, be exposed to chemical substance or other material (like tobacco smoke) can significantly be accelerated tissue injury or destructive speed.Airway obstruction can further increase dyspnea.Radially weakening of traction possibly cause airway walls to become " relaxing ", makes that the air flue wall part subsides or subsides fully when exhaling.This air flue during owing to exhale subsides and airway obstruction, and emphysema are individual possibly breathe out air outside the lung.
Chronic bronchitis is a type of COPD, it is characterized by that airway smooth muscle shrinks, smooth muscle is loose, mucus produces too much, mucous gland hypertrophy and airway walls inflammation.Similar with asthma, these are local inflammation cytokine, the complicated results of interaction that sucks stimulus object, systemic hormone, local nerve system and central nervous system unusually.With respiratory obstruction is that reversible asthma is different to a great extent, and the airway obstruction of chronic bronchitis mainly is chronic and nonvolatil.Owing to breathe hard, asthma, the uncomfortable in chest and chronic sympton that produces mucous cough, for chronic bronchitis patient, breathing is difficult usually.
Different techniques can be used for assessing the order of severity and the progress of pneumonopathy.For example, pulmonary function test (pft), motor capacity and quality of life questionnaire by individual through being commonly used to estimate.Pulmonary function test (pft) relates to the objective and repeatable measurement of basic physiological lung parameter, like total air flow, lung volume and gas exchange.The index that is used to assess the pulmonary function test (pft) of obstructive pulmonary disease comprises ratio, total lung capacity, TLC (TLC), airway resistance and the arterial blood gas test of 1 second forced expiratory volume (FEV1), forced vital capacity (FVC), FEV1 and FVC.FEV1 is a patient pulmonary when being full of air fully, the volume of air that forced expiration was breathed out in first second.FEV1 also is the average discharge that takes place in FE first second.This parameter can be used for assessment and determines whether to exist any airway obstruction and influence thereof.FVC is a patient pulmonary when being full of air fully, the total volume of air that forced expiration can be breathed out.The ratio of all gas that the gas comprises that can breathe out in first second when FEV1/FVC is forced expiration can be breathed out.After giving at least a bronchodilator, FEV1/FVC ratio is less than the existence of 0.7 definition COPD.TLC is the total amount of gas in the lung when pulmonary is full of fully, and TLC may increase when in obstructive pulmonary patient's lung, bottling up air.Airway resistance is defined as barometric gradient and the ratio of the air velocity between alveolar and the mouth between alveolar and the mouth.The resistance of equally, given air flue is defined as through the barometric gradient of this given air flue and the ratio of the air-flow of this air flue of process.The amount of the oxygen in the ABG thermometrically blood and the amount of carbon dioxide, and be that assessment pulmonary and respiratory system are brought oxygen into blood and carbon dioxide taken out of the most direct method of external ability from blood from air.
The motor capacity test is that the patient carries out the objective of active ability and repeatably detection.Six minutes walk test (6MWT) be a kind of motor capacity test, wherein patient's walking as much as possible on smooth surface in 6 minutes.Another kind of motor capacity test relates to the largest motion ability of measuring patient.For example, the amount of doctor's power that can measuring patient on cycle ergometer, can produce.The patient can breathe 30% oxygen and live load can increase 5-10 watt in per 3 minutes.
Quality of life the questionnaire assess holistic health and happiness.It is a kind of quality of life questionnaire that the St.George's breathes questionnaire, and it comprises 75 problems, and it is designed for measures the influence of obstructive pulmonary disease to total health status, daily life and perception happiness.The therapeutic effect of pneumonopathy can use pulmonary function test (pft), motor capacity test and/or questionnaire to assess.Can be based on the results modification therapeutic scheme of these tests and/or questionnaire.
Anaplastic treatment relates to through melting in the lung airway walls of numerous bronchial trees and destroys smooth muscle tension force such as bronchus heat, eliminates smooth muscle and nerve in pulmonary's airway walls thus.The air flue of treatment can not be well in response to the stimulus object, systemic hormone and the part that suck and central nervous system's input.Unfortunately, the smooth muscle tension force of airway walls possibly can have a negative impact to pulmonary function with neural this destruction thus.For instance, the suction stimulus object such as smog or other toxicant can stimulate irritant receptor of lung usually and produce cough and air flue smooth muscle contraction.Eliminate nerve in the airway walls and removed partial function of nervous system and import, thereby eliminated lung is discharged toxicant through strong cough ability with nervus centralis.Eliminate airway smooth muscle tension force and possibly eliminate the ability that air flue tightens, thereby allow deeper to infiltrate through in the lung such as the harmful substance of toxicant.
Asthma and COPD are serious diseases, and its patient is more and more.Present treatment technology comprises prescription drugs, and both not exclusively success can not have no side effect.In addition, many patients do not observe its drug prescription dosage.Therefore, the treatment that can improve gas-flow resistance and not need patient's compliance need be provided.
Brief description
At least some embodiments relate to device in the tube chamber, and said device can be removed hollow organ's innervation, can prevent, minimize or limit simultaneously narrow possibility.Can treat the target area of organ, and can not cause the undesirable narrow of appreciable impact organ dysfunction.In certain embodiments, device melts the independent purpose zone that is spaced apart from each other in the tube chamber.Even take place narrowly, also can avoid extending the continuous narrow ring of 360 degree.If said organ is an air flue, can forms damage, and can not cause gas-flow resistance that any increase that perceives takes place.
In some embodiments, be used to treat individual system and comprise that size is set at the elongate member that can move along the air flue chamber.Said assembly can weaken the signal that is transmitted by nervous tissue (the for example nervous tissue of nerve trunk), can the inner surface of air flue irreversibly not destroyed to any significant degree simultaneously.In certain embodiments, one or more electrode output RF energies are handled rear portion 90 degree of air flue circumference to 180 degree, thereby remove the innervation of lung.When destroying destination organization, cooling system (for example, cooling duct) can control electrode and/or the temperature of airway tissue.
In some versions, tissue injury can be enough to cause cicatrization, reduces, limit or eliminate basically because narrowing down of perceiving of scar tissue, the air flue chamber generation that causes such as narrow but can place electrode.The spacing distance of damage can be enough to prevent that the tissue between the contiguous damage from thickening.Disclosed at least some embodiments of this paper can melt basically airway walls whole circumference and not can with the plane of air flue axis in form successive ablation tissue ring.
In some embodiments, method comprises the nervous tissue that destroys first main bronchus, is passed to the almost whole far-end bronchial trees that are connected with said first main bronchus to prevent the nervous system signal basically.Most of in the bronchial tree of the said first main bronchus far-end or all can't receive the nervous system signal.In certain embodiments, nervous tissue is between the lung that trachea and bronchus branch extends through.Said method also comprises the nervous tissue that destroys second main bronchus, is passed to the almost whole far-end bronchial trees that are connected with said second main bronchus to prevent the nervous system signal basically.In certain embodiments, along the rear portion air flue less than 180 ° or in the required part delivery of energy of air flue circumference.This has limited the amount of the tissue that is exposed to emitted energy.
In some embodiments, innervation is removed and is related to the damage that generation can influence outside adventitial tissue layer, and wherein nerve trunk is arranged in said outside adventitial tissue layer on anatomical structure.In the innervation of lung is removed, melt the nerve trunk that runs through right side and left side main bronchus outside and can cut off the airway smooth muscle that is lining in the lung airway and the product mucus body of gland and vagal contact that are positioned at air flue effectively.When this thing happens, airway smooth muscle was lax, and mucus produces and reduces.These variations can reduce the airway obstruction under the morbid state (such as COPD and asthma).The airway obstruction that reduces makes breathing easier, and this can improve individual quality of life and health status.
The air flue arm is in be lower than second temperature of said first temperature can heat damage nervous tissue through the temperature of nervous tissue being brought up to first temperature (for example, melting temperature).In some embodiments, a part that is positioned at the radially inner airway walls of nervous tissue can be in first temperature, to prevent that this part airway walls is caused permanent damage.Said first temperature can be enough high, and can cause permanent damage to nervous tissue.In some embodiments, nervous tissue is a part that is arranged in the nerve trunk of the outside connective tissue of airway walls.It is functional that smooth muscle in the airway walls and nervous tissue can keep, so that smooth muscle tension force maintains aspiration level.Air flue can shrink/expand in response to stimulating (stimulation that for example, is caused by the stimulus object, local nerve system or the systemic hormone that suck).In other embodiments, nervous tissue is nervous ramification or the part of nerve fiber in the airway walls.In other embodiments, simultaneously or destroy the nervous tissue of nerve trunk and the nervous tissue of nervous ramification/fiber in succession.But various types of starting elements (for example ablation) can be used for exporting energy.
Some embodiments are utilized the advantage of big airways anatomical structure.Vagal air flue nerve trunk is usually located at the latter half of main bronchus air flue.Main airway (being trachea, right side and left side main bronchus) Background Region does not have cartilage.The cartilaginous ring of these air flues is not a whole circumference, and only has soft tissue along their rear portion.In addition, can realize damaging away from the nervous tissue of air flue nerve trunk through producing damage less than 360 degree of (for example, significantly less than) air flue circumference to being positioned at the air flue latter half.For example, 180 degree of processing air flue circumference, 150 degree or 130 degree maybe be just enough for the innervation of effective removal air flue.Because damage has remarkable arc length less than 360 degree, therefore can significantly reduce or prevent airway constriction.
Electrode can have complicated shape (comprising arc, polygon) or have any other shape or structure.Electrode can be V-arrangement, U-shaped, L shaped, T shape, W shape, straight, crooked or above combination.In some embodiments, electrode assemblie is zigzag configuration, curl shape structure, winding escalator or coil shape structure, corkscrew shape (corkscrew) structure, helical configuration, Z-shaped structure, above combination etc.Corkscrew shape electrode assemblie can have the electrode that can independently control, and said electrode forms the discontinuous or successive damage that is substantially corkscrew shape.
Another embodiment comprises and can or all produce the successive electrode assemblie that is substantially corkscrew weakened and emaciated body wound along the part of air flue circumference.For same circumferential area, it is less that the cicatrix with small surface area produces the probability can form narrow tissue net.At least some embodiments can be handled narrow target area, to form corresponding narrow damage.The blade electrode assemblie can carry out such processing, thereby further reduces scar tissue.
Another embodiment depends on nerve, tremulous pulse and the vein that tends to companion's row in the human anatomy structure.Carrying out before the air flue innervation removes, can use the energy of ultrasonic or other type to confirm arteriae bronchiales or the venous position of walking near air flue nerve trunk place very.After confirming the position of blood vessel, with near the air flue zone of energy process blood vessel to melt the air flue nerve trunk.This technology minimizes or limits the volume of handled tissue, thereby reduces or eliminate narrow risk.
In some versions, conduit forms the damage of at least one place in the degree of depth of expectation.For example, can in a bronchus airway walls, form the damage of a place or many places corkscrew shape or spiral type, and can in another airway walls, form arc damage, thereby remove the innervation of bronchial tree different piece.Damage can or be positioned at the depths of airway walls along the inner surface of air flue, perhaps can be along the outer surface of air flue.
In some embodiments, the energy delivery apparatus comprises catheter shaft and the ablation member that is connected with said catheter shaft.Said ablation member comprises can be from collapsed mode energy emitter between cooling element that deployed condition moves and cartilage, and energy emitter comprises a plurality of electrodes that the longitudinal axis around said ablation member departs from a circumferential direction each other between said cartilage.Said electrode is configured to can be to a plurality of target areas of air flue delivery of energy, and said a plurality of target areas separate each other with respect to the longitudinal axis of said air flue.Said energy emitter and said cooling element are configured to cooperatively interact and damage to form between cartilage, and the surface texture of damage and said air flue separates and between the cartilaginous ring of said air flue between said cartilage.
In certain embodiments, delivery apparatus comprises ablation member in the tube chamber, and said ablation member comprises deployable device and a plurality of ablation and/or electrode.Said electrode is separated along the circumference of said deployable member, and can export energy to dispersive target area, thereby forms damage in said target area.At least a portion of first damage separates with second damage in the axial direction, and contiguous or overlapping with said second damage in a circumferential direction.
In certain embodiments, the individual method of treatment comprises with respect to air flue places ablation member, and exports energy from said ablation member to axially spaced air flue target area.When the long axis direction of said air flue is observed, the profile of said target area is overlapping.
In other embodiments, the individual method of treatment comprises the energy emitter that moves delivery apparatus along air flue.At least one electrode of said energy emitter is placed between the cartilaginous ring of said air flue., damage to being positioned at from said electrode to form between cartilaginous ring along the target area delivery of energy of the position that the major axis of said air flue axially separates.
The certain methods of handling tissue comprises ablation member is placed on the air flue intracavity, and utilizes at least one electrode of being placed near the said ablation member said air flue inner surface delivery of energy of organizing to said air flue.The energy of being sent destroys the target area that axially separates along said air flue, and the target area part of feasible qualification maximum cross section, said target area width is separated with the inner surface of said air flue.
In some embodiments, delivery apparatus comprises catheter shaft and the ablation member that is connected with said catheter shaft.Said ablation member comprises the deployable elements that can move to deployed condition from collapsed mode.When said deployable member was in deployed condition, energy emitter can be sent energy and produce damage, and said damage has the end that is axially offset to one another along the axial length of body structure.
Delivery apparatus can produce the continuous or discrete damage in a place or many places.Said damage can have different shapes, comprises arc, spirally (spiral shape), spiral type (helical shape), waveform, curl shape or above combination.In order to produce successive damage, ablation member can have the very near electrode of being separated by, to form successive substantially damage.Perhaps, said ablation member can have long electrode or energy emitter, and they have corresponding spirally, spiral type, curl shape etc.In other embodiments, electrode can separate enough distances, to form discontinuous damage.Can preference pattern, the size of interval and damage comes the processing target zone.
In certain embodiments, can form damage simultaneously along the diverse location of airway walls.In some versions, can form oblique damage at the offside of air flue.Whole damage can be between cartilaginous ring damages said ring avoiding.In other embodiments, damage can be passed trachea or cartilaginous ring.
Description of drawings
In the accompanying drawings, same reference number is represented similar element or assembly.
Fig. 1 has shown near lung, the lung and blood vessel and nerve in the lung.
Fig. 2 has shown according to an embodiment and has been placed on the intracavity processing system in the left principal bronchus.
Fig. 3 has shown the delivery apparatus that the access to plant from be placed on left principal bronchus stretches out.
Fig. 4 A is the air flue of bronchial tree and the sectional view of the ablation member of subsiding.
Fig. 4 B is the air flue of bronchial tree and the sectional view of unfolded ablation member.
Fig. 5 A is the sectional view that when the smooth muscle contraction of air flue and mucus are in the air flue chamber, is centered around the air flue around the ablation member of subsiding.
Fig. 5 B is the sectional view that is centered around unfolded ablation member air flue on every side.
Fig. 6 is the figure of tissue depth with respect to tissue temperature.
Fig. 7 is the side view of the ablation member in the air flue.
Fig. 8 is the isometric view with delivery apparatus of ablation member.
Fig. 9 is the sectional view of the elongate bars obtained of the line 9-9 along Fig. 8.
Figure 10 is the side view of ablation member.
Figure 11 is the longitdinal cross-section diagram of the ablation member of Figure 10.
Figure 12 is the partial cross section figure of therapy system, and wherein delivery apparatus stretches out from access to plant.
Figure 13 is the side view of ablation member.
Figure 14 is the sectional view that is centered around the air flue around the unfolded ablation member, and this sectional view is that the line 14-14 along Figure 13 obtains.
Figure 15 is the side view of ablation member.
Figure 16 is the side view that is used to produce the ablation member of oblique damage.
Figure 17 is the side view with ablation member of inner passage.
Figure 18 is the sectional view of the ablation member of Figure 17 of obtaining of 18-18 along the line.
Figure 19 is the side view with ablation member of outlet.
Figure 20 is the sectional view of the ablation member of Figure 19 of obtaining of 20-20 along the line.
Figure 21 is the side view with ablation member of V-arrangement electrod-array.
Figure 22 is the side view with ablation member of T shape electrode.
Figure 23 is the side view of multiple tooth ablation member.
Figure 24 is the side view with the right ablation member of electrode assemblie.
But Figure 25 is the side view with ablation member of cooling electrode assembly.
Figure 26 is the sectional view of the electrode assemblie that obtains of the line 26-26 along Figure 25.
Figure 27 A-31B has shown isothermal line and corresponding damage.
Figure 32 is the side view of helical form ablation member.
Figure 33 is the side view of another helical form ablation member.
Figure 34 is the isometric view with ablation member of isolated electrode.
Figure 35 is the isometric view that is placed on the ablation member of the Figure 34 in the air flue body cavity.
Figure 36 is the isometric view of the damage that forms of the ablation member by Figure 34.
Figure 37 is the isometric view of ablation member with electrode of coolant cools.
Figure 38 is the sectional view of the ablation member obtained of the line 38-38 along Figure 37.
Figure 39 A is the isometric view with ablation member of crooked energy emitter.
Figure 39 B is the isometric view by the blood vessel of the ablation member processing of Figure 39 A.
Figure 40 A is another isometric view of the ablation member of Figure 39 A.
Figure 40 B is the isometric view by the blood vessel of the ablation member processing of Figure 40 A.
Figure 41 is the isometric view of the ablation member of another embodiment.
Figure 42 is the isometric view that is in the ablation member of sending configuration.
Figure 43 is the isometric view that is in the ablation member of the Figure 42 that launches configuration.
Figure 43 A is the side view of the ablation member of Figure 43.
Figure 44 is the sectional view of distal section of the ablation member of Figure 43.
Describe in detail
Fig. 1 has showed the people's lung 10 with left lung 11 and right lung 12.Trachea 20 from nose with mouthful to extending below and being divided into left principal bronchus 21 and right principal bronchus 22.Left principal bronchus 21 is all distinguished branch with right principal bronchus 22 and is formed lobar bronchi, segmental bronchi and inferior segmental bronchus, and they have diameter that diminishes gradually and the length that shortens gradually along outside direction (being distal direction).30 of main pulmonary arteries pass through from the right ventricle of heart and in the place ahead of radix pulmonis 24.At radix pulmonis 24 places, tremulous pulse 30 branches into left and right pulmonary artery, and left and right pulmonary artery branch shape successively becomes ramose blood vessel network.These blood vessels can extend along the air flue of bronchial tree 27.Bronchial tree 27 comprises left principal bronchus 21, right principal bronchus 22, bronchioles and alveolar.Vagus nerve 41,42 extends and branch's formation nerve trunk 45 along trachea 20.
Left vagus nerve 41 passes cervical region with 42 of right vagus nerves from brain stem, and passes through chest downwards in the both sides of trachea 20.Vagus nerve 41,42 expands into nerve trunk 45, and nerve trunk 45 comprises the plexus pulmonalis of the front and rear that holds trachea 20, left principal bronchus 21 and right principal bronchus 22.Also the branch branch airway along bronchial tree 27 extends nerve trunk 45 in the branch branch airway outside of bronchial tree 27.Nerve trunk 45 is neural trunks, comprises that the hard sheath by connective tissue wraps in nerve fibre bundle together.
The major function of lung 10 is that airborne exchange of oxygen is gone into blood, and with the carbon dioxide exchange in the blood in air.When the oxygen containing air of richness was drawn into lung 10, gas exchange process began.The contraction of diaphram and intercostal chest muscle wall cooperatively interacts and reduces the pressure in the chest, makes rich oxygen containing air flow cross the air flue of lung 10.For example, air through port and nose, trachea 20, then through bronchial tree 27.Air finally is delivered to alveolar sac and carries out gas exchange process.
The blood of oxygen poor pumps through pulmonary artery 30 from right side of heart and also finally is delivered to the alveolar blood capillary.Be rich in the carbon dioxide refuse in the blood of this oxygen poor.Thin semipermeable membrane separates oxygen poor blood in the blood capillary and the rich oxygen containing air in the alveolar.These blood capillaries surround alveolar and in the middle of alveolar, extend.Diffuse into blood from airborne oxygen through film, and come the carbon dioxide of autoblood to diffuse in the air of alveolar through film.Then, new rich oxygen containing blood flows to heart from the branch vessel of alveolar blood capillary through the pulmonary vein system.Heart is delivered to whole body everywhere with the oxygen containing blood pump of richness.When diaphram and Intercostal muscle were lax, the air that has consumed oxygen in the lung was breathed out, and lung and thoracic wall return elastically normal relaxed condition.By this way, air can flow through branch's bronchioles, bronchus 21,22 and trachea 20, and final through port and nose discharge.
Fig. 2 has shown processing system 200, thereby it can handle the air-flow in adjustment expiration or air-breathing or expiration and the breathing process.Increase gas exchange in order to reduce gas-flow resistance, processing system 200 can be used for enlarging (for example, expansion) air flue.The nervous tissue (for example nervous tissue) that can influence in some versions, (in the inside of lung or outside) nerve trunk expands air flue.Nervous system uses the signal of telecommunication and chemical signal that the communication between brain and the lung 10 is provided.The activity of autonomic nervous tissue network sensation and adjusting respiratory system and vascular system.Nervous tissue comprise use chemical signal and the signal of telecommunication from a body part to feeling to another body part transmission and the fiber of movable information.For example, nervous tissue can be with the form transmitting sports information of nervous system input, such as the signal that causes muscle contraction or other reaction.Fiber can be made up of neuron.Nervous tissue can be held by connective tissue (being epineurium).Autonomic nervous system comprises the sympathetic nervous system parasympathetic nervous system of unifying.Sympathetic nervous system mainly participate in stress during " excitement " function.Parasympathetic nervous system is mainly participated in " plant " function during energy keeps.The sympathetic nervous system parasympathetic nervous system of unifying is simultaneously movable, and usually tract is produced mutual effect.The innervation of blood vessel comes from this two systems, and the innervation of air flue mainly is parasympathetic in itself, and between the lung of right vagus nerve 42 and left vagus nerve 41 and brain, transmits.
Can be in these nerve trunk 45 one or more on carry out the part that any amount of operation influences the lung relevant with these nerve trunk.Because some nervous tissue in the network of nerve trunk 45 (for example imports other nerve; The nerve that is connected with esophagus, get into the nerve of abdominal part etc. through chest), so thereby can targeting minimize, limit or eliminate basically other non-target nerve or structure are caused undesirable destruction in specific site.Some fiber of front and rear plexus pulmonalis imports little nerve trunk, and these little nerve trunk are extended along trachea 20 and branch's bronchus and bronchiolar outer surface when outwards walking into lung 10.Along branch's bronchus, these little nerve trunk are bifurcated and fiber sent into airway walls each other constantly.
In some scheme, melt nervous tissue to weaken along the transmission of the signal of can causing of transmitting of vagus nerve 41,42 or muscle, mediate muscle contraction, mucus generation, inflammation, edema etc.Weaken and to include but not limited to obstruction, restriction, blocking-up and/or interrupt signal transmission.For example, weaken and to comprise the signal amplitude that reduces nerve signal or weaken transmission through nerve signal.Reduce or distad stop that the nervous system input of air flue can change airway smooth muscle tension force, generations of air flue mucus, airway inflammation etc., thereby control air flows into and outflow lung 10.Reduce or stop from air flue and lung to the local effect cell or to central nervous system's sensation input can also reduce that reflection bronchial stenosis, reflection mucus produce, the release of inflammatory mediator and in body lung or the organ nervous system that possibly cause the airway walls edema of other cell import.In some embodiments, can reduce the nervous system input, thereby correspondingly reduce airway smooth muscle tension force.In some embodiments, air flue mucus produces the amount that is reduced can be enough to cause cough and/or the substantive decline of gas-flow resistance.In some embodiments, the amount that airway inflammation reduced can be enough to make gas-flow resistance and reduce the ongoing inflammatory damage of airway walls is substantive.Signal weakening can make smooth muscle loosening, prevents, limits or eliminate basically the mucus generation of producing myxocyte and reduce inflammation.Under this mode, can change healthy air flue and/or ill air flue to regulate pulmonary function.After the processing, can utilize various types of questionnaires or test to assess individual reaction to handling.If desired or hope, can carry out other operates and reduces the cough frequency, reduces dyspnea, reduces asthma etc.
The main bronchus 21,22 (i.e. 1 grade of air flue (airway generation 1)) that can handle Fig. 1 and 2 influences the distal portions of bronchial tree 27.In some embodiments, at processing left side, positions and right side main bronchus 21,22 along left side and right side radix pulmonis 24 and left lung 11 and right lung 12 outsides.Treatment site can be positioned at vagus nerve branch and trachea and main bronchus 21,22 distally of remittance place and the nearside of lung 11,12 mutually.The single processing procedure that relates to two kinds of treatment application can be used to handle the most of or whole bronchial tree 27 of bronchial tree 27.The overwhelming majority that extends into the bronchial tree in the lung 11,12 can be affected, thereby high-caliber curative effect is provided.Because the arteriae bronchiales of main bronchus 21,22 have big relatively diameter and high heat absorption capacity, handle the undesirable destruction that produces so can protect these arteriae bronchiales to exempt from.
Fig. 3 has shown the delivery apparatus of conduit system 204 forms, and wherein conduit system 204 extends through access to plant 206.Conduit system 204 can be handled the air flue of main bronchus 21,22, and the air flue in main bronchus 21,22 distally.Ablation member 208 can be placed on outside the pulmonary, in right side or left side main bronchus, lobe of the lung bronchioles or the middle bronchus.Middle bronchus is formed by the part of right side main bronchus and is middle period bronchioles and the bronchiolar origin of inferior lobe.Ablation member 208 can also be placed in the more high-grade air flue distal part that (for example,>2 grades air flue) influences bronchial tree 27.
Can guide catheter system 204 carry out various operation through zigzag air flue, for example, the innervation of the cut-off parts lobe of the lung, the whole lobe of the lung, a plurality of lobe of the lung or a lung or two lungs.In some embodiments, handle lobar bronchi to cut off the innervation of the lobe of the lung.For example, but targeting in along one or more treatment site of lobar bronchi to cut off the innervation of the whole lobe of the lung that is connected with this lobar bronchi.Can handle the left lung bronchus to influence upper left leaf and/or left inferior lobe.Can handle the lobus dexter bronchus to influence right upper lobe, right middle lobe and/or right lower lobe.Can be side by side or one after the other handle the lobe of the lung.In some embodiments, the doctor can handle a lobe of the lung.Based on the effectiveness of handling, the doctor can simultaneously or one after the other handle other lobe of the lung.By this way, can handle the different separated region of bronchial tree.
Can be through handling each segmental bronchi to single treatment site delivery of energy along each segmental bronchi.For example, can be to each segmental bronchi delivery of energy of right lung.In some versions, apply 10 energy and can handle the most of or almost whole of right lung.In some versions, utilize the different energy that is less than 36 times to apply and to handle the most of or almost whole of two lungs.According to the anatomical structure of bronchial tree, often can utilizing once or twice, energy applies the innervation that cuts off segmental bronchi.
When nervous tissue is melted, can keep such as other tissue of mucous gland, cilium, smooth muscle, body pipe (for example blood vessel) etc. or the function of anatomical structure.Nervous tissue comprises neurocyte, nerve fiber, dendron and such as neuroglial supporting tissue.Neurocyte transmission electric pulse, and nerve fiber is the aixs cylinder of the prolongation of the said pulse of guiding.Said electric pulse is converted into chemical signal, thereby sets up communication with effector lymphocyte or other neurocyte.For instance, can cut off the innervation of the part air flue of bronchial tree 27, to weaken one or more nervous system signals by nervous tissue's transmission.Cut off innervation and can comprise destruction all nervous tissues, thereby the more distal location that makes all signals can't be passed to bronchial tree through the damaged section of nerve trunk basically perhaps conducts to more near the central nervous system from bronchial tree along one section nerve trunk of air flue.In addition; The directly sensory receptors of transmitting along nerve fiber from air flue (for example; Cough and costimulatory receptor) also will be interrupted near effector lymphocyte's (for example, joint back neurocyte, smooth muscle cell, myxocyte, inflammatory cell and vascular cell) signal.If a plurality of nerve trunk are extended along air flue, then can destroy each nerve trunk.Therefore, the nerve supply along segmental bronchus tree can be cut off.When signal was cut off, the distally airway smooth muscle can relax, and this causes air flue expansion, myxocyte to reduce the mucus generation or inflammatory cell stops to produce airway walls swelling and edema.These variations reduce gas-flow resistance and then increase the gas exchange in the lung 10, thereby reduce, restriction or eliminate one or more symptoms basically, such as dyspnea, asthma, uncomfortable in chest etc.The tissue of encirclement or vicinity purpose nervous tissue may be affected, but can not receive permanent damage.In some embodiments; For example; Before processing and after handling; The blood of analog quantity can be sent to the bronchial wall tissue along the bronchus blood vessel of the air flue that is processed, and the blood of analog quantity can be sent to the alveolar sac of bronchial tree 27 distal regions along the lung blood vessel of the air flue that is processed.These blood vessels can continue to transport blood to keep competent gas exchange.In some embodiments, the destruction of airway smooth muscle does not reach significant degree.For example, the not obvious smooth muscle than segment that influences respiratory function can be changed reversiblely in the airway walls.If energy is used to destroy the outer nervous tissue of air flue, the energy of treatment effective dose can not arrive the major part of non-purpose smooth muscle tissue.
Handle left principal bronchus 21 and one of right principal bronchus 22, thereby handle a side of bronchial tree 27.Can handle other main bronchus 21,22 based on the effectiveness of first processing.For example, can handle left principal bronchus 21 and handle left lung 11.Can handle right principal bronchus 22 to handle right lung 12.In some embodiments, single processing system can be destroyed the nervous tissue of one of bronchus 21,22, and in the nervous tissue that need not under the situation of trachea 20 taking-up processing systems, can also destroy other main bronchus 21,22.Therefore, just can destroy need not to take out under the situation of processing systems along the nervous tissue of main bronchus 21,22 from trachea 20.In some embodiments, can carry out all or at least quite a few (for example, bronchus air flue of at least 50%, 70%, 80%, 90%) basically that single operation comes management of patients bronchial tree easily.In other operation, after handling one of lung 11,12, can take out processing system from the patient.If desired, can in operation subsequently, handle other lung 11,12.
Fig. 4 A is the view in transverse section of healthy air flue 100, is example with the bronchus.Inner surface 102 is defined by 110 of epithelial cell plicated layers, and epithelial cell is surrounded by substrate 112a.Smooth muscle tissue's layer 114 surrounds substrate 112a.Hypothallus 112b is between muscular tissue 114 and connective tissue 124.Mucous gland 116, cartilaginous lamina 118, blood vessel 120 and nerve fiber 122 are in the hypothallus 112b.Arteriae bronchiales branch 130 and nerve trunk 45 are positioned at wall 103 outsides of air flue 100.Shown tremulous pulse 130 is positioned at the connective tissue 124 that surrounds airway walls 103 with nerve trunk 45, and its direction can be parallel to air flue 100 usually.In Fig. 1, for example, 45 of nerve trunk are extended to alveolar from vagus nerve 41,42 and along air flue 100.Nerve fiber 122 is arranged in airway walls 103 and extends to muscular tissue 114 from nerve trunk 45.The nervous system signal transmits to muscle 114 and mucous gland 116 from nerve trunk 45 through nerve fiber 122.In addition, signal transmits to the central nervous system through nerve trunk 45 from sensory receptors (for example, cough, stimulus object and stretching).
Can destroy, stimulate or otherwise change cilium to cause required replying along epithelial cell 110, thus the transportation of control (for example, increase or reduce) mucomembranous cilium.Can suck a lot of particulate matters when the people breathes, the function of air flue performance filter is removed particulate matter from air.Mucomembranous cilium transportation system is for the mechanism of all air flue performance self-cleanings of whole lung 10.Mucomembranous cilium transportation is to remove mucous main method from the distal part of lung 10, and then as the main immunologic barrier of lung 10.For example, the inner surface 102 of Fig. 4 A can be covered and be coated with mucus by cilium.As the part of mucomembranous cilium transportation system, mucus is caught the particulate matter (for example, deleterious pollutant are such as tobacco smoke) of many suctions and is made these particulate matters to laryngeal movement.The distal position mucous blanket that the fibre swing of cilium makes lung 10 moves through larynx with the pantostrat of the particulate matter of catching, and moves to pharynx and be used for discharging from respiratory system.Ablation member 208 can be destroyed cilium to reduce the mucomembranous cilium transportation or to stimulate cilium to improve the mucomembranous cilium transportation.
Natural body function can help prevent, reduces or limit the damage to tissue.130 blood can absorb heat energy in the blood vessel, can carry the heated zones of heat energy away from branch 130 then.By this way, blood can alleviate or avoid the damage to blood vessel 130.After handling, arteriae bronchiales branch 130 can continue to keep the health of lung tissue.Melt in the embodiment at some RF, the RF energy of ablation member 208 output q.s destroys whole vertical section of nerve trunk 45 and does not destroy blood vessel 130.
Assessment to treatment effect can be at least to a certain extent based on one or more air flue characteristics, pulmonary function test (pft), motor capacity test and/or questionnaire.Can assess to follow the tracks of and to monitor their progress individuality.If desired or hope, can carry out other process up to realizing required reaction.Can use the dissimilar instrument that is used to assess the air flue characteristic.During melting, can show from the feedback of instrument whether target tissue is melted.In case target tissue is melted, the non-destination organization of health followed destruction (if any) thereby can stop to treat minimizing or limiting.
Can assess to confirm on-unit the different qualities of air flue.Said air flue characteristic includes but not limited to; The physical property of air flue (for example; Air flue compliance, shrinkage etc.), the dimension in airway resistance, air flue chamber (for example; The shape of air flue, the diameter of air flue etc.), the reactivity of air flue (for example, reactivity), muscle property (for example, muscle tone, muscular tone etc.), inflammatory cell, inflammatory cytokine etc. to stimulating.In some embodiments, can change the variation of monitoring the air flue muscle property through the pressure that measurement is expanded in the ablation member 208 of known pressure.The effect (if any) that the doctor changes confirm handle according to pressure, said effect include but not limited to whether destination organization has been stimulated, melted etc.
Fig. 5 A and 5B are the view in transverse section of the part of air flue 100, and air flue 100 has the smooth muscle tissue 114 that is in contraction state, from the mucus 150 of the mucous gland 116 of undue growth and inflammatory swelling and the edema fluid do that airway walls 103 is thickened.Muscular tissue 114, mucus 150 of shrinking and the airway walls 103 that thickens cooperatively interact and occlusion lumen 101 partly, and this causes high relatively gas-flow resistance.Destroy nervous tissue 45 and come relaxed muscle tissue 114, expansion air flue 100, thus reduce gas-flow resistance, therefore allow more air to arrive the alveolar sac that is used for gas exchange process.Airway resistance reduces the channel opener that possibly show air flue, the channel opener that for example weakens in response to the nervous system input of these air flues.Can limit or minimize narrow, can significantly not increase with the gas-flow resistance after guaranteeing to handle.Therefore, processing should be guaranteed the permanent reduction of air flue gas-flow resistance, even after processing a very long time.
With (for example handle rudimentary air flue (low generation ariways); Main bronchus, lobar bronchi, segmental bronchi) decline of relevant airway resistance can be greater than the slippage of the airway resistance relevant with processing high level air flue (high generation ariways) (for example, inferior segmental bronchus).The air flue that the doctor can select to be suitable for handling is realized reducing of desired airway resistance, and can be in the patient oral cavity, and the bronchial tree of treatment site nearside, trachea or any other suitable position are measured.Can be before treating, in the treatment and/or treatment back measures airway resistance.In some embodiments, for example through using the position measurement airway resistance of exhaust-gas treatment system in bronchial tree, said exhaust-gas treatment system allows to breathe than the zone in distally from treatment site.
Fig. 6 and 7 is presented in the ablation member 208 by the top layer heating of RF energy and cools off the effect that is produced with the deep layer heating and by the top layer of circulating coolant.Coolant absorbs heat energy, makes the tissue that contacts with the cooling section 209 of ablation member 208 be cooled.Cooling section 209 can damage the tissue between ablation member 208 and neural or other purpose tissue to limit or to prevent from the heat energy of airway walls 100 absorption capacities.
Transverse axis among Fig. 6 is corresponding to the degree of depth (unit be millimeter) from getting into airway walls tissue with the point of the contact point of electrode assemblie 214 or adjacent electrode assembly 214, and the longitudinal axis is corresponding to tissue temperature (unit be degree centigrade).Except as otherwise noted, the temperature among the figure is degree centigrade.Figure puts corresponding to contact point or contact area between electrode assemblie 214 and the airway walls tissue last " 0 ".Three curve A, B and C among the figure are corresponding to the RF energy of being sent into three kinds of different capacity levels of tissue.Temperature among the figure is high to about 100 ° of C.Shown about 100 ° of C or lower slightly temperature because this temperature is considered to RF melt during the upper limit of tissue temperature.When about 90 ° of C, tissue fluid comes to life, coagulation of tissues and carbonization, thus increase its impedance greatly and damage its ability to airway walls organized delivery RF energy.Therefore, tissue temperature maintains that to be lower than about 90 ° of C be desirable.When about 50 ° of C, the following temperature of line 216 expressions: be higher than this temperature histiocyte death then takes place; Being lower than this temperature then organizes and will can not receive secular substantial influence (or any The Long-term Effect).
Curve A shown in Figure 6 is illustrated in what happens when carrying out or not carrying out electrode assemblie 214 coolings under relatively low power (for example, the about 10 watts RF energy) level.Curve A is divided into three sections A1, A2 and A3.The extension of phantom line segments A2 representative exponential curve A3 when not applying cooling.As viewed through curve A, when not cooling off, the temperature at electrode tissue interface reaches 80 ° of C, and index descends along with the increase of the distance in the tissue that gets into air flue 100.As shown in the figure, curve A 3 intersects with the dead boundaries of 50 ° of C histiocytes being represented by line 216 at about 5 millimeters degree of depth place.Therefore, during electrodeless cooling, the degree of depth that cell death takes place is served as reasons apart from represented about 5 millimeters of d1.Under this power level, further cell death will stop.
If adopt initiatively cooling, temperature drops to obviously lower level, for example, as curve A 1 represented be about 35 ° of C at 0 millimeter place in the electrode tissue interface distance.Because this temperature is lower than 50 ° of C, thus the point that intersects at the cell death line of curve A 2 and 50 ° of C apart from d2 (for example 3 millimeters the degree of depth) apart from the surface before cell death can not take place.From 3 millimeters to as cell death will take place apart from 5 mm depths of d3 representative.This cooling ablation procedure is favourable, because it allows cell death and disorganization to locate to take place in distance electrode-organizational interface's one segment distance (or distance range), and can not destroy the tissue under epithelial cell and the epithelial cell.In some embodiments, can melt the nervous tissue of walking and do not destroy epithelial cell or understructure, such as substrate and smooth muscle cell along the air flue outside.
Curve B is illustrated in what happens when carrying out or not carrying out the electrode cooling under the higher power level (like 20 watts RF energy).The extension of the exponential curve of the non-refrigerated situation lower curtate B3 of section B 2 representatives of curve B.Can find out; Electrode tissue temperature at the interface is near 100 ° of C; This is worthless, because at this temperature undertissue-electrode interface place tissue fluid boiling and tissue coagulation and carbonization will take place, and then can significantly increase tissue impedance and damage the ability of in airway walls, sending extra RF energy.Through initiatively cooling is provided, the temperature at curve B 1 show electrode-organizational interface place drops to about 40 ° of C, and at 2 millimeters the degree of depth to curve B 3 and 50 ° of about 8 millimeters degree of depth generation cell deaths that intersect on the dead border of C histiocyte like the d4 representative.Therefore, can find out that it is possible using higher power level the cell death in darker and bigger zone to be provided and not to reach undesirable high temperature (temperature that for example, causes coagulation of tissues and carbonization in electrode tissue at the interface).Said system can be used in and realizes the subsurface cell death of airway epithelia, thus do not need deface, thus help the patient from treatment, to recover as early as possible.
Curve C is represented higher power level, for example, and 40 watts RF energy.Curve C comprises section C1, C2 and C3.Dotted line section C2 is the extension of exponential curve C3.Section C2 shows that electrode tissue temperature at the interface far surpasses 100 ° of C, and under less than the refrigerative situation of active, is inappropriate.Using under the refrigerative situation of active; The temperature at electrode tissue interface is near 80 ° of C; And progressively raise and near 95 ° of C, exponentially property decline subsequently intersects at by about 15 mm distance of representing apart from d6 in electrode tissue interface apart from the airway epithelia surface with 50 ° of C cell death lines 216.Because initial temperature is higher than 50 ° of C cell death lines 216, it is dead from epithelial surface to about 15 millimeters degree of depth histiocyte will to take place, thereby disorganization big and dark zone is provided.
Fig. 7 has showed the cross section TEMPERATURE SPECTROSCOPY of one section airway walls, thereby the RF energy is sent ablation tissue through this section airway walls.Term " melts (ablate) " or the material alterations of electrical properties, engineering properties, chemical property or other character that " melting (ablation) " (derivative words that comprises them) includes but not limited to organize.Melt and to relate to breaking-up or permanent damage, damage or tissue damage.For example, melt that disorganization, lysis, the cell size that can comprise localization reduce, downright bad or above combination.Under the pulmonary ablation application background, term " melts " and comprises the character that changes nervous tissue fully, thereby blocks the nervous tissue of signal of telecommunication transmission through melting basically.
Isothermal curve is represented when power being applied to electrode assemblie 214 and with coolant (for example; The saline of room temperature or brine ice) when being delivered in the capsule 212, the temperature that the temperature that electrode assemblie 214 reaches and distance electrode-organizational interface 215 get into the different depth place of airway walls 100.Term " element (element) " under the background of " deployable elements (expandable element) " or " deployable elements (deployable element) " comprises independent component or a plurality of independent component.For instance, deployable elements can be a plurality of capsules of single capsule or fluid communication with each other.
Feed the speed of capsule 212 and the temperature of coolant and the size of capsule 212 through power delivery rate, the coolant of regulating counter electrode assembly 214 and can change isothermal line.Through selecting the power delivery rate of suitable coolant temperature and flow velocity and counter electrode assembly 214, realize that the temperature of A=60 ° of C of isothermal line, B=55 ° C, C=50 ° C, D=45 ° C, E=40 ° C and F=37 ° of C is possible.Further regulate and make that the temperature that realizes A=50 ° of C of isothermal line, B=47.5 ° C, C=45 ° C, D=42.5 ° C, E=40 ° C and F=37 ° of C also is possible.Have only 50 ° of C isothermal lines can be heated to and be enough to inducing cell death with interior those zones that comprise.In some versions, the tissue at about 2mm to 8mm degree of depth place can be melted in the airway walls, and other the non-destination organization less than 2mm degree of depth place will remain below the temperature that can cause cell death in the airway walls.
With reference to Fig. 8, conduit system 204 comprises control module 210, and control module 210 links to each other with the conduit with elongate bars 230 207.Deployed condition shown in capsule 212 can expand into from collapsed mode.When capsule 212 expands, can electrode assemblie 214 be moved to airway walls.Expansible capsule 212 can help electrode assemblie 214 is maintained near (for example, be close to said tissue or contact with said tissue) of tissue that delivery of energy passes through.Coolant can absorb heat energy and come cooling bladder 212 or electrode assemblie 214 or both.
Control module 210 generally includes controller 244 and fluid delivery system 246.Controller 244 includes but not limited to one or more processors, microprocessor, digital signal processor (DSP), field programmable gate array (FPGA) and/or special IC (ASIC), storage device, bus (bus) and power supply etc.For example, controller 244 can comprise the processor with one or more storage device intercommunications.Bus can be connected to processor with inside or external power source.Memorizer can adopt various ways, comprises, for example, one or more buffers, buffer (register), random-access memory (ram) and/or read only memory (ROM).Controller 244 also can comprise the display screen 245 and input equipment 250 such as screen.Input equipment 250 can comprise keyboard, touch pad etc., and can be operated by user and control conduit 207.
Controller 244 can be stored different programs.User can select to be used for the program of the characteristic of record organization and required target area.For example, the lung that is filled with air has high relatively impedance, and lymph node can have medium impedance, and blood vessel can have low relatively impedance.Controller 244 can be confirmed suitable program based on impedance.Can optimize performance based on the feedback of the pick off of detected temperatures, tissue impedance etc.For example, controller 244 can be controlled the operation of ablation member 208 based on tissue temperature.If the tissue surface temperature overheating can strengthen cooling and/or reduce electrode power, protect surface texture simultaneously thereby produce the deep layer damage.
Internal electric source 248 (dotted line is represented among Fig. 8) can be a power generator, such as radio frequency (RF) electromotor.Can be with required frequency output RF energy.The instance of frequency includes but not limited to the frequency range of about 50KHZ to about 1000MHZ.When the RF energy was directed in the tissue, energy was converted to heat in tissue, made the temperature of tissue reach about 40 ° of C to about 99 ° of C.Can apply the RF energy and continue about 1 second to about 120 seconds.In some embodiments, RF generator 248 has single passage and about 1 watt to the 25 watts RF energy of transmissibility, and has the ability of continuous-flow.Also can use frequency, interval and the power output of other scope.In addition, internal electric source 248 can be an energy accumulating device, such as one or more batteries.Can be with energy delivery to electrode assemblie 214, it converts electric energy to RF energy or another kind of suitable form of energy.Other form of energy that can be sent comprises microwave, ultrasonic, unidirectional current or electromagnetic energy.In addition, can utilize cryogenic ablation.Can send through bar 230 and be used for cooling off the low temperature heat exchanger on the ablation member 208 being in cryogenic fluid.
Fluid delivery system 246 comprises fluid source 260 that is connected in supply pipe 268 and the fluid container 262 that is connected in return pipe 272.Fluid source 260 can comprise the container that is contained in the outer cover unit 264 (for example, bottle, jar, groove or be used to hold the container of fluidic other type).In the embodiment that can pressurize, fluid source 260 comprise one or more can be to the pressue device (for example, one or more pumps, compressor etc.) of coolant pressurization.Temperature control equipment (for example, Po Er pastes (Peltier) device, heat exchanger etc.) can cool off or regenerative fluid.Fluid can be a coolant, comprises saline, deionized water, cold-producing medium, cryogenic liquid, gas etc.In other embodiments, fluid source 260 can be can preserve cold coolant and it is delivered to the heat-insulated container of supply pipe 268.Coolant distad flows through elongate bars 230 along delivery lumen 326, and fills ablation member 208.Flow through elongate bars 230 through return cavity 324 proximads from the coolant in the ablation member 208, and finally flow into container 262.
Pick off 247 (shown in the dotted line) is connected with controller 244 communications.Controller 244 can be based on controlling conduit 207 from the signal of pick off 247 (for example, pressure transducer, temperature sensor, thermocouple, pressure transducer, touch sensor etc.).Pick off can also place on the electrode assemblie 214, places or places on any other position along elongate bars 230.In the close loop maneuver pattern; Can energy delivery be arrived electrode assemblie 214 based on the feedback signal from pick off 247, said pick off can be configured to transmit the signal that (or transmission) shows one or more tissue signatures, Energy distribution, tissue temperature or any other measurable purpose parameter.Based on these readings, controller 244 is regulated the operation of electrode assemblie 214.In the open loop operator scheme, the operation of electrode assemblie 214 can be set by user input.For example, user can tissues observed temperature or impedance readings and manual adjustments power level.In addition, power supply can be configured to fixed power mode.In other embodiments, conduit system 204 can be switched between close loop maneuver pattern and open loop operator scheme.
With reference to Fig. 8 and 9, elongate bars 230 comprises power line chamber 320a-h, delivery lumen 326 and return cavity 324.Power line 280a-280h (being referred to as " 280 ") extends through power line chamber 320a-320h (being referred to as " 320 ") respectively and controller 244 and electrode assemblie 214 is coupled together.Can being processed by one or more following materials in whole or in part of elongate bars 230: metal, alloy are (for example; Steel alloy; Such as rustless steel), plastics, polymer and above combination and other biocompatible materials; And can be flexible, thereby can easily pass through hyperbranched air flue.
With reference to Figure 10 and 11, power line 280 from power supply 248 to electrode assemblie 214 delivery of energy.In some embodiments, power line 280 passes the outer wall of chamber 234 and capsule 212.In other embodiments, the adapter of electrode assemblie 214 is arranged in chamber 234.Power line 280 can extend between adapter and elongate bars 230, thereby avoids being exposed to body fluid.
Can operate adjacent electrode 229 with bipolar fashion, one of them electrode is anodal, and another electrode is a negative pole, makes it possible to the RF power delivery through tissue.If electrode 229 is a monopolar electrode, this electrode can be connected to independent power line 280 so, thereby allows to control independently each electrode.Perhaps, electrode 229 can be connected to same power line so that co-operate.
Capsule 212 in whole or in part can be by polymer, plastics, silicon, rubber, polyethylene, polrvinyl chloride, chemical inert material, non-toxic materials, electrically insulating material or above materials such as combination are processed.Heat passage for strengthening, the capsule sidewall can comprise one or more Heat Conduction Materials with high heat conductance.For example, heat conduction bar (for example, bonding jumper) can help heat energy is come out from focus (if any) conduction.Capsule 212 (for example can conform to airway surface; Cartilaginous ring; Side is propped up etc.) on irregularly shaped, and can process by following material in whole or in part: expandable material, such as polyurethane (for example; Low hardness polyurethane) or the highly conforming properties material of other type, said material can be transparent, translucent or opaque.Capsule 212 can have different expanded shape, comprises hot dog shape, oval, cylindrical etc.For handler's bronchial tree, the diameter D of swelling bag 212 can for about 12mm to about 18mm.For the motility of enhancement process, the diameter of expansible capsule can for about 5mm to about 25mm.The size of capsule 212 can be set to other organ or tissue that can handle other animal.Shown in figure 11, expand in order to make capsule 212, fluid is sent and through inlet 225 along delivery lumen 326.Coolant flows along return cavity 324 proximads at chamber 234 internal recycle then.
Figure 12 and 13 has showed an illustrative methods utilizing processing system 200.With before implementing treatment, during the treatment and/or after treating, can observe air flue 100 and locate and evaluation process site and non-destination organization.Access to plant 206 can be guiding tube, delivery sheath, tracheascope or endoscope, and can comprise one or more finders, such as optical viewing arrangement (for example, photographing unit), optical system (for example a, set of shots) etc.Can stimulate (for example, electricity irritation) zones of different, to confirm the position of air flue nerve trunk or morbid state along the air flue circumference.The airway smooth muscle in distally that can be through measuring the point of implementing to stimulate along airway length shrinks the detection that realizes bronchoconstriction.Can change through the pressure of monitoring expansible capsule or the pick off of air flue nearside or other type of contacting with air flue is measured muscle contraction.Said technology can minimize or limit the circumferential area of the air flue that is processed, thereby reduces or eliminate the risk of airway constriction.Can confirm nerve location through following manner: measure the electroneurographic signal of the point on the air flue circumference, with the position of confirming that air flue is neural.Can use air flue nerve signal stimulus object to increase the nerve signal amplitude, thereby be convenient to the air flue nerve signal location around the air flue circumference such as cold air, histamine or phenyl two guanidines.
When body cavity moves the access to plant 206 of Figure 12, the ablation member 208 of subsiding is maintained in the service aisle 386.Ablation member 208 is distad shifted out working chamber 386 and makes its expansion, thereby electrode assemblie 214 is moved to (for example, contacting near airway walls or with airway walls) near the airway walls.The RF energy can come heat tissue (for example, textura epidermoidea and deep tissues) through tissue, thereby forms damage in the target area.Target area and relevant damage are substantially corresponding to the dotted line of Figure 13 and 14.
The term " damage " that this paper uses is meant that by the tissue of permanent destruction promptly, phalangeal cell is dead.In some cases, energy is sent the cell beyond the zone that is called " damage " is caused destruction temporary transient or non-lethality.For example, energy as herein described is sent and can temporarily be destroyed or change epithelial cell or smooth muscle cell.Yet advantageously, through using the difference cooling, these cells can recover and keep function, therefore are not considered to the part of said " damage ".By contrast, ablation member 208 can be to being positioned at the airway walls depths or causing permanent damage at airway walls outside nervous tissue or other destination organization, thereby weaken the nerve signal that causes some pneumonopathy.
The cooling section 209 contact airway walls 100 of Figure 13, thus can cools tissue when electrode assemblie 214 output energy.It is this that to carry out the heating of top layer and deep layer and carry out the refrigerative clean effect in top layer through circulating coolant through the RF energy be with the skin of heat accumulation to airway walls 100.The temperature of connective tissue can be higher than the temperature of epithelium, substrate and/or smooth muscle.For example, the temperature of connective tissue is can be enough high and can cause damage to nerve trunk tissue or other deep tissues, makes other non-destination organization of air flue remain on lower temperature to prevent or to limit the damage to non-destination organization simultaneously.
Figure 13 and 14 has shown the independent damage 237a-h in eight places (being referred to as " 237 ").Adjacent damage 237 axially departs from along the longitudinal axis 233 of ablation member 208 each other.Shown in figure 14, every place damage 237 can have the arc length of about 45 degree, makes the whole circumference of the basic upper edge of damage array airway walls 100 extend.The length of exposed electrodes element is corresponding to the width of damage 237.Can select the length (for example, the length of electrode member 231d, 231e) of exposed electrodes element based on the desired width of damage 237.Advantageously, can form damage 237 simultaneously.For example, can form all or most damage 237 simultaneously, to avoid between ablation process, to move ablation member.In other embodiments, thus can start different electrode 229 forms damage in succession.Can electrode assemblie 214 be moved to different positions and melt different tissues.Therefore, can side by side or one after the other carry out the one or many damage based on required processing.
Utilize conventional ablation catheter, ablation procedure can be enough to cause cicatrization, and said cicatrix possibly cause partial air flue constriction or narrow.Because the diverse location that damage 237 is in along airway length is so can alleviate narrow influence.Shown embodiment is very suitable for cutting off the innervation of air flue, avoids forming successive scar tissue ring simultaneously.The continuous scar tissue ring of spending along the inner periphery extension 360 of air flue 100 can significantly reduce the sectional area in air flue chamber, and then significantly increases gas-flow resistance.Staggered damage 237 can help to alleviate reducing of air flue chamber cross-sectional area.
Figure 14 has shown and has damaged 237 position.Shown in figure 14, damage 237 exterior contour along the major axis of air flue 100 and with the virtual plane of said axis on projection define successive basically closed hoop.Because nerve trunk 45 along air flue 100 longitudinal extensions, can be in the degree of depth that sufficient to guarantee melts all nerve trunk so damage 237.In other embodiments, electrode assemblie 214 can only be used to handle the part of air flue circumference, for example 180 of air flue circumference degree, 150 degree or 130 degree.This maybe be just enough for the innervation of effective cut-out air flue 100.Therefore, can effectively cut off nerve signal and can not form the damage of extending, and this can further reduce narrow formation along whole airway walls.
During RF melted, heat can be concentrated in one or more internal layers (for example, substrate) of airway walls or concentrate in the inner membrance (for example, epithelium) of airway walls.And the one or more blood vessels in the arteriae bronchiales branch can be positioned at damage.Can control the heat that uses electrode 214 to be produced, make that the ramose blood of the arteriae bronchiales of flowing through can protect these branches to avoid the hot injury, even said nervous tissue is positioned near the said arterial branch when the nerve trunk tissue is damaged.Conduit 207 can produce relative cell death than the zonule.For example, can destroy in the middle of the airway walls 100 or along the tissue of 2mm to the 3mm section of the outer surface of airway walls 100.Through using suitable power and suitable cooling, can produce damage in any desired degree of depth.
The resistance of air flue cartilaginous ring or cartilage layers is usually significantly greater than the resistance of air flue soft tissue (for example, smooth muscle or connective tissue).The air flue cartilage hinders energy stream (for example, electric radio-frequency current), and makes when electrode during near cartilage, forms therapeutic by radio-frequency electrical energy and damages and influence the air flue nerve trunk and become challenging.
Shown energy emitter 214 can be used as energy emitter between cartilage.The size of electrode member 227 can be set to the interval that meets cartilaginous ring 235a, 235b (being referred to as " 235 ") substantially.Shown in figure 13, each electrode member 227 is placed between two adjacent ring 235a, the 235b, makes damage 237 place fully in the space 333 of 235 of cartilaginous rings.
Electrode 229 can be used as localizer between cartilage, and its preferential help is seated in electrode member 227 in the space 333, and then makes and be easy to handle or be easy to examine correct positioning.For example, electrode member 227 can outwards be given prominence to and be easy to move into and coupling is more softish, in the better space 333 of compliance.Thereby electrode 229 can be used for indicating ablation member 208.
Figure 15 has shown electrode, and this electrode is the monopolar electrode that connects through a power line.Can simultaneously electric power be delivered to said electrode.Can place any amount of electrode along capsule 212.For example, can be along the circumference of said capsule one or more electrodes at interval equably or unevenly.
Figure 16 has shown that direction has the electrode 310a-310c (being referred to as " 310 ") at oblique angle with respect to the longitudinal axis 312 of ablation member 300.Power line 316a-316c (being referred to as " 316 ") is to dividing other electrode 310 that energy is provided.(although do not show, can other electrode be placed on the invisible rear side of ablation member 300).Electrode 310 can be a bipolar electrode.For instance, electrode 310a can comprise electrode member 318a, 319a, and electrode member 318a, 319a can positive and negative (or negative electrode and anodes), so as between element 318a, 319a transmission RF energy.
Can based on circle spacing of expecting between the length, adjacent damage of the damage that will form wait the angle [alpha] of selecting between electrode 310 and the longitudinal axis 312 directions.Shown angle [alpha] is about 45 degree.If desired or hope, also possibly be other angle.Can exist between the adjacent electrode 310 be untreated, unmarred tissue regions.
Shown in figure 16; Place damage by electrode or electrode pair 310a produce is overlapping with the start-up portion of next the place's damage that is produced by electrode adjacent on the circumference or electrode pair 310b in a circumferential direction, thereby guarantees to handle the whole circumference (or its part) of tubular body structure.If an end of the damage that is produced through electrode 310a is vertically drawn a virtual line, near the end of this virtual adjacent damage that line and 310b produced is crossing or approaching so.Therefore, the end of adjacent damage axially departs from and overlapping in a circumferential direction along axle 312.
Figure 17 has shown ablation member 400, and it comprises extensible basket 414 and electrode 413,415.Basket 414 comprises hollow member, and the coolant said hollow member of can flowing through is come cooling electrode 413,415.Can select the longitudinal length of basket 414, make basket 414 extend across a plurality of cartilaginous rings.Electrode 413,415 can be placed between the said ring.For example, microscler basket 414 can extend across at least three cartilaginous rings (by vertical dotted line 431,432,433 expressions of Figure 17).Electrode 413 is placed on cartilaginous ring 431, between 432.Electrode 415 is placed on cartilaginous ring 432, between 433.When basket 414 launched, the distance B that the electrode of adjacent rows is 413,415 was equivalent to the distance between cartilaginous ring substantially, and then guarantees that electrode 413,415 can be seated between cartilaginous ring.Electrode 413a can have first polarity, and electrode 413b can have antipole property, makes energy between said electrode, to flow.Electrode pair 413a, 413b and adjacent electrode depart from certain angle to 415a, 415b, thereby form on the circumferencial direction overlapping and in axially spaced damage.Overlapping D can handle the whole circumference of air flue apart from sufficient to guarantee.
Figure 18 has shown that along the chamber 427,429 flow and the fluid through decompression member 423,425 respectively.Term used herein " decompression member " is meant, and is not limited to, and is configured to reduce the device of the pressure of working fluid.Decompression member can be reduced to the pressure of working fluid the pressure for vaporization that is equal to or less than working fluid.Working fluid can comprise cold-producing medium (for example, low-temperature refrigerant or non-low-temperature refrigerant).In some embodiments, the form of decompression member is air relief valve or expansion valve, and they can make at least a portion vaporization of the working fluid that therefrom flows through.The working fluid (for example, cold-producing medium, cryogen etc.) of decompression member vaporization effective dose is to reduce the temperature of working fluid.In some patterns, the almost whole or most of working fluid through element 423,425 is converted into low temperature, low-pressure gas by weight.In some embodiments, decompression member 423,425 can be the valve that nozzle group valve, needle valve, Joule-Thomson valve, throttle element or any pressure that other is suitable for providing required descend.For example, Joule-Thomson valve can cause lower downstream temperature from the reclaiming by swelling work capacity of liquid.In some embodiments, can enough Flow-rate adjustment elements (for example, valve system) substitute decompression member, be under the situation such as the non-cold-producing medium of water especially at working fluid.
With reference to Figure 18, the gases at high pressure P of Figure 18
1Through delivery lumen 427,429.Gases at high pressure P
1Through element 423,425, and admission passage 436,438, pressure drops to P in passage 436,438
2Pressure is from P
1Drop to P
2Cause gas temperature from T
1Drop to T
2The amplitude of variations in temperature is by computes:
T
1-T
2=μ(P
1-P
2)
Wherein
T is the temperature of gas;
P is the pressure of gas;
μ is the Joule-Thomson coefficient of gas;
Subscript 1 expression condition of high voltage; And
Subscript 2 expression low pressure conditions.
As combine Figure 19 and 20 to be discussed, when the gas in the passage 436,438 is discharged through outlet and dropped to ambient pressure, second pressure takes place descend.If ablation member 400 is used for respiratory system, then ambient pressure is an atmospheric pressure.This temperature drops to:
T
2-T
3=μ(P
2-P
ATM)
Joule-Thomson coefficient (μ) is special for every kind of gas or admixture of gas.The standard temperature value of μ is:
Carbon dioxide
Air
These coefficients show, descend CO for given pressure
2The temperature suppression ratio that causes descends big 5 times by the similar pressure that air produces.
It is desirable in lung, using air.Can use carbon dioxide, but condition to be the flow velocity of coolant gas enough low and be no more than individuality this extra carbon dioxide is discharged the outer ability of lung.If the coolant in the ooling channel is the highly pressurised liquid such as liquid air or liquid carbon dioxide, then cooling effect can be enhanced.Also experience is from the heat absorption phase transformation of highly pressurised liquid to gases at high pressure through decompression member (for example, choke valve) for highly pressurised liquid, and this makes the temperature of gas be lower than the temperature of highly pressurised liquid.Then, discussed as combining Figure 19 and 20, before discharging through outlet 441, this gas is through the P that associates
1To P
2Joule-Thomson expansion, temperature is further descended.
Figure 19 and 20 has shown the ablation member 437 similar substantially with 18 ablation member 400 with Figure 17, but following details difference to some extent.Ablation member 437 comprises along the opening of long element setting or exports 439 array.The coolant of long element of flowing through can spill to cool off contiguous tissue from opening 439.In addition, be arranged on the opening of far-end 443 or export 441 and can discharge coolant.Shown in figure 20, the coolant of representing with arrow can spill from exporting 439,441.By this way, coolant can cool off ablation member 437 and direct tissue cooling can be provided.Randomly, the pressure that outlet 441 can be configured to provide suitable descends, thereby makes coolant Joule-Thomson expansion vaporization by mentioned earlier, reduces coolant temperature thus.
Figure 21 has shown ablation member 450, and it has along deployable member 453 at the isolated V-arrangement electrode of circumferencial direction.Electrode 455 has end 456,457, and the tip 459 of end 456,457 and adjacent electrode 455 is overlapping.Electrode can be to V-arrangement target area output energy, and said V-arrangement target area is opened and formed the V-arrangement damage along the air flue circle spacing equally.Untreated tissue between V-arrangement damage can assist in ensuring that the air flue chamber can be owing to scar tissue or narrow and significantly narrow down.
Figure 22 has shown ablation member 460, and it comprises the extensible element 462 that carries T shape electrode.Electrode 463 has free terminal 464, and free terminal 464 is overlapping with the end 465 of adjacent electrode 467.The electrode 461 of alignment can form the damage that many places are substantially T shape in a circumferential direction.In other embodiments, electrode can be U-shaped, S shape, W shape, L shaped or any other suitable shape.In addition, in any one of these embodiments, electrode can with electrode shown in Figure 16 similarly with the pattern vertical misalignment of oblique or spiral.
Figure 23 has shown ablation member 500, and it comprises and can electrode 512 be placed on first group leader's shape member 511a-511d (being referred to as " 511 ") between the cartilaginous ring 513,515 (showing with dotted line).Long element 521a-521d (being referred to as " 521 ") carries and is placed on cartilaginous ring 515, the electrode 523a between 518,523b, 523c, 523d (being referred to as " 523 ").Electrode 512 forms damage at ring 513, between 515.Electrode 523 forms damage at ring 515, between 518.Long element 511,521 can be flexible or elastic bar or line; They are radially outward setovered; Make electrode against airway walls; And they are configured to use each electrode pair can handle the different circumferential area of airway walls with being placed on the position of departing from a circumferential direction with respect to electrode 512 by electrode 523, making.One end of the damage between collagen in the gap in a circumferential direction can and adjacent collagen between the adjacent damage in gap overlapping.Thereby damage separates each other on can be axially, but overlapping with respect to body cavity in a circumferential direction.Long element 511,521 can be contracted in the tubular sheath 510, makes long element 511,521 collapse to the radial contraction configuration that is suitable for importing in the air flue.
Figure 24 has shown the ablation member 600 with extensible energy emitter assembly 610.Extensible electrode assemblie 623 can surround the whole or most of of extensible member 620, and extensible member 620 is shown as capsule.Insulator 625 extends between the end on the part of electrode assemblie 623.Electrode 623 can have zigzag configuration (demonstration), curl shape structure or waveform structure, thereby can allow expansion and can around capsule 620, extend about 90 degree to about 360 degree.During use, exposed electrodes 623 can be regional towards pending air flue, for example, and the rear side that nerve trunk is usually located at.Perhaps, emitter assemblies 610 can comprise a plurality of exposed electrodes, and said electrode is separated by insulated part, thereby produces dispersive damage.
Randomly, second energy emitter 618 is placed on the distally of energy emitter 610.Energy emitter 618 has exposed electrodes 621 and insulator 623.Electrode 621 can cooperate with electrode 623 and form and depart from a circumferential direction and damage at axially spaced-apart complementary (for example, eclipsed).For example, electrode 623 can form the damage that arc length is about 180 degree along the top of airway walls.Electrode 621 can form the damage that arc length is about 180 degree along the bottom of airway walls.The damage of two places is extended along the whole circumference of airway walls jointly.Can produce or produce in succession damage simultaneously.
Figure 25 has shown ablation member 700, and it comprises the energy emitter of electrode assemblie 710 forms, and electrode assemblie 710 is wrapped in around the extensible element 712.Electrode assemblie 710 comprises pipeline 731 and a plurality of electrode 715a-h (being referred to as " 715 ").Electrode 715 can while or formation damage in succession.
With reference to Figure 26, electrode 715a can be the tubular metallic member of hollow, and when capsule 712 expanded, said electrode was directed with the cardinal principle circumferencial direction.Pipeline 731 is sent coolant (saline or other coolant) continuously through electrode 716.
Can different coolants be sent through capsule 712 and pipeline 731.Can flow through delivery lumen 761, the pipeline 731 of flowing through of coolant come cooling electrode 715.Can flow through delivery lumen 751 and flow into capsule 712 of another coolant.Coolant in capsule 712 and the pipeline 731 can flow to nearside through return cavity 739.In other embodiments, the coolant Continuous Flow is through electrode assemblie 710 and capsule 712.
Can independent lead pair be electrically connected with each electrode 715.Can operate each electrode 715 independently.In other embodiments, electrode 715 is bipolar, and it is paired to be arranged to antipole property.As about before embodiment said, thereby electrode 715 is can be relative to each other directed and place and form the damage in the space between cartilage.With the U.S. Patent application of submitting on May 8th, 2009 the 12/463rd; The U.S. Patent application the 12/913rd that No. 304 and on October 27th, 2010 submit to; Incorporate this paper by reference in full into No. 702, above-mentioned patent application discloses can be with technology, material, conduit and the parts of ablation member 700 uses.
Temperature through regulating coolant, coolant flow speed, the heat-carrying capacity of coolant, the thermodynamic behaviour (for example, the heat transfer performance of capsule) or the amount of delivered power of capsule can be controlled the damage shape.Figure 27 A-31B shows through formed temperature spectrogram of the cooling that progressively improves capsule and corresponding damage.Can be through reducing coolant temperature or improving coolant flow speed or both improve the cooling capacity of capsule.Change the coolant capacity of electrode simultaneously or, also can realize setting through the cooling capacity substantially constant that keeps capsule damage through improving or reducing the power that is delivered to tissue.For instance, the ablation member 700 of Figure 25 can be used in the damage that forms Figure 27 B, 27C, 28B, 29B, 30B and 31B.Because the diameter of capsule 712 is greater than the diameter of electrode channel 753, so than the high velocity stream through electrode 715a, relatively low along the flow velocity on capsule surface.Produced the difference cooling like this.Flow if electrode 715a and capsule 712 have independently, then coolant can be in different temperature and/or flow velocity to be used for the difference cooling.
80 ° of C of isothermal line in Figure 27 A display organization, 60 ° of C and 40 ° of C and Temperature Distribution.Figure 27 B shows the isothermal damage 804 corresponding to Figure 27 A.The only coolant that can absorb a large amount of heats of coolant in the cooling duct 753.Capsule 712 does not absorb great amount of heat energy and can be filled with temperature and equals room temperature or the fluid in the scope of about 20 ° of C-30 ° of C substantially.In some embodiments, utilize surrounding air to come swelling bag 712, and capsule 712 can keep electrode 715a against tissue 825.In other embodiments, utilize warm saline to come swelling bag 712.Damage 804 has and is substantially semicircular shape.Can increase or reduce radius r and depth D through the temperature that reduces or improve coolant in the cooling duct 753 respectively.In addition or alternatively, can increase or reduce radius r and depth D through the flow velocity that reduces or improve coolant respectively.
Can cold coolant be sent through capsule 712 to reduce the cross-sectional width of the damage on the tissue surface 825.Figure 28 A and Figure 28 B show when coolant cools electrode 715a and when cryogenic coolant with low-speed flow the isothermal line during through capsule 712 and be substantially oval-shaped damage 804 accordingly.Coolant in the capsule 712 absorbs the heat energy of capacity, thereby protection contacts with capsule-organizational interface or contiguous tissue.(comprise the embodiment shown in Figure 28 B) in some embodiments, damage 804 cross-sectional widths on the surface 825 are less than the cross-sectional width of the damage 804 on surface 825 among Figure 27 B.The cross-sectional width of the damage 804 of Figure 28 B increases to Breadth Maximum W with the degree of depth
Maximum, and drop to the darkest zone 830 subsequently.Breadth Maximum W
MaximumDepth D less than damage 804.The width of the damage 804 on Figure 28 B display surface 825 is not more than about 150% of electrode width.
Figure 29 A and Figure 29 B show when cryogenic coolant with high velocity stream through the coolant of capsule 712 or extremely low temperature with low-speed flow the isothermal line during through capsule 712 with damage 804.Similar lachrymal damage 804 is extended from tissue surface 825.The shallow-layer of damage 804 or the width of narrow zone 834 approximate the cross-sectional width W of electrode 715a
ETherefore, the maximum cross-section width that has of the damage 804 of surface on 825 is not more than about 150% of electrode tissue interface.This has guaranteed to destroy the surface texture of minimum.Damage 804 outwards narrows down from shallow-layer part 834 to the zone 835 that enlarges gradually.The damage cross section width increases to Breadth Maximum W gradually with the degree of depth
MaximumBreadth Maximum W
MaximumCan be than the cross-sectional width about 1 on surface 825 to about 5 times.The darkest zone 830 of damage 804 is a part circular.
Figure 30 A and 30B show that the coolant when extremely low temperature damages 804 with isothermal line and tear drop shape that high velocity stream can form through through capsule 712 time.Damage 804 is from tissue surface 825 extensions and have narrow shallow-layer zone 834, and this shallow-layer zone 834 outwards extends to wide by dark regional 852 fast.The width in shallow-layer zone 834 is less than the width W of electrode 715a
ECross-sectional width is rapidly increased to Breadth Maximum W with the degree of depth
MaximumTherefore, most of volume of damage 804 is positioned at and organizes the depths.
Figure 31 A and Figure 31 B show that isothermal line that coolant when extremely low temperature can form during through capsule 712 with high velocity flow circularly damages 804 with corresponding.Damage 804 is positioned at from the depth D of tissue surface 825.The maximum cross-section width W of damage 804
MaximumIn depth D
Breadth MaximumThe place.Damage 804 and electrode tissue interface be separate and can have different shapes according to the flow velocity and the temperature of coolant.The difference cooling can be used in and obtains other damage shape of imbedding, such as being substantially ellipse, elongated shape etc.
Can select D according to the position of target area
Breadth MaximumIn order to destroy nervous tissue, D
Maximum WidthCan be at least about 2mm to guarantee damage and comprise nervous tissue and to alleviate or avoid smooth muscle tissue is caused obvious impairment.These embodiments are highly suitable for handling airway walls, because the degree of depth of smooth muscle tissue is not less than 2mm usually.By this way, the cross-sectional width of target area can reach maximum in the degree of depth darker than smooth muscle tissue.Most (and whole basically in some embodiments) damage is arranged in the tissue of non-flat muscular tissue, and its position in airway walls is darker than smooth muscle tissue zone usually.In addition, can be to any destruction of the smooth muscle cell in the airway walls less than under the situation of not destroying nervous tissue, changing the reactive of air flue in fact or shrinking (such as because asthma, COPD or other pneumonopathy) required destructive amount.
Damage can separate through protection zone and tissue surface, a large amount of organizing not by permanent damage in the protection zone.Figure 31 B and Figure 32 B display depth are D
PProtection zone 861.Advantageously, because organizing in a large number not by permanent damage in the protection zone 861, its function of organization can be retained.The D of the degree of depth
PCan be at least about 1mm to about 2mm to melt nervous tissue.
Figure 32 has shown spiral type ablation member 900, and it comprises crooked (being shown as spiral type) main body 910 (be shown as be tapered with the coupling air flue gradually thin) and electrode 912a, 912b, 912c (being referred to as " 912 ").Randomly, can one or more decompression members be placed in the main body 910 and serve as Joule-Thomson valve, thus the temperature of reduction coolant.
Therefore electrode 912 can be similar each other substantially, and be applicable to other electrode for the description of an electrode with also being equal to, only if point out in addition.Electrode 912a comprises a plurality of outlets 916,918.The coolant of being represented by arrow can flow out outlet 916,918.Electrode 912a can be connected with the outer surface of main body 910.This allows electrode 912 outwards outstanding enough distances, thereby can contact with organizing physics.The arrangement of electrode 912 can produce such damage; Said damage departs from a circumferential direction each other; But have the overlapping of some circumferencial direction at its edge, the dummy line of promptly vertically drawing through the end of place damage downwards along air flue will intersect with the end of next place's damage.Because electrode 912 is spaced apart along spirillum 910, thus the damage that they produced air flue axially on also spaced apart, and then reduce narrow probability.
Randomly, can place capsule through interior zone 920.Can the capsule of the capsule that is substantially conical capsule, columniform capsule, hot dog shape or other suitable shape be inserted interior zone 920.
Figure 33 has shown the spiral type ablation member of being processed by tubulose conductivity internals 952; Said ablation member 952 has the exposure section that array of spaced forms electrode 960a, 960b, 960c (being referred to as " 960 "), and on spacer segment, has the insulation covering to form insulating regions 962a, 962b, 962c.Coolant can be through ablation member 520 circulations with cooling electrode 960.For extra tissue cooling is provided, randomly, the outlet (not shown) during coolant can cover through inner tubular member and/or insulating properties is sent away.
Figure 34 has shown the ablation member 1000 that comprises isolated bipolar electrode 1010a-f (being referred to as " 1010 ") array.Electrode arrangement is that opposite polarity is right, make each bipolar between obliquely produce damage.Electrode 1010 can form the oblique damage of crossing over cartilaginous ring.Shown in figure 35, ablation member 1000 is placed in the air flue 1012.Electrode 1010 is placed between the said ring.Electrode 1010a-c can produce the damage 1030 of Figure 36.One end 1032 of damage 1030 is near ring 1034.The other end 1036 adjacent loops 1038.Terminal 1032,1036 along axially skew each other of air flue 1012.Shown in figure 36, terminal 1032,1036 axial dipole field is significantly greater than terminal 1032,1036 circumferential distance.In some scheme, terminal 1032,1036 distance is at least 1 millimeter, 5 millimeters, 10 millimeters.In some embodiments, terminal 1032,1036 axial distance is greater than the distance between adjacent cartilaginous ring.This guaranteed the damage can cross over said ring.
The centre portion of the damage 1030 of Figure 36 is crossed over ring 1034, the ring between 1,038 1040. Electrode 1010d, 1010e, 1010f at ablation member 1000 dorsal parts form damage 1041.Shown damage 1041,1030 is positioned at offside and is in the different axial positions along air flue.
Figure 37 and 38 shown depart from a circumferential direction and spaced apart in the axial direction, can carry out refrigerative electrode 1050a, 1050b through internal spray.Coolant flow 1054 leaves through delivery lumen 1052 and after opening.The coolant that sprays flows with cooling electrode 1050a along the cooling duct 1056 of opening.Coolant leaves chamber 1060 through outlet 1062a, 1062b.Coolant flows along return cavity 1072.When cooling, can operate electrode 1050a, 1050b with monopolar mode or double pole mode.
Figure 39 A-40B has shown ablation member 1080, and it comprises the energy emitter of electrode assemblie 1082 forms.Electrode assemblie 1082 comprises electrode 1084a-f (being referred to as " the 1084 ") array that can form damage 1083 (Figure 39 B and 40B).Can form a large amount of dissimilar curl shape, curved, zigzag, Z-shaped or structure that other are different.Shown damage 1083 is substantially spiral type and crosses over a plurality of cartilaginous rings.Ablation member 1080 can have any amount of this type electrode assemblie 1082.For example, can a pair of spiral type ablation member 1082 be placed on the outside of ablation member 1080.
Shown damage 1083 is successive, and has the end of opening along major axis 1089 axially spaced-aparts of air flue 1085,1087. Terminal 1085,1087 also angled each other departing from.Shown in Figure 39 B and 40B, terminal 1085, between 1087 along the distance of axle 1089 greater than the distance between the adjacent ring.Like this, a plurality of rings are crossed in damage 1083.
Electrode 1084 can be closer to each other and the successive basically damage 1083 of formation.The distance that in other embodiments, can increase by 1084 at electrode is to provide many places isolated damage.Isolated damage can be arranged in and damage 1083 shapes similar, but also possibly be other shape and pattern of lesions.
Figure 41 has shown ablation member 1100, and it has the electrode assemblie 1110 that is wrapped in around the capsule 1111.Electrode assemblie 1110 comprises the pipe 1113 that is suitable for holding coolant, and has the far-end 1115 with the internal communication of capsule 1111.Electrode is installed, is adhered to, sprays or otherwise is connected in the outside of pipe 1113.By this way, can coolant be delivered to the inside of capsule 1111 through conduit, with swelling bag 1111, coolant is from capsule 1111 flowing pipes 1113, and then cooling electrode.Perhaps, coolant can cooling electrode, and cooling bladder 1111 subsequently.Electrode assemblie 1110 can provide difference cooling, the damage that has certain shape with formation with capsule 1111.
Figure 42-44 has shown and can move to the ablation member 1200 of launching configuration (Figure 43 and 44) from sending configuration (Figure 42).In sending configuration, the distal part of ablation member 1,200 1211 is lined up line with the portions of proximal of catheter shaft 1213, so that the air flue that is inserted with ablation member 1200 or the longitudinal axis of other body cavity align substantially.In launching configuration, the distal part 1211 crooked or distortion of ablation member 1200, thus form ring 1215, the plane that ring 1215 is positioned at transverse to the longitudinal axis of catheter shaft 1213 near-ends.By this way, ring 1215 can extend in the periphery of inner wall of air flue, thereby electrode 1220 is placed spaced positions place on a series of circumferencial directions of air flue.
In launching configuration, said ring can be spiral or can be positioned at the plane that becomes oblique angle with the longitudinal axis of catheter shaft 1213, makes electrode 1220 be placed in the position that axially separates along airway walls.Can utilize various known means to launch to encircle 1215.For example, draught line can extend through the chamber of catheter shaft slidably, and is fixed near the point the far-end, makes tension force on the draught line will encircle 1215 and is launched into required configuration.Perhaps, the distal part of conduit can be disposed for launching by pre-setting, and can be resilient, makes distal part between delivery period, can be compressed in the sheath, then, is released through the said sheath of withdrawing, and makes distal part recover to launch configuration.
Delivery apparatus disclosed herein can be handled digestive system, nervous system, vascular system or other system.For example, can handle vascular system through vascular delivery elongate member disclosed herein, tube chamber inner catheter and delivery apparatus.Processing system disclosed herein and parts thereof can be as the attached means of other medical care precess; Said other therapy is such as Wicresoft's operation, open-sky technique, semi open model operation or other operation technique (for example, lung volume dwindles operation) that arrives required target spot can be provided.Various thoracic surgeries can provide the entering lung tissue.Be used to provide the entering technology and the method that arrive the target area to carry out by doctor and/or robot system.Those skilled in the art understand the multiple diverse ways that can arrive the target area.
Lead, delivery sheath, optical instrument, introducer, sleeve pipe, biopsy needle or other suitable medical apparatus can be used to guide said delivery device.If the target processing site is in patient's distal position (for example, near the treatment site the radix pulmonis 24 of Fig. 1), then a lot of instruments and technology can be used in and arrive the site.For example, use such as the exercisable delivery apparatus of aforesaid endoscope and tracheascope and can be at an easy rate the elongate member of flexibility be positioned in the individual's body.
Semi-rigid or rigid elongate assembly can be sent in the following manner: use sleeve pipe, access port, use semi open model operable rigid delivery sheath, open-sky technique that more straight other means of delivery/method of sending passage maybe can be provided.Advantageously, the rigidity of semi-rigid or rigid elongate assembly can be enough strong, thereby arrive and handle tissue at a distance, such as vagus nerve, nervous ramification, nerve fiber and/or along the nerve trunk of air flue, and do not send elongate member through air flue.Embodiment disclosed herein and technology can be used with other operation, such as bronchus hot forming art.
Only if context has requirement in addition; Whole description and claim are all followed: word " comprises (comprise) " and alternative word; Such as " comprising (comprises) " and " comprising (comprising) "; All should be interpreted as implication open, that comprise, promptly be interpreted as " including but not limited to ".
Can be with above-mentioned different embodiments combination so that other embodiment to be provided.Under the instruction of the detailed description of preceding text, can carry out these to embodiment and change and other change.Embodiment disclosed herein, characteristic, system, device, material, method and technology in some embodiments with the described embodiment of following document, characteristic, system, device, material, method and technology in any one or a plurality of similar: the application the 12/463rd that on May 8th, 2009 submitted to; The U. S. application the 12/913rd that on October 27th, No. 304 1 submitted to; The U.S. Provisional Patent Application the 61/255th that on October 27th, No. 702 1 submitted to; No. the 61/260th, 348, the U.S. Provisional Patent Application of submitting in No. 367 and on November 11st, 2009.By reference each integral body in these applications is integrated with this paper.In addition; Embodiment described herein, characteristic, system, device, material, method and technology can be applied to above-mentioned U.S. Patent application series the 12/463rd in certain embodiments; Disclosed embodiment, characteristic, system, device, material, method and technology or use in No. the 12/913rd, 702, No. 304 and the U. S. application submitted on October 27th, 2010 with their combinations.For example, disclosed device can merge electrode disclosed herein or further feature in No. the 12/913rd, 702, No. the 12/463rd, 304, U.S. Patent application series and the U. S. application submitted on October 27th, 2010.
In addition; Embodiment described herein, characteristic, system, delivery apparatus, material, method and technology can be applied to the application the 12/463rd of submission on May 8th, 1 in certain embodiments; The U. S. application the 12/913rd that on October 27th, No. 304 1 submitted to; 702, the U.S. Provisional Patent Application of submitting on October 27th, 2009 the 61/255th; Any or multiple in U.S. Provisional Patent Application the 61/260th, No. 348 disclosed embodiment, characteristic, system, device, material, method and technology of submitting in No. 367 and on November 11st, 2009 or be used in combination with them.
Usually; In following claims; Used term should not be interpreted as claim is limited to description and the disclosed specific embodiments of claims, and should be interpreted as all possible embodiment of the equivalent way of the four corner that comprises that claim is represented.Therefore, claims do not receive the restriction of disclosure.
Can other embodiment be provided with each embodiment combination mentioned above.The whole United States Patent (USP)s, the U.S. Patent application that go out with the application materials tabular that this description is quoted is open, U.S. Patent application, foreign patent, foreign patent application and non-patent publications are incorporated this paper by reference in full into.If necessary can utilize the design of different patents, application and publication to change the various aspects of said embodiment, thereby other embodiment is provided.
Under the instruction of the similar description of preceding text, can carry out these to said embodiment and change and other change.Usually; In following claims; Term should not be interpreted as claims are limited to this description and the disclosed concrete embodiment of claims, and should be interpreted as all possible embodiment of the four corner of the equivalents that comprises that these claim is enjoyed.Therefore, claims should not receive the restriction of disclosure.
Claims (51)
1. energy delivery apparatus, it comprises catheter shaft and ablation member,
Said ablation member links to each other with said catheter shaft, and comprises energy emitter between cooling element and cartilage,
Said cooling element can move from collapsed mode and be deployed condition,
Energy emitter comprises a plurality of electrodes that the longitudinal axis around said ablation member squints at circumferencial direction each other between said cartilage; Said electrode is configured to can be to a plurality of target areas of air flue delivery of energy; Said a plurality of target area is spaced apart from each other with respect to the longitudinal axis of said ablation member; And wherein said energy emitter and said cooling element are configured to cooperatively interact and form and damage between cartilage, and the surface texture of damage and said air flue separates and between the cartilaginous ring of said air flue between said cartilage.
2. energy delivery apparatus as claimed in claim 1, wherein said energy emitter are configured to produce the damage that is spaced apart from each other along the major axis of said air flue.
3. energy delivery apparatus as claimed in claim 1, wherein said target area along the long axis direction of said air flue with the orthogonal virtual plane of the major axis of said air flue on projection limit basic closed ring.
4. energy delivery apparatus as claimed in claim 1, at least a portion of wherein said ablation member are spirally or spiral type.
5. energy delivery apparatus as claimed in claim 1, wherein when when the chamber of said air flue is observed downwards, at least a portion of two target areas is eclipsed.
6. energy delivery apparatus as claimed in claim 1, wherein said catheter shaft have and are used for the delivery lumen of sending coolant to said cooling element and said energy emitter.
7. energy delivery apparatus as claimed in claim 1; The cooling duct of wherein said energy emitter is what to separate with the chamber of said cooling element; Thereby allow the passage of first coolant, and allow chamber the second coolant independent delivery to said cooling element from said catheter shaft independent delivery to said energy emitter.
8. energy delivery apparatus as claimed in claim 1, wherein said energy emitter comprises the electrode with coolant channel, said coolant channel is used to make coolant from wherein flowing through.
9. energy delivery apparatus as claimed in claim 1, wherein said cooling element comprises extensible basket, and said extensible basket has the hollow elongated member, and said hollow elongated member has coolant channel.
10. energy delivery apparatus as claimed in claim 1; Wherein at least one electrode is configured to when said cooling element is in deployed condition, to export the part that enough RF energies melt the nerve trunk of extending along bronchial tree; Thereby weaken the nervous system signal of a part that transfers to said bronchial tree; And wherein said cooling element absorbs enough heat energy from the wall of said air flue, thereby can limit or prevent the tissue between said energy emitter and the said nervous tissue is damaged.
11. delivery apparatus in the tube chamber, it comprises:
Ablation member; Said ablation member comprises extensible device and a plurality of electrode; The circle spacing of the said extensible member in said electrode edge opens and can be to dispersive target area output energy; Thereby it is form damage in said target area, and at least a portion of wherein first damage is spaced apart with second damage in the axial direction, and contiguous or overlapping with second damage in a circumferential direction.
12. delivery apparatus in the tube chamber as claimed in claim 11, wherein said electrode is configured to form one group of damage, and said one group of damage axially separates with the longitudinal axis of second group of damage along said ablation member.
13. delivery apparatus in the tube chamber as claimed in claim 11, wherein said electrode is V-arrangement or T shape.
14. delivery apparatus in the tube chamber as claimed in claim 11, wherein said extensible device comprises a plurality of teeth, and said tooth has the free terminal that carries said electrode.
15. delivery apparatus in the tube chamber as claimed in claim 11, wherein at least one electrode has the cooling duct, and fluid can flow through said cooling duct and cool off said electrode, and wherein said extensible device comprises capsule or extensible basket.
16. delivery apparatus in the tube chamber as claimed in claim 11; Wherein said extensible device can be that spiral launches configuration from sending configuration mobile; And when said extensible device was in the expansion configuration, said electrode is placed in can be to the position of target area delivery of energy.
17. delivery apparatus in the tube chamber as claimed in claim 11, wherein said electrode can be by such placements: make the target area along the y direction of said ablation member with the orthogonal virtual plane of the said longitudinal axis on projection limit basic closed ring.
18. delivery apparatus in the tube chamber as claimed in claim 11, wherein said electrode can be by such placements: make the target area along the y direction of said ablation member with the orthogonal virtual plane of the said longitudinal axis on projection limit arc processing region.
19. delivery apparatus in the tube chamber as claimed in claim 11, wherein said electrode are configured to can be to the contiguous target area output energy in two places, makes that the eclipsed distance of circumference is at least 0.5mm between the contiguous target area, said two places.
20. the method that treatment is individual, it comprises:
Place ablation member with respect to air flue; And
To target area that the axially spaced-apart of said air flue is opened output energy, and wherein when along the long axis direction observation of said air flue, the profile of said target area is overlapping from said ablation member.
21. method as claimed in claim 20; First place that also is included in said target area forms first damage; And in second place of said target area formation, second damage; And wherein when when the long axis direction of said air flue is observed, it is a part of overlapping that the part of said first damage and said second is damaged.
22. method as claimed in claim 20, wherein said ablation member are configured to and can form damage in said target area, the chamber of said air flue is surrounded in the damage of every place at least in part.
23. method as claimed in claim 20; Comprise that also heating is in the degree of depth in the said airway walls and causes cell death greater than the tissue at about 2mm place, will be in the degree of depth in the said airway walls simultaneously and maintain the temperature that is lower than the cell death occurrence temperature less than the tissue at 2mm place.
24. method as claimed in claim 20 also comprises coolant sent through said ablation member and comes in the cooling airway degree of depth less than the tissue at 2mm place.
25. the method that treatment is individual, it comprises:
Move the energy emitter of delivery apparatus along air flue;
At least one electrode of said energy emitter is placed between the cartilaginous ring of said air flue; And
From the target area delivery of energy of said electrode, damage to form between cartilaginous ring to the position that axially separates along said air flue major axis.
26., comprise that also the wall that cools off said air flue is to protect the interior tissue of said air flue like the said method of claim 25.
27., also comprise at least two places damage that formation overlaps each other in a circumferential direction like the said method of claim 25.
28. like the said method of claim 25; One of wherein said damage is positioned at and orthogonal first virtual plane of the major axis of said air flue; And another place's damage is positioned at and orthogonal second virtual plane of the major axis of said air flue, and wherein said first virtual plane and said second virtual plane are along the major axis axially-spaced of said air flue.
29. like the said method of claim 25, when also being included in delivery of energy, cool off the wall of said air flue, thereby limit or prevent the cells of tissues death between nerve trunk and said energy emitter.
30. like the said method of claim 25; Comprise that also heating is in the degree of depth in the said airway walls and causes cell death at least about the tissue at 2mm place, will be in the degree of depth in the said airway walls simultaneously and maintain the temperature that is lower than the cell death occurrence temperature less than the tissue at 2mm place.
31. like the said method of claim 25, also comprise when said electrode is exported energy, coolant sent through said electrode.
32. handle the method for tissue, it comprises:
Ablation member is placed on the air flue intracavity; And
Utilize and be placed near the organize delivery of energy of at least one electrode of said air flue inner surface in the said ablation member to said air flue; Wherein said energy destroys the target area that axially separates along said air flue, and the target area part of the maximum cross-section width of the said target area of feasible qualification is separated with the inner surface of said air flue.
33., when also being included in delivery of energy a plurality of electrodes are placed between the cartilaginous ring like the said method of claim 32.
34., comprise that also delivery of energy is to form spiral type damage of at least one place or spirally damage like the said method of claim 32.
35. like the said method of claim 32, the maximum cross-section width of target area, wherein at least one place is positioned at apart from the air flue inner surface degree of depth place of 2mm at least of the said ablation member of contact.
36. like the said method of claim 32, also comprise the tissue that destroys target area, at least one place, make the darker degree of depth place, cross-sectional width smooth muscle tissue zone in of destructive tissue than said tissue reach maximum.
37. like the said method of claim 32, wherein delivery of energy comprises destruction target area, at least one place, makes the major part of this target area be positioned at outside the smooth muscle tissue zone of said tissue.
38. like the said method of claim 37, wherein most of volume of destructive tissue be positioned at outside the smooth muscle tissue zone.
39. delivery apparatus comprises
Catheter shaft; And
The ablation member that is connected with said catheter shaft; Said ablation member comprises and can move extensible element and energy emitter into deployed condition from sending state; When said extensible element is in deployed condition; Said energy emitter can produce damage by emitted energy, and said damage has the end that is axially offset to one another along the axial length of body structure.
40. delivery apparatus as claimed in claim 39, wherein said energy emitter comprises a plurality of electrodes, and said electrode is configured to form spirally damage, spiral type damage or Z-shaped damage.
41. delivery apparatus as claimed in claim 39, wherein said energy emitter are wrapped in said extensible component ambient.
42. delivery apparatus as claimed in claim 39; One end of wherein said energy emitter extends around said extensible element in a circumferential direction; The other end of said energy emitter extends around said extensible element in a circumferential direction, and the zone line of said energy emitter around said extensible element with respect to the oblique extension of the longitudinal axis of said ablation member.
43. delivery apparatus as claimed in claim 39, a plurality of electrodes of wherein said energy emitter along said ablation member with respect to the oblique extension of the longitudinal axis of said ablation member.
44. delivery apparatus as claimed in claim 39, wherein said energy emitter comprise a plurality of isolated electrodes, thereby can form spirally, spiral type or Z-shaped damage.
45. delivery apparatus as claimed in claim 44, wherein said damage are successive damage.
46. delivery apparatus as claimed in claim 45, wherein said damage are discontinuous damage.
47. the method that treatment is individual comprises:
Ablation member is positioned in the air flue, and
From said ablation member delivery of energy, thereby form the damage of at least one place, said damage has the opposite end that on the long axis direction of said air flue, axially departs from each other.
48. method as claimed in claim 47, wherein when the major axis of said ablation member is measured, said opposite end is at a distance of the distance of 5mm at least.
49. method as claimed in claim 47 comprises that also delivery of energy is to form spirally or spiral successive damage.
50. method as claimed in claim 47 also comprises forming spirally or spiral discontinuous damage.
51. method as claimed in claim 47, the damage of wherein at least one place comprises along a plurality of isolated damages of said air flue.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611095404.9A CN106618731B (en) | 2009-11-11 | 2010-11-11 | Systems, devices, and methods for treating tissue and controlling stenosis |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US26034909P | 2009-11-11 | 2009-11-11 | |
US61/260,349 | 2009-11-11 | ||
PCT/US2010/056424 WO2011060200A1 (en) | 2009-11-11 | 2010-11-11 | Systems, apparatuses, and methods for treating tissue and controlling stenosis |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201611095404.9A Division CN106618731B (en) | 2009-11-11 | 2010-11-11 | Systems, devices, and methods for treating tissue and controlling stenosis |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102711645A true CN102711645A (en) | 2012-10-03 |
CN102711645B CN102711645B (en) | 2016-12-28 |
Family
ID=43480739
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201080060627.6A Active CN102711645B (en) | 2009-11-11 | 2010-11-11 | For processing tissue and controlling narrow system and device |
CN201611095404.9A Active CN106618731B (en) | 2009-11-11 | 2010-11-11 | Systems, devices, and methods for treating tissue and controlling stenosis |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201611095404.9A Active CN106618731B (en) | 2009-11-11 | 2010-11-11 | Systems, devices, and methods for treating tissue and controlling stenosis |
Country Status (9)
Country | Link |
---|---|
US (5) | US9149328B2 (en) |
EP (3) | EP2842510B1 (en) |
JP (3) | JP6000851B2 (en) |
KR (1) | KR101820542B1 (en) |
CN (2) | CN102711645B (en) |
AU (1) | AU2010319477A1 (en) |
CA (1) | CA2780608C (en) |
IL (1) | IL219605A0 (en) |
WO (1) | WO2011060200A1 (en) |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103735307A (en) * | 2014-01-14 | 2014-04-23 | 沈诚亮 | Bronchial thermoplasty catheter |
CN103860258A (en) * | 2012-12-12 | 2014-06-18 | 北京中孵友信医药科技股份有限公司 | Self-adaptive annular positioning endovascular catheter |
CN105555220A (en) * | 2013-07-22 | 2016-05-04 | 波士顿科学国际有限公司 | Medical devices for renal nerve ablation |
CN105636538A (en) * | 2013-10-18 | 2016-06-01 | 波士顿科学国际有限公司 | Balloon catheters with flexible conducting wires and related methods of use and manufacture |
CN105744907A (en) * | 2013-11-19 | 2016-07-06 | 伊西康公司 | Thoracoscopic methods for treatment of bronchial disease |
CN106264715A (en) * | 2015-06-29 | 2017-01-04 | 韦伯斯特生物官能(以色列)有限公司 | There is the conduit of closed loop array with plane internal linear electrode part |
CN106880400A (en) * | 2015-12-16 | 2017-06-23 | 上海微创电生理医疗科技有限公司 | Electrophysiologicalcatheter catheter and radio frequency ablation system |
CN110944581A (en) * | 2017-07-28 | 2020-03-31 | 美敦力公司 | Expandable element for delivery of electric fields |
US11039772B2 (en) | 2015-06-29 | 2021-06-22 | Biosense Webster (Israel) Ltd. | Catheter with stacked spine electrode assembly |
US11083400B2 (en) | 2014-11-20 | 2021-08-10 | Biosense Webster (Israel) Ltd. | Catheter with high density electrode spine array |
US11116436B2 (en) | 2015-06-30 | 2021-09-14 | Biosense Webster (Israel) Ltd. | Catheter having closed electrode assembly with spines of uniform length |
US12144629B2 (en) | 2023-06-20 | 2024-11-19 | Biosense Webster (Israel) Ltd. | Catheter having closed electrode assembly with spines of uniform length |
Families Citing this family (112)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7027869B2 (en) | 1998-01-07 | 2006-04-11 | Asthmatx, Inc. | Method for treating an asthma attack |
US7921855B2 (en) | 1998-01-07 | 2011-04-12 | Asthmatx, Inc. | Method for treating an asthma attack |
US6702811B2 (en) | 1999-04-05 | 2004-03-09 | Medtronic, Inc. | Ablation catheter assembly with radially decreasing helix and method of use |
US7617005B2 (en) | 2002-04-08 | 2009-11-10 | Ardian, Inc. | Methods and apparatus for thermally-induced renal neuromodulation |
US20140018880A1 (en) | 2002-04-08 | 2014-01-16 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for monopolar renal neuromodulation |
US8347891B2 (en) | 2002-04-08 | 2013-01-08 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and apparatus for performing a non-continuous circumferential treatment of a body lumen |
US7756583B2 (en) | 2002-04-08 | 2010-07-13 | Ardian, Inc. | Methods and apparatus for intravascularly-induced neuromodulation |
US7653438B2 (en) | 2002-04-08 | 2010-01-26 | Ardian, Inc. | Methods and apparatus for renal neuromodulation |
US20040226556A1 (en) | 2003-05-13 | 2004-11-18 | Deem Mark E. | Apparatus for treating asthma using neurotoxin |
US7803168B2 (en) | 2004-12-09 | 2010-09-28 | The Foundry, Llc | Aortic valve repair |
US7608275B2 (en) | 2005-07-22 | 2009-10-27 | The Foundry, Llc | Systems and methods for delivery of a therapeutic agent |
WO2007136566A2 (en) | 2006-05-19 | 2007-11-29 | Prorhythm, Inc. | Ablation device with optimized input power profile and method of using the same |
US8483831B1 (en) | 2008-02-15 | 2013-07-09 | Holaira, Inc. | System and method for bronchial dilation |
EP2662046B1 (en) | 2008-05-09 | 2023-03-15 | Nuvaira, Inc. | Systems and assemblies for treating a bronchial tree |
US11376061B2 (en) * | 2008-11-11 | 2022-07-05 | Covidien Lp | Energy delivery device and methods of use |
EP2376011B1 (en) | 2009-01-09 | 2019-07-03 | ReCor Medical, Inc. | Apparatus for treatment of mitral valve insufficiency |
US8903488B2 (en) | 2009-05-28 | 2014-12-02 | Angiodynamics, Inc. | System and method for synchronizing energy delivery to the cardiac rhythm |
US9895189B2 (en) | 2009-06-19 | 2018-02-20 | Angiodynamics, Inc. | Methods of sterilization and treating infection using irreversible electroporation |
CN107049479B (en) * | 2009-10-27 | 2020-10-16 | 努瓦拉公司 | Delivery device with coolable energy emitting assembly |
US8911439B2 (en) | 2009-11-11 | 2014-12-16 | Holaira, Inc. | Non-invasive and minimally invasive denervation methods and systems for performing the same |
EP2842510B1 (en) | 2009-11-11 | 2022-08-24 | Nuvaira, Inc. | Device for treating tissue and controlling stenosis |
US10575893B2 (en) | 2010-04-06 | 2020-03-03 | Nuvaira, Inc. | System and method for pulmonary treatment |
US20120029512A1 (en) * | 2010-07-30 | 2012-02-02 | Willard Martin R | Balloon with surface electrodes and integral cooling for renal nerve ablation |
EP2627274B1 (en) | 2010-10-13 | 2022-12-14 | AngioDynamics, Inc. | System for electrically ablating tissue of a patient |
US9028417B2 (en) | 2010-10-18 | 2015-05-12 | CardioSonic Ltd. | Ultrasound emission element |
US20130218068A1 (en) | 2010-10-18 | 2013-08-22 | CardioSonic Ltd. | Therapeutics reservoir |
US8585601B2 (en) | 2010-10-18 | 2013-11-19 | CardioSonic Ltd. | Ultrasound transducer |
US9566456B2 (en) | 2010-10-18 | 2017-02-14 | CardioSonic Ltd. | Ultrasound transceiver and cooling thereof |
JP2013544133A (en) | 2010-10-25 | 2013-12-12 | メドトロニック アーディアン ルクセンブルク ソシエテ ア レスポンサビリテ リミテ | Catheter apparatus having a multi-electrode array for renal neuromodulation and related systems and methods |
WO2012086492A1 (en) | 2010-12-21 | 2012-06-28 | テルモ株式会社 | Balloon catheter and electrification system |
EP2694150A1 (en) | 2011-04-08 | 2014-02-12 | Covidien LP | Iontophoresis drug delivery system and method for denervation of the renal sympathetic nerve and iontophoretic drug delivery |
US8936594B2 (en) * | 2011-06-14 | 2015-01-20 | Aerin Medical Inc. | Methods and devices to treat nasal airways |
US11304746B2 (en) | 2011-06-14 | 2022-04-19 | Aerin Medical Inc. | Method of treating airway tissue to reduce mucus secretion |
US11033318B2 (en) | 2011-06-14 | 2021-06-15 | Aerin Medical, Inc. | Methods and devices to treat nasal airways |
US11241271B2 (en) | 2011-06-14 | 2022-02-08 | Aerin Medical Inc. | Methods of treating nasal airways |
US9078665B2 (en) | 2011-09-28 | 2015-07-14 | Angiodynamics, Inc. | Multiple treatment zone ablation probe |
CN106823131B (en) * | 2011-09-30 | 2019-12-20 | 柯惠有限合伙公司 | Energy transfer device and method of use |
WO2013052501A1 (en) | 2011-10-05 | 2013-04-11 | Innovative Pulmonary Solutions, Inc. | Apparatus for injuring nerve tissue |
US20130123770A1 (en) * | 2011-11-14 | 2013-05-16 | Boston Scientific Scimed, Inc. | Ablation catheter with cryothermal balloon |
WO2013086461A1 (en) | 2011-12-09 | 2013-06-13 | Metavention, Inc. | Therapeutic neuromodulation of the hepatic system |
US9414881B2 (en) | 2012-02-08 | 2016-08-16 | Angiodynamics, Inc. | System and method for increasing a target zone for electrical ablation |
EP3135237B1 (en) * | 2012-04-13 | 2019-07-24 | Covidien LP | Energy delivery device |
CN102631240A (en) * | 2012-04-13 | 2012-08-15 | 上海微创电生理医疗科技有限公司 | Cold brine infusion type radiofrequency ablation catheter |
WO2013157009A2 (en) * | 2012-04-18 | 2013-10-24 | CardioSonic Ltd. | Tissue treatment |
WO2013157011A2 (en) | 2012-04-18 | 2013-10-24 | CardioSonic Ltd. | Tissue treatment |
EP4079245A1 (en) | 2012-05-11 | 2022-10-26 | Medtronic Ireland Manufacturing Unlimited Company | Multi-electrode catheter assemblies for renal neuromodulation and associated systems |
US20130310822A1 (en) * | 2012-05-18 | 2013-11-21 | Holaira, Inc. | Compact delivery pulmonary treatment systems and methods for improving pulmonary function |
US11357447B2 (en) | 2012-05-31 | 2022-06-14 | Sonivie Ltd. | Method and/or apparatus for measuring renal denervation effectiveness |
US12082868B2 (en) | 2012-11-13 | 2024-09-10 | Pulnovo Medical (Wuxi) Co., Ltd. | Multi-pole synchronous pulmonary artery radiofrequency ablation catheter |
US11241267B2 (en) | 2012-11-13 | 2022-02-08 | Pulnovo Medical (Wuxi) Co., Ltd | Multi-pole synchronous pulmonary artery radiofrequency ablation catheter |
CN102908191A (en) | 2012-11-13 | 2013-02-06 | 陈绍良 | Multipolar synchronous pulmonary artery radiofrequency ablation catheter |
WO2014089373A1 (en) * | 2012-12-05 | 2014-06-12 | University Of Rochester | Catheter with integrated transeptal puncture needle |
US9398933B2 (en) | 2012-12-27 | 2016-07-26 | Holaira, Inc. | Methods for improving drug efficacy including a combination of drug administration and nerve modulation |
US20140221994A1 (en) * | 2013-02-05 | 2014-08-07 | Covidien Lp | Electrosurgical instrument |
JP2016511027A (en) * | 2013-02-08 | 2016-04-14 | コビディエン エルピー | Lung denervation system and method |
US10076384B2 (en) | 2013-03-08 | 2018-09-18 | Symple Surgical, Inc. | Balloon catheter apparatus with microwave emitter |
EP4410338A3 (en) | 2013-03-13 | 2024-10-16 | Nuvaira, Inc. | Fluid delivery system and method for treatment |
WO2014143898A1 (en) * | 2013-03-15 | 2014-09-18 | Holaira, Inc. | Systems, devices, and methods for treating a pulmonary disorder with an agent |
US9179974B2 (en) | 2013-03-15 | 2015-11-10 | Medtronic Ardian Luxembourg S.A.R.L. | Helical push wire electrode |
US10933259B2 (en) | 2013-05-23 | 2021-03-02 | CardioSonic Ltd. | Devices and methods for renal denervation and assessment thereof |
US20160128767A1 (en) | 2013-06-05 | 2016-05-12 | Metavention, Inc. | Modulation of targeted nerve fibers |
EP3019106A1 (en) * | 2013-07-11 | 2016-05-18 | Boston Scientific Scimed, Inc. | Medical device with stretchable electrode assemblies |
DE102013109505B4 (en) * | 2013-08-30 | 2015-11-12 | Karl Storz Gmbh & Co. Kg | Medical instrument and electrosurgical system |
US20150073515A1 (en) | 2013-09-09 | 2015-03-12 | Medtronic Ardian Luxembourg S.a.r.I. | Neuromodulation Catheter Devices and Systems Having Energy Delivering Thermocouple Assemblies and Associated Methods |
WO2015038886A1 (en) * | 2013-09-12 | 2015-03-19 | Holaira, Inc. | Systems, devices, and methods for treating a pulmonary disease with ultrasound energy |
DE102013219509A1 (en) | 2013-09-27 | 2015-04-02 | Olympus Winter & Ibe Gmbh | Expandable cooled electrode |
AU2014240225A1 (en) | 2013-10-01 | 2015-04-16 | Uptake Medical Technology Inc. | Preferential volume reduction of diseased segments of a heterogeneous lobe |
WO2015089377A1 (en) | 2013-12-12 | 2015-06-18 | Holaira, Inc. | Catheter and handle assembly, systems, and methods |
US9579149B2 (en) | 2014-03-13 | 2017-02-28 | Medtronic Ardian Luxembourg S.A.R.L. | Low profile catheter assemblies and associated systems and methods |
US10736690B2 (en) | 2014-04-24 | 2020-08-11 | Medtronic Ardian Luxembourg S.A.R.L. | Neuromodulation catheters and associated systems and methods |
US10709490B2 (en) | 2014-05-07 | 2020-07-14 | Medtronic Ardian Luxembourg S.A.R.L. | Catheter assemblies comprising a direct heating element for renal neuromodulation and associated systems and methods |
US20150342669A1 (en) * | 2014-05-29 | 2015-12-03 | Boston Scientific Scimed, Inc. | Devices and methods for controlled energy delivery to airways |
RU2692219C2 (en) * | 2014-07-11 | 2019-06-21 | Пулново Медикал (Уси) Ко., Лтд. | Multipolar synchronous radio-frequency ablation catheter for pulmonary artery |
US12114911B2 (en) | 2014-08-28 | 2024-10-15 | Angiodynamics, Inc. | System and method for ablating a tissue site by electroporation with real-time pulse monitoring |
US10485604B2 (en) | 2014-12-02 | 2019-11-26 | Uptake Medical Technology Inc. | Vapor treatment of lung nodules and tumors |
US9795780B2 (en) * | 2014-12-18 | 2017-10-24 | Abbott Cardiovascular Systems Inc. | System for denervation |
US10531906B2 (en) | 2015-02-02 | 2020-01-14 | Uptake Medical Technology Inc. | Medical vapor generator |
US10376308B2 (en) | 2015-02-05 | 2019-08-13 | Axon Therapies, Inc. | Devices and methods for treatment of heart failure by splanchnic nerve ablation |
CA2988609C (en) | 2015-06-12 | 2023-09-05 | The University Of Sydney | Microwave ablation device |
US10207110B1 (en) | 2015-10-13 | 2019-02-19 | Axon Therapies, Inc. | Devices and methods for treatment of heart failure via electrical modulation of a splanchnic nerve |
DE102016106478A1 (en) * | 2016-04-08 | 2017-10-12 | Biotronik Ag | Device for emitting energy and / or measuring electrical activity |
US10524859B2 (en) * | 2016-06-07 | 2020-01-07 | Metavention, Inc. | Therapeutic tissue modulation devices and methods |
WO2018013570A1 (en) * | 2016-07-11 | 2018-01-18 | Retrovascular, Inc. | Bi-polar tissue ablation device and methods of use thereof |
CN109843160B (en) | 2016-07-29 | 2022-04-15 | 阿克松疗法公司 | Devices, systems, and methods for treating heart failure through cardiac nerve ablation |
MX2019003483A (en) | 2016-10-04 | 2019-09-02 | Avent Inc | Cooled rf probes. |
US10905492B2 (en) | 2016-11-17 | 2021-02-02 | Angiodynamics, Inc. | Techniques for irreversible electroporation using a single-pole tine-style internal device communicating with an external surface electrode |
EP3551109A4 (en) | 2016-12-07 | 2020-07-22 | Nuvaira, Inc. | Method and systems for reducing treatment variability and increasing treatment efficacy and durability |
CN110621345A (en) | 2017-03-20 | 2019-12-27 | 索尼维有限公司 | Pulmonary hypertension treatment |
US20180280080A1 (en) | 2017-03-31 | 2018-10-04 | Biosense Webster (Israel) Ltd. | Balloon catheter with large area electrodes |
US10617867B2 (en) * | 2017-04-28 | 2020-04-14 | Farapulse, Inc. | Systems, devices, and methods for delivery of pulsed electric field ablative energy to esophageal tissue |
US11129673B2 (en) | 2017-05-05 | 2021-09-28 | Uptake Medical Technology Inc. | Extra-airway vapor ablation for treating airway constriction in patients with asthma and COPD |
US11344364B2 (en) | 2017-09-07 | 2022-05-31 | Uptake Medical Technology Inc. | Screening method for a target nerve to ablate for the treatment of inflammatory lung disease |
US11350988B2 (en) | 2017-09-11 | 2022-06-07 | Uptake Medical Technology Inc. | Bronchoscopic multimodality lung tumor treatment |
US11419658B2 (en) | 2017-11-06 | 2022-08-23 | Uptake Medical Technology Inc. | Method for treating emphysema with condensable thermal vapor |
US10561461B2 (en) | 2017-12-17 | 2020-02-18 | Axon Therapies, Inc. | Methods and devices for endovascular ablation of a splanchnic nerve |
AU2019206388B2 (en) * | 2018-01-10 | 2021-10-14 | Adagio Medical, Inc. | Cryoablation element with conductive liner |
CN111886043B (en) | 2018-01-26 | 2024-03-29 | 阿克松疗法公司 | Method and apparatus for intravascular ablation of visceral nerves |
JP2020018606A (en) * | 2018-08-01 | 2020-02-06 | テルモ株式会社 | Medical device |
US20200038101A1 (en) * | 2018-08-03 | 2020-02-06 | Biosense Webster (Israel) Ltd. | Unipolar reference electrode for electrophysiology mapping catheter |
DE102018120761A1 (en) * | 2018-08-24 | 2020-02-27 | Biotronik Se & Co. Kg | Electrode lead with integrated deformation sensor |
US11653927B2 (en) | 2019-02-18 | 2023-05-23 | Uptake Medical Technology Inc. | Vapor ablation treatment of obstructive lung disease |
US20200390496A1 (en) * | 2019-06-14 | 2020-12-17 | Avolt, Llc | Electromagnetic radiation ablation tips made of magnetic materials |
EP4241836A3 (en) | 2019-06-20 | 2023-11-29 | Axon Therapies, Inc. | Devices for endovascular ablation of a splanchnic nerve |
CN110507406A (en) * | 2019-08-29 | 2019-11-29 | 上海市东方医院(同济大学附属东方医院) | Cryoablation catheter and application thereof |
US11291500B2 (en) | 2019-11-05 | 2022-04-05 | Sirona Medical Technologies, Inc. | Multi-modal catheter for improved electrical mapping and ablation |
WO2021146724A1 (en) | 2020-01-17 | 2021-07-22 | Axon Therapies, Inc. | Methods and devices for endovascular ablation of a splanchnic nerve |
WO2021157100A1 (en) * | 2020-02-08 | 2021-08-12 | 日本ライフライン株式会社 | Balloon-type electrode catheter |
CA3188689A1 (en) * | 2020-08-11 | 2022-02-17 | Alexis G. Nahama | Treating pulmonary inflammatory disease by neural ablation |
US20220087739A1 (en) * | 2020-09-18 | 2022-03-24 | Acclarent, Inc. | Ent instrument with expandable ablation feature |
KR20220061898A (en) * | 2020-11-06 | 2022-05-13 | 연세대학교 산학협력단 | Biological data acquisition apparatus and biological data processing apparatus using the same |
US12082877B2 (en) | 2021-01-22 | 2024-09-10 | CRC EP, Inc. | Ablation catheter and operation method of same |
US20240164842A1 (en) * | 2022-11-21 | 2024-05-23 | Nuvaira, Inc. | Utilization of three-dimensional navigation technology during lung denervation procedures |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997025917A1 (en) * | 1996-01-19 | 1997-07-24 | Ep Technologies, Inc. | Multi-function electrode structures for electrically analyzing and heating body tissue |
WO1999042047A1 (en) * | 1998-02-19 | 1999-08-26 | Conway-Stuart Medical, Inc. | Method for electrosurgically treating a sphincter |
WO2000066017A1 (en) * | 1999-05-04 | 2000-11-09 | Curon Medical, Inc. | Electrodes for creating lesions in tissue regions at or near a sphincter |
US20080262489A1 (en) * | 2007-04-23 | 2008-10-23 | Minnow Medical, Llc | Thrombus removal |
US20090131928A1 (en) * | 1998-01-14 | 2009-05-21 | Respiratory Diagnostic, Inc. | GERD treatment apparatus and method |
Family Cites Families (1126)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US612724A (en) | 1898-10-18 | Bert j | ||
US1155169A (en) | 1914-11-28 | 1915-09-28 | John Starkweather | Surgical instrument. |
US1207479A (en) | 1915-03-05 | 1916-12-05 | Holger Bisgaard | Self-retaining gatheter. |
US1216183A (en) | 1916-09-18 | 1917-02-13 | Charles M Swingle | Electrotherapeutic rejuvenator. |
US1695107A (en) | 1926-11-24 | 1928-12-11 | Willi Landau | Therapeutic implement |
US2072346A (en) | 1934-10-04 | 1937-03-02 | Ward R Smith | Drainage tube |
US2279714A (en) | 1940-10-26 | 1942-04-14 | Firm Asclepio Mira Limitada | Cystoscope |
US3320957A (en) | 1964-05-21 | 1967-05-23 | Sokolik Edward | Surgical instrument |
US3568659A (en) | 1968-09-24 | 1971-03-09 | James N Karnegis | Disposable percutaneous intracardiac pump and method of pumping blood |
US3667476A (en) | 1970-04-27 | 1972-06-06 | Bio Data Corp | Apparatus for monitoring body temperature and controlling a heating device to maintain a selected temperature |
US3692029A (en) | 1971-05-03 | 1972-09-19 | Edwin Lloyd Adair | Retention catheter and suprapubic shunt |
US3995617A (en) | 1972-05-31 | 1976-12-07 | Watkins David H | Heart assist method and catheter |
US3949743A (en) | 1973-03-19 | 1976-04-13 | Schick Incorporated | Medicated vapor production method and apparatus |
GB1459397A (en) | 1973-03-22 | 1976-12-22 | Biopulse Co Ltd | Apparatus for treating organisms by applying an electrical signal thereto |
FR2232331B1 (en) | 1973-06-06 | 1978-03-24 | Guerin A Ets | |
SU545358A1 (en) | 1974-07-11 | 1977-02-05 | Предприятие П/Я В-2481 | Circulatory Support Device |
US4078864A (en) | 1976-07-08 | 1978-03-14 | United Technologies Corporation | Method and apparatus for viewing and measuring damage in an inaccessible area |
US4095602A (en) | 1976-09-27 | 1978-06-20 | Leveen Harry H | Multi-portal radiofrequency generator |
US4129129A (en) | 1977-03-18 | 1978-12-12 | Sarns, Inc. | Venous return catheter and a method of using the same |
US4116589A (en) | 1977-04-15 | 1978-09-26 | Avco Corporation | Extracorporeal pulsatile blood pump comprised of side by side bladders |
US4154246A (en) | 1977-07-25 | 1979-05-15 | Leveen Harry H | Field intensification in radio frequency thermotherapy |
US4351330A (en) | 1978-01-30 | 1982-09-28 | Scarberry Eugene N | Emergency internal defibrillation |
JPS54154759U (en) | 1978-04-20 | 1979-10-27 | ||
US4503863A (en) | 1979-06-29 | 1985-03-12 | Katims Jefferson J | Method and apparatus for transcutaneous electrical stimulation |
US4305402A (en) | 1979-06-29 | 1981-12-15 | Katims Jefferson J | Method for transcutaneous electrical stimulation |
US4557272A (en) | 1980-03-31 | 1985-12-10 | Microwave Associates, Inc. | Microwave endoscope detection and treatment system |
US4565200A (en) | 1980-09-24 | 1986-01-21 | Cosman Eric R | Universal lesion and recording electrode system |
US4502490A (en) | 1980-10-28 | 1985-03-05 | Antec Systems Limited | Patient monitoring equipment, probe for use therewith, and method of measuring anesthesia based on oesophagal contractions |
JPS57168656A (en) | 1981-04-10 | 1982-10-18 | Medos Kenkyusho Kk | Endoscope laser coagulator |
US4706688A (en) | 1981-05-18 | 1987-11-17 | Don Michael T Anthony | Non-invasive cardiac device |
US4612934A (en) | 1981-06-30 | 1986-09-23 | Borkan William N | Non-invasive multiprogrammable tissue stimulator |
US4584998A (en) | 1981-09-11 | 1986-04-29 | Mallinckrodt, Inc. | Multi-purpose tracheal tube |
JPS5883966A (en) | 1981-11-13 | 1983-05-19 | テルモ株式会社 | Blood circuit for membrane type artificial lung |
DE3247793C2 (en) | 1981-12-31 | 1986-01-09 | Harald 7200 Tuttlingen Maslanka | High frequency surgical loop electrode |
US5370675A (en) | 1992-08-12 | 1994-12-06 | Vidamed, Inc. | Medical probe device and method |
US4512762A (en) | 1982-11-23 | 1985-04-23 | The Beth Israel Hospital Association | Method of treatment of atherosclerosis and a balloon catheter for same |
US4773899A (en) | 1982-11-23 | 1988-09-27 | The Beth Israel Hospital Association | Method of treatment of artherosclerosis and balloon catheter the same |
US4567882A (en) | 1982-12-06 | 1986-02-04 | Vanderbilt University | Method for locating the illuminated tip of an endotracheal tube |
US4784135A (en) | 1982-12-09 | 1988-11-15 | International Business Machines Corporation | Far ultraviolet surgical and dental procedures |
JPS59167707A (en) | 1983-03-14 | 1984-09-21 | Toshiba Corp | Sample value controller |
ZW6584A1 (en) | 1983-04-18 | 1985-04-17 | Glaxo Group Ltd | Phenethanolamine derivatives |
US4646737A (en) | 1983-06-13 | 1987-03-03 | Laserscope, Inc. | Localized heat applying medical device |
US4704121A (en) | 1983-09-28 | 1987-11-03 | Nimbus, Inc. | Anti-thrombogenic blood pump |
US4625712A (en) | 1983-09-28 | 1986-12-02 | Nimbus, Inc. | High-capacity intravascular blood pump utilizing percutaneous access |
US4522212A (en) | 1983-11-14 | 1985-06-11 | Mansfield Scientific, Inc. | Endocardial electrode |
FR2561929B1 (en) | 1984-03-27 | 1989-02-03 | Atesys | IMPLANTED AUTOMATIC APPARATUS FOR VENTRICULAR DEFIBRILLATION |
US4621882A (en) | 1984-05-14 | 1986-11-11 | Beta Phase, Inc. | Thermally responsive electrical connector |
US4649935A (en) | 1984-05-21 | 1987-03-17 | Symtonic Sa | Method of treating neurovegetative disorders and apparatus therefor |
US4573481A (en) | 1984-06-25 | 1986-03-04 | Huntington Institute Of Applied Research | Implantable electrode array |
US4649924A (en) | 1984-08-14 | 1987-03-17 | Consiglio Nazionale Delle Ricerche | Method for the detection of intracardiac electrical potential fields |
JPS6148350A (en) | 1984-08-15 | 1986-03-10 | オリンパス光学工業株式会社 | Medical laser apparatus |
US4799479A (en) | 1984-10-24 | 1989-01-24 | The Beth Israel Hospital Association | Method and apparatus for angioplasty |
US5019075A (en) | 1984-10-24 | 1991-05-28 | The Beth Israel Hospital | Method and apparatus for angioplasty |
US4772112A (en) | 1984-11-30 | 1988-09-20 | Cvi/Beta Ventures, Inc. | Eyeglass frame including shape-memory elements |
US4754065A (en) | 1984-12-18 | 1988-06-28 | Cetus Corporation | Precursor to nucleic acid probe |
EP0189329A3 (en) | 1985-01-25 | 1987-06-03 | Robert E. Fischell | A tunneling catheter system for transluminal arterial angioplasty |
GB2171309B (en) | 1985-02-26 | 1988-11-02 | North China Res I Electro Opti | Microwave therapeutic apparatus |
US4739759A (en) | 1985-02-26 | 1988-04-26 | Concept, Inc. | Microprocessor controlled electrosurgical generator |
US4862886A (en) | 1985-05-08 | 1989-09-05 | Summit Technology Inc. | Laser angioplasty |
US4658836A (en) | 1985-06-28 | 1987-04-21 | Bsd Medical Corporation | Body passage insertable applicator apparatus for electromagnetic |
US4976709A (en) | 1988-12-15 | 1990-12-11 | Sand Bruce J | Method for collagen treatment |
US4989604A (en) | 1985-10-03 | 1991-02-05 | Accu Science Corporation | Electromagnetic device |
US4643186A (en) | 1985-10-30 | 1987-02-17 | Rca Corporation | Percutaneous transluminal microwave catheter angioplasty |
US4683890A (en) | 1985-12-23 | 1987-08-04 | Brunswick Manufacturing Co., Inc. | Method and apparatus for controlled breathing employing internal and external electrodes |
DE8607358U1 (en) | 1986-03-18 | 1986-05-28 | Ruß, Jürgen, 5300 Bonn | Tubular, flexible probe for insertion into the trachea and bronchi |
US4827935A (en) | 1986-04-24 | 1989-05-09 | Purdue Research Foundation | Demand electroventilator |
US4709698A (en) | 1986-05-14 | 1987-12-01 | Thomas J. Fogarty | Heatable dilation catheter |
US4790305A (en) | 1986-06-23 | 1988-12-13 | The Johns Hopkins University | Medication delivery system |
US4767402A (en) | 1986-07-08 | 1988-08-30 | Massachusetts Institute Of Technology | Ultrasound enhancement of transdermal drug delivery |
IE60941B1 (en) | 1986-07-10 | 1994-09-07 | Elan Transdermal Ltd | Transdermal drug delivery device |
US4754752A (en) | 1986-07-28 | 1988-07-05 | Robert Ginsburg | Vascular catheter |
US5215103A (en) | 1986-11-14 | 1993-06-01 | Desai Jawahar M | Catheter for mapping and ablation and method therefor |
US5231995A (en) | 1986-11-14 | 1993-08-03 | Desai Jawahar M | Method for catheter mapping and ablation |
US5027829A (en) | 1986-12-15 | 1991-07-02 | Larsen Lawrence E | Apparatus for diathermy treatment and control |
US4976710A (en) | 1987-01-28 | 1990-12-11 | Mackin Robert A | Working well balloon method |
GB8704104D0 (en) | 1987-02-21 | 1987-03-25 | Manitoba University Of | Respiratory system load apparatus |
IT1203503B (en) | 1987-02-25 | 1989-02-15 | Cardiosistemi Spa | VENOUS DRAINAGE CANNULA |
GB8705451D0 (en) | 1987-03-09 | 1987-04-15 | Driver Southall | Combinational weighing systems |
US4802492A (en) | 1987-03-11 | 1989-02-07 | National Jewish Center For Immunology And Respiratory Medicine | Method for determining respiratory function |
SU1457935A1 (en) | 1987-03-17 | 1989-02-15 | Предприятие П/Я А-1405 | Apparatus for electroanalgesia |
US4779614A (en) | 1987-04-09 | 1988-10-25 | Nimbus Medical, Inc. | Magnetically suspended rotor axial flow blood pump |
US4904472A (en) | 1987-04-10 | 1990-02-27 | The University Of Virginia Alumni Patent Foundation | Use of adenosine antagonists in the treatment of bradyarrhythmias and mechanical dysfunction associated with cardiopulmonary resuscitation |
MC1921A1 (en) | 1987-04-10 | 1989-04-06 | Sankei Yakuhin Kk | ACYL DERIVATIVES |
CN87208158U (en) | 1987-05-20 | 1988-10-19 | 张雪珊 | Dual-functional domestic lamp |
US5849026A (en) | 1987-05-20 | 1998-12-15 | Zhou; Lin | Physiotherapy method |
EP0293068A1 (en) | 1987-05-27 | 1988-11-30 | Teijin Limited | An electric therapeutic apparatus |
US4808164A (en) | 1987-08-24 | 1989-02-28 | Progressive Angioplasty Systems, Inc. | Catheter for balloon angioplasty |
JPS6446056U (en) | 1987-09-17 | 1989-03-22 | ||
US4846152A (en) | 1987-11-24 | 1989-07-11 | Nimbus Medical, Inc. | Single-stage axial flow blood pump |
US4817586A (en) | 1987-11-24 | 1989-04-04 | Nimbus Medical, Inc. | Percutaneous bloom pump with mixed-flow output |
US4895557A (en) | 1987-12-07 | 1990-01-23 | Nimbus Medical, Inc. | Drive mechanism for powering intravascular blood pumps |
US5588432A (en) | 1988-03-21 | 1996-12-31 | Boston Scientific Corporation | Catheters for imaging, sensing electrical potentials, and ablating tissue |
US4907589A (en) | 1988-04-29 | 1990-03-13 | Cosman Eric R | Automatic over-temperature control apparatus for a therapeutic heating device |
US4906229A (en) | 1988-05-03 | 1990-03-06 | Nimbus Medical, Inc. | High-frequency transvalvular axisymmetric blood pump |
US5010892A (en) | 1988-05-04 | 1991-04-30 | Triangle Research And Development Corp. | Body lumen measuring instrument |
EP0415997A4 (en) | 1988-05-18 | 1992-04-08 | Kasevich Associates, Inc. | Microwave balloon angioplasty |
DE3821544C2 (en) | 1988-06-25 | 1994-04-28 | H Prof Dr Med Just | Dilatation catheter |
US4967765A (en) | 1988-07-28 | 1990-11-06 | Bsd Medical Corporation | Urethral inserted applicator for prostate hyperthermia |
US4908012A (en) | 1988-08-08 | 1990-03-13 | Nimbus Medical, Inc. | Chronic ventricular assist system |
US4920978A (en) | 1988-08-31 | 1990-05-01 | Triangle Research And Development Corporation | Method and apparatus for the endoscopic treatment of deep tumors using RF hyperthermia |
JP2686982B2 (en) | 1988-09-02 | 1997-12-08 | 日産自動車株式会社 | Method for forming clear coating film |
US4902129A (en) | 1988-09-06 | 1990-02-20 | Schott Fiber Optics | Orientation indicator for a flexible fiberscope or endoscope including method of manufacture |
US5151100A (en) | 1988-10-28 | 1992-09-29 | Boston Scientific Corporation | Heating catheters |
US4955377A (en) | 1988-10-28 | 1990-09-11 | Lennox Charles D | Device and method for heating tissue in a patient's body |
US5191883A (en) | 1988-10-28 | 1993-03-09 | Prutech Research And Development Partnership Ii | Device for heating tissue in a patient's body |
US4945912A (en) | 1988-11-25 | 1990-08-07 | Sensor Electronics, Inc. | Catheter with radiofrequency heating applicator |
US4969865A (en) | 1989-01-09 | 1990-11-13 | American Biomed, Inc. | Helifoil pump |
US5779698A (en) | 1989-01-18 | 1998-07-14 | Applied Medical Resources Corporation | Angioplasty catheter system and method for making same |
US4944722A (en) | 1989-02-23 | 1990-07-31 | Nimbus Medical, Inc. | Percutaneous axial flow blood pump |
US5057107A (en) | 1989-04-13 | 1991-10-15 | Everest Medical Corporation | Ablation catheter with selectively deployable electrodes |
US5433730A (en) | 1989-05-03 | 1995-07-18 | Intermedics, Inc. | Conductive pouch electrode for defibrillation |
US5152286A (en) | 1989-05-08 | 1992-10-06 | Mezhotraslevoi Nauchnoinzhenerny Tsentr "Vidguk" | Method of microwave resonance therapy and device therefor |
US5114423A (en) | 1989-05-15 | 1992-05-19 | Advanced Cardiovascular Systems, Inc. | Dilatation catheter assembly with heated balloon |
US5107835A (en) | 1989-05-22 | 1992-04-28 | Physiodynamics | Electrotherapeutic treatment |
US5006119A (en) | 1989-05-25 | 1991-04-09 | Engineering & Research Associates, Inc. | Hollow core coaxial catheter |
US5074860A (en) | 1989-06-09 | 1991-12-24 | Heraeus Lasersonics, Inc. | Apparatus for directing 10.6 micron laser radiation to a tissue site |
DE3920862A1 (en) | 1989-06-26 | 1991-01-03 | Teves Gmbh Alfred | AUXILIARY STEERING FOR MOTOR VEHICLES |
US4985014A (en) | 1989-07-11 | 1991-01-15 | Orejola Wilmo C | Ventricular venting loop |
US5084044A (en) | 1989-07-14 | 1992-01-28 | Ciron Corporation | Apparatus for endometrial ablation and method of using same |
US5005559A (en) | 1989-07-27 | 1991-04-09 | Massachusetts Institute Of Technology | Video-graphic arthroscopy system |
US5292331A (en) | 1989-08-24 | 1994-03-08 | Applied Vascular Engineering, Inc. | Endovascular support device |
US5562608A (en) | 1989-08-28 | 1996-10-08 | Biopulmonics, Inc. | Apparatus for pulmonary delivery of drugs with simultaneous liquid lavage and ventilation |
US5057105A (en) | 1989-08-28 | 1991-10-15 | The University Of Kansas Med Center | Hot tip catheter assembly |
WO1991003267A1 (en) | 1989-08-28 | 1991-03-21 | Sekins K Michael | Lung cancer hyperthermia via ultrasound and/or convection with perfluorocarbon liquids |
EP0490979B1 (en) | 1989-09-08 | 1996-11-13 | Boston Scientific Corporation | Physiologic low stress angioplasty |
US5270305A (en) | 1989-09-08 | 1993-12-14 | Glaxo Group Limited | Medicaments |
US5167223A (en) | 1989-09-08 | 1992-12-01 | Tibor Koros | Heart valve retractor and sternum spreader surgical instrument |
US5100388A (en) | 1989-09-15 | 1992-03-31 | Interventional Thermodynamics, Inc. | Method and device for thermal ablation of hollow body organs |
DE3931041C2 (en) | 1989-09-16 | 2000-04-06 | Boehringer Ingelheim Kg | Esters of thienyl carboxylic acids with amino alcohols, their quaternization products, processes for their preparation and medicaments containing them |
US5117828A (en) | 1989-09-25 | 1992-06-02 | Arzco Medical Electronics, Inc. | Expandable esophageal catheter |
US5007908A (en) | 1989-09-29 | 1991-04-16 | Everest Medical Corporation | Electrosurgical instrument having needle cutting electrode and spot-coag electrode |
US5036848A (en) | 1989-10-16 | 1991-08-06 | Brunswick Biomedical Technologies, Inc. | Method and apparatus for controlling breathing employing internal and external electrodes |
US4991603A (en) | 1989-10-30 | 1991-02-12 | Siemens-Pacesetter, Inc. | Transvenously placed defibrillation leads via an inferior vena cava access site and method of use |
US5203832A (en) | 1989-11-17 | 1993-04-20 | Long Manufacturing Ltd. | Circumferential flow heat exchanger |
US5009636A (en) | 1989-12-06 | 1991-04-23 | The Kendall Company | Dual-lumen catheter apparatus and method |
US5254088A (en) | 1990-02-02 | 1993-10-19 | Ep Technologies, Inc. | Catheter steering mechanism |
ATE120377T1 (en) | 1990-02-08 | 1995-04-15 | Howmedica | INFLATABLE DILATATOR. |
US6536427B2 (en) | 1990-03-02 | 2003-03-25 | Glaxo Group Limited | Inhalation device |
FR2659240B1 (en) | 1990-03-06 | 1997-07-04 | Daniel Galley | EPIDURAL ELECTRODE SYSTEM CALLED TO BE INTRODUCED INTO THE EPIDURAL SPACE. |
US5549559A (en) | 1990-03-22 | 1996-08-27 | Argomed Ltd. | Thermal treatment apparatus |
US5056529A (en) | 1990-04-03 | 1991-10-15 | Groot William J De | Apparatus and method for performing a transbroncheal biopsy |
US5139029A (en) | 1990-04-06 | 1992-08-18 | Henry Fishman | Allergy testing apparatus and method |
US5096916A (en) | 1990-05-07 | 1992-03-17 | Aegis Technology, Inc. | Treatment of chronic obstructive pulmonary disease (copd) by inhalation of an imidazoline |
US5236413B1 (en) | 1990-05-07 | 1996-06-18 | Andrew J Feiring | Method and apparatus for inducing the permeation of medication into internal tissue |
US5078716A (en) | 1990-05-11 | 1992-01-07 | Doll Larry F | Electrosurgical apparatus for resecting abnormal protruding growth |
US5624392A (en) | 1990-05-11 | 1997-04-29 | Saab; Mark A. | Heat transfer catheters and methods of making and using same |
US5265604A (en) | 1990-05-14 | 1993-11-30 | Vince Dennis J | Demand - diaphragmatic pacing (skeletal muscle pressure modified) |
US5056519A (en) | 1990-05-14 | 1991-10-15 | Vince Dennis J | Unilateral diaphragmatic pacer |
US5054486A (en) | 1990-05-31 | 1991-10-08 | Mamoru Yamada | Remedial techniques for the treatment of painful disorders such as intervertebral disc hernia and the like |
US5190540A (en) | 1990-06-08 | 1993-03-02 | Cardiovascular & Interventional Research Consultants, Inc. | Thermal balloon angioplasty |
US5360443A (en) | 1990-06-11 | 1994-11-01 | Barone Hector D | Aortic graft for repairing an abdominal aortic aneurysm |
CA2081896A1 (en) | 1990-06-15 | 1991-12-16 | James E. Shapland | Drug delivery apparatus and method |
SE500550C2 (en) | 1990-06-18 | 1994-07-11 | Siemens Elema Ab | Methods and apparatus for reducing gas re-breathing from the harmful space |
US5103804A (en) | 1990-07-03 | 1992-04-14 | Boston Scientific Corporation | Expandable tip hemostatic probes and the like |
US5188602A (en) | 1990-07-12 | 1993-02-23 | Interventional Thermodynamics, Inc. | Method and device for delivering heat to hollow body organs |
US5135517A (en) | 1990-07-19 | 1992-08-04 | Catheter Research, Inc. | Expandable tube-positioning apparatus |
US5100423A (en) | 1990-08-21 | 1992-03-31 | Medical Engineering & Development Institute, Inc. | Ablation catheter |
AU664157B2 (en) | 1990-09-14 | 1995-11-09 | American Medical Systems, Inc. | Combined hyperthermia and dilation catheter |
US5170803A (en) | 1990-09-28 | 1992-12-15 | Brunswick Biomedical Technologies, Inc. | Esophageal displacement electrode |
US5053033A (en) | 1990-10-10 | 1991-10-01 | Boston Advanced Technologies, Inc. | Inhibition of restenosis by ultraviolet radiation |
US5030645A (en) | 1990-10-15 | 1991-07-09 | Merck & Co., Inc. | Method of treating asthma using (S)-α-fluoromethyl-histidine and esters thereof |
US5105826A (en) | 1990-10-26 | 1992-04-21 | Medtronic, Inc. | Implantable defibrillation electrode and method of manufacture |
US5174288A (en) | 1990-11-30 | 1992-12-29 | Medtronic, Inc. | Method and apparatus for cardiac defibrillation |
US5165420A (en) | 1990-12-21 | 1992-11-24 | Ballard Medical Products | Bronchoalveolar lavage catheter |
US5224491A (en) | 1991-01-07 | 1993-07-06 | Medtronic, Inc. | Implantable electrode for location within a blood vessel |
US5170802A (en) | 1991-01-07 | 1992-12-15 | Medtronic, Inc. | Implantable electrode for location within a blood vessel |
US5324255A (en) | 1991-01-11 | 1994-06-28 | Baxter International Inc. | Angioplasty and ablative devices having onboard ultrasound components and devices and methods for utilizing ultrasound to treat or prevent vasopasm |
US5409453A (en) | 1992-08-12 | 1995-04-25 | Vidamed, Inc. | Steerable medical probe with stylets |
US5415166A (en) | 1991-02-15 | 1995-05-16 | Cardiac Pathways Corporation | Endocardial mapping apparatus and cylindrical semiconductor device mounting structure for use therewith and method |
US5345936A (en) | 1991-02-15 | 1994-09-13 | Cardiac Pathways Corporation | Apparatus with basket assembly for endocardial mapping |
US5465717A (en) | 1991-02-15 | 1995-11-14 | Cardiac Pathways Corporation | Apparatus and Method for ventricular mapping and ablation |
RU2091054C1 (en) | 1991-03-25 | 1997-09-27 | Владивостокский государственный медицинский университет | Method for treating asthmatic bronchitis in children affected with constitutional diathesis |
US5116864A (en) | 1991-04-09 | 1992-05-26 | Indiana University Foundation | Method for preventing restenosis following reconfiguration of body vessels |
EP0588988A4 (en) | 1991-04-10 | 1996-08-07 | British Tech Group Usa | Defibrillator and demand pacer catheter and method |
US5405362A (en) | 1991-04-29 | 1995-04-11 | The Board Of Regents For The University Of Texas System | Interactive external defibrillation and drug injection system |
US5239982A (en) | 1991-06-07 | 1993-08-31 | Baxter International Inc. | Catheter depth gauge and method of use |
US5213576A (en) | 1991-06-11 | 1993-05-25 | Cordis Corporation | Therapeutic porous balloon catheter |
US5379765A (en) | 1991-06-12 | 1995-01-10 | Kajiwara; Nagao | Monitoring apparatus for use in obtaining bronchial electrocardiogram |
US5255678A (en) | 1991-06-21 | 1993-10-26 | Ecole Polytechnique | Mapping electrode balloon |
US5383917A (en) | 1991-07-05 | 1995-01-24 | Jawahar M. Desai | Device and method for multi-phase radio-frequency ablation |
JPH0522345A (en) | 1991-07-12 | 1993-01-29 | Hitachi Ltd | Optimum management decision system for maximum transfer unit |
WO1993001862A1 (en) | 1991-07-22 | 1993-02-04 | Cyberonics, Inc. | Treatment of respiratory disorders by nerve stimulation |
GB9120306D0 (en) | 1991-09-24 | 1991-11-06 | Graham Herbert K | Method and compositions for the treatment of cerebral palsy |
JPH05121329A (en) | 1991-10-30 | 1993-05-18 | Toshiba Corp | Method and apparatus for manufacturing compound thin film |
US5405366A (en) | 1991-11-12 | 1995-04-11 | Nepera, Inc. | Adhesive hydrogels having extended use lives and process for the preparation of same |
DE4140689B4 (en) | 1991-12-10 | 2007-11-22 | Boehringer Ingelheim Kg | Inhalable powders and process for their preparation |
IL104068A (en) | 1991-12-12 | 1998-10-30 | Glaxo Group Ltd | Surfactant-free pharmaceutical aerosol formulation comprising 1,1,1,2-tetrafluoroethane or 1,1,1,2,3,3,3-heptafluoro-n- propane as propellant |
US5658549A (en) | 1991-12-12 | 1997-08-19 | Glaxo Group Limited | Aerosol formulations containing propellant 134a and fluticasone propionate |
ATE204743T1 (en) | 1991-12-18 | 2001-09-15 | Minnesota Mining & Mfg | AEROSOL COMPOSITIONS FOR MEDICINAL SUSPENSIONS |
CA2058179C (en) | 1991-12-20 | 1999-02-09 | Roland Drolet | Basic electrophysiological conditioning system and method |
FR2685208B1 (en) | 1991-12-23 | 1998-02-27 | Ela Medical Sa | VENTRICULAR CANNULA DEVICE. |
US5366443A (en) | 1992-01-07 | 1994-11-22 | Thapliyal And Eggers Partners | Method and apparatus for advancing catheters through occluded body lumens |
US6159194A (en) | 1992-01-07 | 2000-12-12 | Arthrocare Corporation | System and method for electrosurgical tissue contraction |
US6053172A (en) | 1995-06-07 | 2000-04-25 | Arthrocare Corporation | Systems and methods for electrosurgical sinus surgery |
US5231996A (en) | 1992-01-28 | 1993-08-03 | Medtronic, Inc. | Removable endocardial lead |
RU2053814C1 (en) | 1992-02-11 | 1996-02-10 | Новиков Валерий Николаевич | Method for treatment of local endobronchitis |
US5555883A (en) | 1992-02-24 | 1996-09-17 | Avitall; Boaz | Loop electrode array mapping and ablation catheter for cardiac chambers |
US5263493A (en) | 1992-02-24 | 1993-11-23 | Boaz Avitall | Deflectable loop electrode array mapping and ablation catheter for cardiac chambers |
US5344398A (en) | 1992-02-25 | 1994-09-06 | Japan Crescent, Inc. | Heated balloon catheter |
US5540681A (en) | 1992-04-10 | 1996-07-30 | Medtronic Cardiorhythm | Method and system for radiofrequency ablation of tissue |
US5269758A (en) | 1992-04-29 | 1993-12-14 | Taheri Syde A | Intravascular catheter and method for treatment of hypothermia |
US5443470A (en) | 1992-05-01 | 1995-08-22 | Vesta Medical, Inc. | Method and apparatus for endometrial ablation |
US5331947A (en) | 1992-05-01 | 1994-07-26 | Shturman Cardiology Systems, Inc. | Inflatable sheath for introduction of ultrasonic catheter through the lumen of a fiber optic endoscope |
US5255679A (en) | 1992-06-02 | 1993-10-26 | Cardiac Pathways Corporation | Endocardial catheter for mapping and/or ablation with an expandable basket structure having means for providing selective reinforcement and pressure sensing mechanism for use therewith, and method |
US5281218A (en) | 1992-06-05 | 1994-01-25 | Cardiac Pathways Corporation | Catheter having needle electrode for radiofrequency ablation |
US5324284A (en) | 1992-06-05 | 1994-06-28 | Cardiac Pathways, Inc. | Endocardial mapping and ablation system utilizing a separately controlled ablation catheter and method |
US5271383A (en) | 1992-06-05 | 1993-12-21 | Wilk Peter J | Method for reducing intussusception |
US5772590A (en) | 1992-06-30 | 1998-06-30 | Cordis Webster, Inc. | Cardiovascular catheter with laterally stable basket-shaped electrode array with puller wire |
US5782239A (en) | 1992-06-30 | 1998-07-21 | Cordis Webster, Inc. | Unique electrode configurations for cardiovascular electrode catheter with built-in deflection method and central puller wire |
US5411025A (en) | 1992-06-30 | 1995-05-02 | Cordis Webster, Inc. | Cardiovascular catheter with laterally stable basket-shaped electrode array |
AU4686993A (en) | 1992-07-30 | 1994-03-03 | Temple University - Of The Commonwealth System Of Higher Education | Direct manual cardiac compression device and method of use thereof |
US5630794A (en) | 1992-08-12 | 1997-05-20 | Vidamed, Inc. | Catheter tip and method of manufacturing |
GB9219102D0 (en) | 1992-09-09 | 1992-10-21 | Fairfax Andrew J | Flowmeters |
US5662108A (en) | 1992-09-23 | 1997-09-02 | Endocardial Solutions, Inc. | Electrophysiology mapping system |
US6647617B1 (en) | 1992-09-23 | 2003-11-18 | Graydon Ernest Beatty | Method of construction an endocardial mapping catheter |
US7189208B1 (en) | 1992-09-23 | 2007-03-13 | Endocardial Solutions, Inc. | Method for measuring heart electrophysiology |
US5553611A (en) | 1994-01-06 | 1996-09-10 | Endocardial Solutions, Inc. | Endocardial measurement method |
US6603996B1 (en) | 2000-06-07 | 2003-08-05 | Graydon Ernest Beatty | Software for mapping potential distribution of a heart chamber |
US5311866A (en) | 1992-09-23 | 1994-05-17 | Endocardial Therapeutics, Inc. | Heart mapping catheter |
DE69315354T2 (en) | 1992-09-23 | 1998-03-19 | Endocardial Solutions Inc | ENDOCARD-MAPPING SYSTEM |
US6240307B1 (en) | 1993-09-23 | 2001-05-29 | Endocardial Solutions, Inc. | Endocardial mapping system |
US7930012B2 (en) | 1992-09-23 | 2011-04-19 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Chamber location method |
US5309910A (en) | 1992-09-25 | 1994-05-10 | Ep Technologies, Inc. | Cardiac mapping and ablation systems |
US5313943A (en) | 1992-09-25 | 1994-05-24 | Ep Technologies, Inc. | Catheters and methods for performing cardiac diagnosis and treatment |
US5293869A (en) | 1992-09-25 | 1994-03-15 | Ep Technologies, Inc. | Cardiac probe with dynamic support for maintaining constant surface contact during heart systole and diastole |
US5471982A (en) | 1992-09-29 | 1995-12-05 | Ep Technologies, Inc. | Cardiac mapping and ablation systems |
US6086581A (en) | 1992-09-29 | 2000-07-11 | Ep Technologies, Inc. | Large surface cardiac ablation catheter that assumes a low profile during introduction into the heart |
DE669839T1 (en) | 1992-10-01 | 1996-10-10 | Cardiac Pacemakers | STENT-LIKE STRUCTURE FOR DEFLICTION ELECTRODES. |
WO1994007446A1 (en) | 1992-10-05 | 1994-04-14 | Boston Scientific Corporation | Device and method for heating tissue |
US5431696A (en) | 1992-10-13 | 1995-07-11 | Atlee, Iii; John L. | Esophageal probe for transeophageal cardiac stimulation |
US5807306A (en) | 1992-11-09 | 1998-09-15 | Cortrak Medical, Inc. | Polymer matrix drug delivery apparatus |
US5391197A (en) | 1992-11-13 | 1995-02-21 | Dornier Medical Systems, Inc. | Ultrasound thermotherapy probe |
US5956501A (en) | 1997-01-10 | 1999-09-21 | Health Hero Network, Inc. | Disease simulation system and method |
US5348554A (en) | 1992-12-01 | 1994-09-20 | Cardiac Pathways Corporation | Catheter for RF ablation with cooled electrode |
US5545161A (en) | 1992-12-01 | 1996-08-13 | Cardiac Pathways Corporation | Catheter for RF ablation having cooled electrode with electrically insulated sleeve |
US5256141A (en) | 1992-12-22 | 1993-10-26 | Nelson Gencheff | Biological material deployment method and apparatus |
US5393207A (en) | 1993-01-21 | 1995-02-28 | Nimbus, Inc. | Blood pump with disposable rotor assembly |
US5409483A (en) | 1993-01-22 | 1995-04-25 | Jeffrey H. Reese | Direct visualization surgical probe |
US5797960A (en) | 1993-02-22 | 1998-08-25 | Stevens; John H. | Method and apparatus for thoracoscopic intracardiac procedures |
JP3423719B2 (en) | 1993-03-16 | 2003-07-07 | ボストン サイエンティフィック リミテッド | Multiple electrode support mechanism |
US5893847A (en) | 1993-03-16 | 1999-04-13 | Ep Technologies, Inc. | Multiple electrode support structures with slotted hub and hoop spline elements |
US5823189A (en) | 1993-03-16 | 1998-10-20 | Ep Technologies, Inc. | Multiple electrode support structures with spline elements and over-molded hub |
US5725525A (en) | 1993-03-16 | 1998-03-10 | Ep Technologies, Inc. | Multiple electrode support structures with integral hub and spline elements |
WO1994021170A1 (en) | 1993-03-16 | 1994-09-29 | Ep Technologies, Inc. | Flexible circuit assemblies employing ribbon cable |
US5409710A (en) | 1993-04-20 | 1995-04-25 | Endocon, Inc. | Foam cell drug delivery |
US5417687A (en) | 1993-04-30 | 1995-05-23 | Medical Scientific, Inc. | Bipolar electrosurgical trocar |
US6749604B1 (en) | 1993-05-10 | 2004-06-15 | Arthrocare Corporation | Electrosurgical instrument with axially-spaced electrodes |
US5456667A (en) | 1993-05-20 | 1995-10-10 | Advanced Cardiovascular Systems, Inc. | Temporary stenting catheter with one-piece expandable segment |
JPH06339453A (en) | 1993-06-01 | 1994-12-13 | Olympus Optical Co Ltd | Cover-equipped endoscope device |
ES2329232T3 (en) | 1993-06-10 | 2009-11-24 | Allergan, Inc. | TREATMENT OF NEUROMUSCULAR DISORDERS AND AFFECTIONS WITH A DIFFERENT BOTULINIC SEROTYPE. |
FI96815C (en) | 1993-06-23 | 1996-08-26 | Nokia Telecommunications Oy | Procedure for making a call |
US5860974A (en) | 1993-07-01 | 1999-01-19 | Boston Scientific Corporation | Heart ablation catheter with expandable electrode and method of coupling energy to an electrode on a catheter shaft |
WO1995001751A1 (en) | 1993-07-01 | 1995-01-19 | Boston Scientific Corporation | Imaging, electrical potential sensing, and ablation catheters |
US5571088A (en) | 1993-07-01 | 1996-11-05 | Boston Scientific Corporation | Ablation catheters |
GB9314640D0 (en) | 1993-07-15 | 1993-08-25 | Salim Aws S M | Tunnellimg catheter |
US5422362A (en) | 1993-07-29 | 1995-06-06 | Quadra Logic Technologies, Inc. | Method to inhibit restenosis |
US5490521A (en) | 1993-08-31 | 1996-02-13 | Medtronic, Inc. | Ultrasound biopsy needle |
US5507791A (en) | 1993-08-31 | 1996-04-16 | Sit'ko; Sergei P. | Microwave resonance therapy |
US5396887A (en) | 1993-09-23 | 1995-03-14 | Cardiac Pathways Corporation | Apparatus and method for detecting contact pressure |
US6947785B1 (en) | 1993-09-23 | 2005-09-20 | Endocardial Solutions, Inc. | Interface system for endocardial mapping catheter |
US5908446A (en) | 1994-07-07 | 1999-06-01 | Cardiac Pathways Corporation | Catheter assembly, catheter and multi-port introducer for use therewith |
US5607462A (en) | 1993-09-24 | 1997-03-04 | Cardiac Pathways Corporation | Catheter assembly, catheter and multi-catheter introducer for use therewith |
US5626618A (en) | 1993-09-24 | 1997-05-06 | The Ohio State University | Mechanical adjunct to cardiopulmonary resuscitation (CPR), and an electrical adjunct to defibrillation countershock, cardiac pacing, and cardiac monitoring |
US5415656A (en) | 1993-09-28 | 1995-05-16 | American Medical Systems, Inc. | Electrosurgical apparatus |
US5496312A (en) | 1993-10-07 | 1996-03-05 | Valleylab Inc. | Impedance and temperature generator control |
US5400783A (en) | 1993-10-12 | 1995-03-28 | Cardiac Pathways Corporation | Endocardial mapping apparatus with rotatable arm and method |
US5437665A (en) | 1993-10-12 | 1995-08-01 | Munro; Malcolm G. | Electrosurgical loop electrode instrument for laparoscopic surgery |
US5582609A (en) | 1993-10-14 | 1996-12-10 | Ep Technologies, Inc. | Systems and methods for forming large lesions in body tissue using curvilinear electrode elements |
US5881727A (en) | 1993-10-14 | 1999-03-16 | Ep Technologies, Inc. | Integrated cardiac mapping and ablation probe |
US5991650A (en) | 1993-10-15 | 1999-11-23 | Ep Technologies, Inc. | Surface coatings for catheters, direct contacting diagnostic and therapeutic devices |
US5545193A (en) | 1993-10-15 | 1996-08-13 | Ep Technologies, Inc. | Helically wound radio-frequency emitting electrodes for creating lesions in body tissue |
WO1995010322A1 (en) | 1993-10-15 | 1995-04-20 | Ep Technologies, Inc. | Creating complex lesion patterns in body tissue |
US5470352A (en) | 1993-10-29 | 1995-11-28 | Northeastern University | Balloon angioplasty device |
US5599346A (en) | 1993-11-08 | 1997-02-04 | Zomed International, Inc. | RF treatment system |
US6071280A (en) | 1993-11-08 | 2000-06-06 | Rita Medical Systems, Inc. | Multiple electrode ablation apparatus |
US6641580B1 (en) | 1993-11-08 | 2003-11-04 | Rita Medical Systems, Inc. | Infusion array ablation apparatus |
US5536267A (en) | 1993-11-08 | 1996-07-16 | Zomed International | Multiple electrode ablation apparatus |
US5487385A (en) | 1993-12-03 | 1996-01-30 | Avitall; Boaz | Atrial mapping and ablation catheter system |
US5641326A (en) | 1993-12-13 | 1997-06-24 | Angeion Corporation | Method and apparatus for independent atrial and ventricular defibrillation |
US6986893B2 (en) | 1993-12-28 | 2006-01-17 | Allergan, Inc. | Method for treating a mucus secretion |
US6974578B1 (en) | 1993-12-28 | 2005-12-13 | Allergan, Inc. | Method for treating secretions and glands using botulinum toxin |
US6245040B1 (en) | 1994-01-14 | 2001-06-12 | Cordis Corporation | Perfusion balloon brace and method of use |
US5423812A (en) | 1994-01-31 | 1995-06-13 | Ellman; Alan G. | Electrosurgical stripping electrode for palatopharynx tissue |
AUPM411494A0 (en) | 1994-02-25 | 1994-03-24 | Central Sydney Area Health Service | Method and device for the provocation of upper or lower airway narrowing and/or the induction of sputum |
US6216043B1 (en) | 1994-03-04 | 2001-04-10 | Ep Technologies, Inc. | Asymmetric multiple electrode support structures |
US5394880A (en) | 1994-03-17 | 1995-03-07 | Atlee, Iii; John L. | Esophageal stethoscope |
US5598848A (en) | 1994-03-31 | 1997-02-04 | Ep Technologies, Inc. | Systems and methods for positioning multiple electrode structures in electrical contact with the myocardium |
US5454840A (en) | 1994-04-05 | 1995-10-03 | Krakovsky; Alexander A. | Potency package |
US5766605A (en) | 1994-04-15 | 1998-06-16 | Mount Sinai School Of Medicine Of The City University Of New York | Treatment of autonomic nerve dysfunction with botulinum toxin |
JPH07289557A (en) | 1994-04-25 | 1995-11-07 | Inter Noba Kk | Heating treatment method of constricted part of blood vessel and local heating type catheter therefor |
CA2189004A1 (en) | 1994-04-29 | 1995-11-09 | Charles D. Lennox | Resecting coagulated tissue |
US5458596A (en) | 1994-05-06 | 1995-10-17 | Dorsal Orthopedic Corporation | Method and apparatus for controlled contraction of soft tissue |
US5807308A (en) | 1996-02-23 | 1998-09-15 | Somnus Medical Technologies, Inc. | Method and apparatus for treatment of air way obstructions |
US5843021A (en) * | 1994-05-09 | 1998-12-01 | Somnus Medical Technologies, Inc. | Cell necrosis apparatus |
US6152143A (en) | 1994-05-09 | 2000-11-28 | Somnus Medical Technologies, Inc. | Method for treatment of air way obstructions |
US5547469A (en) | 1994-05-13 | 1996-08-20 | Boston Scientific Corporation | Apparatus for performing diagnostic and therapeutic modalities in the biliary tree |
US5478309A (en) | 1994-05-27 | 1995-12-26 | William P. Sweezer, Jr. | Catheter system and method for providing cardiopulmonary bypass pump support during heart surgery |
NZ272354A (en) | 1994-06-17 | 1997-10-24 | Trudell Medical Ltd | Catheter system; method and apparatus for delivering an aerosol form of medication to the lungs, details of method and of catheter apparatus |
US5836905A (en) | 1994-06-20 | 1998-11-17 | Lemelson; Jerome H. | Apparatus and methods for gene therapy |
US6405732B1 (en) | 1994-06-24 | 2002-06-18 | Curon Medical, Inc. | Method to treat gastric reflux via the detection and ablation of gastro-esophageal nerves and receptors |
US6056744A (en) | 1994-06-24 | 2000-05-02 | Conway Stuart Medical, Inc. | Sphincter treatment apparatus |
US5505730A (en) | 1994-06-24 | 1996-04-09 | Stuart D. Edwards | Thin layer ablation apparatus |
US5843077A (en) | 1994-06-24 | 1998-12-01 | Somnus Medical Technologies, Inc. | Minimally invasive apparatus for internal ablation of turbinates with surface cooling |
US5681308A (en) | 1994-06-24 | 1997-10-28 | Stuart D. Edwards | Ablation apparatus for cardiac chambers |
US5827277A (en) | 1994-06-24 | 1998-10-27 | Somnus Medical Technologies, Inc. | Minimally invasive apparatus for internal ablation of turbinates |
US5746224A (en) | 1994-06-24 | 1998-05-05 | Somnus Medical Technologies, Inc. | Method for ablating turbinates |
US6006755A (en) | 1994-06-24 | 1999-12-28 | Edwards; Stuart D. | Method to detect and treat aberrant myoelectric activity |
US6092528A (en) | 1994-06-24 | 2000-07-25 | Edwards; Stuart D. | Method to treat esophageal sphincters |
US5735846A (en) | 1994-06-27 | 1998-04-07 | Ep Technologies, Inc. | Systems and methods for ablating body tissue using predicted maximum tissue temperature |
ATE257675T1 (en) | 1994-06-27 | 2004-01-15 | Boston Scient Ltd | NON-LINEAR CONTROL SYSTEMS FOR HEATING AND REMOVING BODY TISSUE |
US5680860A (en) | 1994-07-07 | 1997-10-28 | Cardiac Pathways Corporation | Mapping and/or ablation catheter with coilable distal extremity and method for using same |
US5496304A (en) | 1994-07-20 | 1996-03-05 | University Of Utah Research Foundation | Surgical marking pen |
DE4427106A1 (en) | 1994-07-30 | 1996-02-01 | Otto Werner Woelky | Process for control of tumours and skin cancer |
US5623940A (en) | 1994-08-02 | 1997-04-29 | S.L.T. Japan Co., Ltd. | Catheter apparatus with a sensor |
US5454782A (en) | 1994-08-11 | 1995-10-03 | Perkins; Rodney C. | Translumenal circumferential energy delivery device |
US8025661B2 (en) | 1994-09-09 | 2011-09-27 | Cardiofocus, Inc. | Coaxial catheter instruments for ablation with radiant energy |
US5522862A (en) | 1994-09-21 | 1996-06-04 | Medtronic, Inc. | Method and apparatus for treating obstructive sleep apnea |
US5549655A (en) | 1994-09-21 | 1996-08-27 | Medtronic, Inc. | Method and apparatus for synchronized treatment of obstructive sleep apnea |
US5885278A (en) | 1994-10-07 | 1999-03-23 | E.P. Technologies, Inc. | Structures for deploying movable electrode elements |
CA2201881C (en) | 1994-10-07 | 2005-12-06 | Sidney D. Fleischman | Flexible structures for supporting electrode elements |
US5836947A (en) | 1994-10-07 | 1998-11-17 | Ep Technologies, Inc. | Flexible structures having movable splines for supporting electrode elements |
US6142994A (en) | 1994-10-07 | 2000-11-07 | Ep Technologies, Inc. | Surgical method and apparatus for positioning a diagnostic a therapeutic element within the body |
US5740808A (en) | 1996-10-28 | 1998-04-21 | Ep Technologies, Inc | Systems and methods for guilding diagnostic or therapeutic devices in interior tissue regions |
US5722401A (en) | 1994-10-19 | 1998-03-03 | Cardiac Pathways Corporation | Endocardial mapping and/or ablation catheter probe |
US5899882A (en) | 1994-10-27 | 1999-05-04 | Novoste Corporation | Catheter apparatus for radiation treatment of a desired area in the vascular system of a patient |
US5630813A (en) | 1994-12-08 | 1997-05-20 | Kieturakis; Maciej J. | Electro-cauterizing dissector and method for facilitating breast implant procedure |
US5669930A (en) | 1994-12-08 | 1997-09-23 | Fuji Systems Corporation | Stent for intracorporeal retention |
EP2314244A1 (en) | 1994-12-13 | 2011-04-27 | Torben Lorentzen | An electrosurgical instrument for tissue ablation, an apparatus, and a method for providing a lesion in damaged and diseased tissue from a mammal |
US5707336A (en) | 1995-01-09 | 1998-01-13 | Cardassist Incorporated | Ventricular assist device |
IT1277790B1 (en) | 1995-02-17 | 1997-11-12 | Tecres Spa | METACARPO-FALANGEA AND INTERPHALANGE PROSTHESES FOR HAND OR FOOT JOINTS |
US5722416A (en) | 1995-02-17 | 1998-03-03 | Ep Technologies, Inc. | Systems and methods for analyzing biopotential morphologies in heart tissue to locate potential ablation sites |
US5605157A (en) | 1995-02-17 | 1997-02-25 | Ep Technologies, Inc. | Systems and methods for filtering signals derived from biological events |
US5630425A (en) | 1995-02-17 | 1997-05-20 | Ep Technologies, Inc. | Systems and methods for adaptive filtering artifacts from composite signals |
US5595183A (en) | 1995-02-17 | 1997-01-21 | Ep Technologies, Inc. | Systems and methods for examining heart tissue employing multiple electrode structures and roving electrodes |
US5601088A (en) | 1995-02-17 | 1997-02-11 | Ep Technologies, Inc. | Systems and methods for filtering artifacts from composite signals |
US5711305A (en) | 1995-02-17 | 1998-01-27 | Ep Technologies, Inc. | Systems and methods for acquiring endocardially or epicardially paced electrocardiograms |
ATE220307T1 (en) | 1995-02-17 | 2002-07-15 | Boston Scient Ltd | ARRANGEMENT FOR SEQUENTIAL MEASURING BIOLOGICAL EVENTS |
US5792064A (en) | 1995-02-17 | 1998-08-11 | Panescu; Dorin | Systems and methods for analyzing cardiac biopotential morphologies by cross-correlation |
US6409722B1 (en) | 1998-07-07 | 2002-06-25 | Medtronic, Inc. | Apparatus and method for creating, maintaining, and controlling a virtual electrode used for the ablation of tissue |
EP0827383B1 (en) | 1995-02-28 | 2007-05-30 | Boston Scientific Corporation | Polymer implements for torque transmission |
US6106524A (en) | 1995-03-03 | 2000-08-22 | Neothermia Corporation | Methods and apparatus for therapeutic cauterization of predetermined volumes of biological tissue |
US5868740A (en) | 1995-03-24 | 1999-02-09 | Board Of Regents-Univ Of Nebraska | Method for volumetric tissue ablation |
EA000891B1 (en) | 1995-04-14 | 2000-06-26 | Глаксо Веллкам Инк. | Metered dose inhaler for fluticasone propionate |
EP1366777B1 (en) | 1995-04-14 | 2005-06-15 | SmithKline Beecham Corporation | Metered dose inhaler for salmeterol |
US5588812A (en) | 1995-04-19 | 1996-12-31 | Nimbus, Inc. | Implantable electric axial-flow blood pump |
US5707218A (en) | 1995-04-19 | 1998-01-13 | Nimbus, Inc. | Implantable electric axial-flow blood pump with blood cooled bearing |
US5620438A (en) | 1995-04-20 | 1997-04-15 | Angiomedics Ii Incorporated | Method and apparatus for treating vascular tissue following angioplasty to minimize restenosis |
US5678535A (en) | 1995-04-21 | 1997-10-21 | Dimarco; Anthony Fortunato | Method and apparatus for electrical stimulation of the respiratory muscles to achieve artificial ventilation in a patient |
GB9508204D0 (en) | 1995-04-21 | 1995-06-07 | Speywood Lab Ltd | A novel agent able to modify peripheral afferent function |
US5607419A (en) | 1995-04-24 | 1997-03-04 | Angiomedics Ii Inc. | Method and apparatus for treating vessel wall with UV radiation following angioplasty |
DE69606845T2 (en) | 1995-04-28 | 2000-06-15 | Target Therapeutics, Inc. | High performance catheter with braided element |
US5688267A (en) | 1995-05-01 | 1997-11-18 | Ep Technologies, Inc. | Systems and methods for sensing multiple temperature conditions during tissue ablation |
WO1996034570A1 (en) | 1995-05-01 | 1996-11-07 | Ep Technologies, Inc. | Systems and methods for obtaining desired lesion characteristics while ablating body tissue |
US5681280A (en) | 1995-05-02 | 1997-10-28 | Heart Rhythm Technologies, Inc. | Catheter control system |
US6575969B1 (en) | 1995-05-04 | 2003-06-10 | Sherwood Services Ag | Cool-tip radiofrequency thermosurgery electrode system for tumor ablation |
US5755753A (en) | 1995-05-05 | 1998-05-26 | Thermage, Inc. | Method for controlled contraction of collagen tissue |
US5817073A (en) | 1995-06-02 | 1998-10-06 | Krespi; Yosef P. | Apparatus for administering local anesthetics and therapeutic medications during endoscopic surgery |
US5540730A (en) | 1995-06-06 | 1996-07-30 | Cyberonics, Inc. | Treatment of motility disorders by nerve stimulation |
US6363937B1 (en) | 1995-06-07 | 2002-04-02 | Arthrocare Corporation | System and methods for electrosurgical treatment of the digestive system |
US5741248A (en) | 1995-06-07 | 1998-04-21 | Temple University-Of The Commonwealth System Of Higher Education | Fluorochemical liquid augmented cryosurgery |
US6132438A (en) | 1995-06-07 | 2000-10-17 | Ep Technologies, Inc. | Devices for installing stasis reducing means in body tissue |
US6090104A (en) | 1995-06-07 | 2000-07-18 | Cordis Webster, Inc. | Catheter with a spirally wound flat ribbon electrode |
US6837888B2 (en) | 1995-06-07 | 2005-01-04 | Arthrocare Corporation | Electrosurgical probe with movable return electrode and methods related thereto |
US5868737A (en) | 1995-06-09 | 1999-02-09 | Engineering Research & Associates, Inc. | Apparatus and method for determining ablation |
US5697925A (en) | 1995-06-09 | 1997-12-16 | Engineering & Research Associates, Inc. | Apparatus and method for thermal ablation |
JPH0947518A (en) | 1995-06-26 | 1997-02-18 | Lederle Japan Ltd | Optical fiber laser probe for photodynamic therapy |
US5873852A (en) | 1995-07-10 | 1999-02-23 | Interventional Technologies | Device for injecting fluid into a wall of a blood vessel |
US6008211A (en) | 1995-07-27 | 1999-12-28 | Pdt Pharmaceuticals, Inc. | Photoactivatable compounds comprising benzochlorin and furocoumarin |
US6023638A (en) | 1995-07-28 | 2000-02-08 | Scimed Life Systems, Inc. | System and method for conducting electrophysiological testing using high-voltage energy pulses to stun tissue |
WO1997004702A1 (en) | 1995-07-28 | 1997-02-13 | Ep Technologies, Inc. | Systems and methods for conducting electrophysiological testing using high-voltage energy pulses to stun heart tissue |
US5782827A (en) | 1995-08-15 | 1998-07-21 | Rita Medical Systems, Inc. | Multiple antenna ablation apparatus and method with multiple sensor feedback |
US5624439A (en) | 1995-08-18 | 1997-04-29 | Somnus Medical Technologies, Inc. | Method and apparatus for treatment of air way obstructions |
US5660175A (en) | 1995-08-21 | 1997-08-26 | Dayal; Bimal | Endotracheal device |
US6037149A (en) | 1995-08-24 | 2000-03-14 | Magainin Pharmaceuticals Inc. | DNA encoding human asthma associated factor 1 |
US6496738B2 (en) | 1995-09-06 | 2002-12-17 | Kenneth L. Carr | Dual frequency microwave heating apparatus |
US6210367B1 (en) | 1995-09-06 | 2001-04-03 | Microwave Medical Systems, Inc. | Intracorporeal microwave warming method and apparatus |
US5848972A (en) | 1995-09-15 | 1998-12-15 | Children's Medical Center Corporation | Method for endocardial activation mapping using a multi-electrode catheter |
US5707400A (en) | 1995-09-19 | 1998-01-13 | Cyberonics, Inc. | Treating refractory hypertension by nerve stimulation |
US5658322A (en) | 1995-10-11 | 1997-08-19 | Regeneration Technology | Bio-active frequency generator and method |
US5891182A (en) | 1995-10-11 | 1999-04-06 | Regeneration Tech | Bio-active frequency generator and method |
AU7328796A (en) | 1995-10-11 | 1997-05-15 | Regeneration Technology | Bio-active frequency generator and method |
DE69531399T2 (en) | 1995-10-16 | 2004-06-09 | Sun Medical Technology Research Corp., Suwa | artificial heart |
US5574059A (en) | 1995-10-27 | 1996-11-12 | Cornell Research Foundation, Inc. | Treating disorders mediated by vascular smooth muscle cell proliferation |
US6198970B1 (en) | 1995-10-27 | 2001-03-06 | Esd Limited Liability Company | Method and apparatus for treating oropharyngeal respiratory and oral motor neuromuscular disorders with electrical stimulation |
US5733316A (en) | 1995-10-27 | 1998-03-31 | Dornier Medical Systems, Inc. | Organ separation for thermal therapy |
US5837001A (en) | 1995-12-08 | 1998-11-17 | C. R. Bard | Radio frequency energy delivery system for multipolar electrode catheters |
US5836874A (en) | 1996-04-08 | 1998-11-17 | Ep Technologies, Inc. | Multi-function electrode structures for electrically analyzing and heating body tissue |
US5891135A (en) | 1996-01-19 | 1999-04-06 | Ep Technologies, Inc. | Stem elements for securing tubing and electrical wires to expandable-collapsible electrode structures |
US5925038A (en) | 1996-01-19 | 1999-07-20 | Ep Technologies, Inc. | Expandable-collapsible electrode structures for capacitive coupling to tissue |
US5846238A (en) | 1996-01-19 | 1998-12-08 | Ep Technologies, Inc. | Expandable-collapsible electrode structures with distal end steering or manipulation |
US5891136A (en) | 1996-01-19 | 1999-04-06 | Ep Technologies, Inc. | Expandable-collapsible mesh electrode structures |
US5871483A (en) | 1996-01-19 | 1999-02-16 | Ep Technologies, Inc. | Folding electrode structures |
US5904711A (en) | 1996-02-08 | 1999-05-18 | Heartport, Inc. | Expandable thoracoscopic defibrillation catheter system and method |
US5695471A (en) | 1996-02-20 | 1997-12-09 | Kriton Medical, Inc. | Sealless rotary blood pump with passive magnetic radial bearings and blood immersed axial bearings |
US5727569A (en) | 1996-02-20 | 1998-03-17 | Cardiothoracic Systems, Inc. | Surgical devices for imposing a negative pressure to fix the position of cardiac tissue during surgery |
US5730726A (en) | 1996-03-04 | 1998-03-24 | Klingenstein; Ralph James | Apparatus and method for removing fecal impaction |
US6033397A (en) | 1996-03-05 | 2000-03-07 | Vnus Medical Technologies, Inc. | Method and apparatus for treating esophageal varices |
US6139527A (en) | 1996-03-05 | 2000-10-31 | Vnus Medical Technologies, Inc. | Method and apparatus for treating hemorrhoids |
US6036687A (en) | 1996-03-05 | 2000-03-14 | Vnus Medical Technologies, Inc. | Method and apparatus for treating venous insufficiency |
US6152899A (en) | 1996-03-05 | 2000-11-28 | Vnus Medical Technologies, Inc. | Expandable catheter having improved electrode design, and method for applying energy |
EP0921765B1 (en) | 1996-03-05 | 2007-05-02 | Vnus Medical Technologies, Inc. | Vascular catheter-based system for heating tissue |
GB9620620D0 (en) | 1996-10-03 | 1996-11-20 | Ici Plc | Illumination system |
US5755760A (en) | 1996-03-11 | 1998-05-26 | Medtronic, Inc. | Deflectable catheter |
NL1002598C2 (en) | 1996-03-13 | 1997-09-17 | Bootsman Holding Bv | Method and device for processing substrate. |
JPH09243837A (en) | 1996-03-14 | 1997-09-19 | Hitachi Cable Ltd | Laser waveguide |
US6458121B1 (en) | 1996-03-19 | 2002-10-01 | Diapulse Corporation Of America | Apparatus for athermapeutic medical treatments |
US5699799A (en) | 1996-03-26 | 1997-12-23 | Siemens Corporate Research, Inc. | Automatic determination of the curved axis of a 3-D tube-shaped object in image volume |
US6258083B1 (en) | 1996-03-29 | 2001-07-10 | Eclipse Surgical Technologies, Inc. | Viewing surgical scope for minimally invasive procedures |
US5863291A (en) | 1996-04-08 | 1999-01-26 | Cardima, Inc. | Linear ablation assembly |
US5694934A (en) | 1996-04-17 | 1997-12-09 | Beth Israel Hospital | MR studies in which a paramagnetic gas is administered to a living patient |
US5979456A (en) | 1996-04-22 | 1999-11-09 | Magovern; George J. | Apparatus and method for reversibly reshaping a body part |
US5733319A (en) | 1996-04-25 | 1998-03-31 | Urologix, Inc. | Liquid coolant supply system |
US6036640A (en) | 1996-04-29 | 2000-03-14 | Medtronic, Inc. | Device and method for repositioning the heart during surgery |
AUPN957296A0 (en) | 1996-04-30 | 1996-05-23 | Cardiac Crc Nominees Pty Limited | A system for simultaneous unipolar multi-electrode ablation |
US6532388B1 (en) | 1996-04-30 | 2003-03-11 | Medtronic, Inc. | Method and system for endotracheal/esophageal stimulation prior to and during a medical procedure |
US6006134A (en) | 1998-04-30 | 1999-12-21 | Medtronic, Inc. | Method and device for electronically controlling the beating of a heart using venous electrical stimulation of nerve fibers |
US5820589A (en) | 1996-04-30 | 1998-10-13 | Medtronic, Inc. | Implantable non-invasive rate-adjustable pump |
US7269457B2 (en) | 1996-04-30 | 2007-09-11 | Medtronic, Inc. | Method and system for vagal nerve stimulation with multi-site cardiac pacing |
US6735471B2 (en) | 1996-04-30 | 2004-05-11 | Medtronic, Inc. | Method and system for endotracheal/esophageal stimulation prior to and during a medical procedure |
US5861022A (en) | 1996-04-30 | 1999-01-19 | Hipskind; S. Gregory | Method for the treatment of hiccups |
US7022105B1 (en) | 1996-05-06 | 2006-04-04 | Novasys Medical Inc. | Treatment of tissue in sphincters, sinuses and orifices |
US5810807A (en) | 1996-05-22 | 1998-09-22 | Ganz; Robert A. | Sphincterotome with deflectable cutting plane and method of using the same |
US5669932A (en) | 1996-05-29 | 1997-09-23 | Isostent, Inc. | Means for accurately positioning an expandable stent |
US5976709A (en) | 1996-05-31 | 1999-11-02 | Hitachi Kinzoku Kabushiki Kaisha | Aluminum alloy member, with insert provided therein, possessing improved damping capacity and process for producing the same |
CN1096283C (en) | 1996-05-31 | 2002-12-18 | 松浦优之 | Low frequency therapy method, apparatus and system |
US5782797A (en) | 1996-06-06 | 1998-07-21 | Scimed Life Systems, Inc. | Therapeutic infusion device |
GB2314273B (en) | 1996-06-17 | 2000-09-27 | Spes | The use of TCET in the prophylaxis and treatment of allergies |
US5800486A (en) | 1996-06-17 | 1998-09-01 | Urologix, Inc. | Device for transurethral thermal therapy with cooling balloon |
US6743197B1 (en) | 1996-07-10 | 2004-06-01 | Novasys Medical, Inc. | Treatment of discrete tissues in respiratory, urinary, circulatory, reproductive and digestive systems |
JPH1026709A (en) | 1996-07-11 | 1998-01-27 | Harufumi Kato | Device for laterally irradiating with laser beam |
US5882346A (en) | 1996-07-15 | 1999-03-16 | Cardiac Pathways Corporation | Shapable catheter using exchangeable core and method of use |
US5919172A (en) | 1996-07-17 | 1999-07-06 | Becton, Dickinson And Company | Hypodermic needle having a differential surface finish |
US7440800B2 (en) | 1996-08-19 | 2008-10-21 | Mr3 Medical, Llc | System and method for managing detrimental cardiac remodeling |
US5755714A (en) | 1996-09-17 | 1998-05-26 | Eclipse Surgical Technologies, Inc. | Shaped catheter for transmyocardial revascularization |
US5855577A (en) | 1996-09-17 | 1999-01-05 | Eclipse Surgical Technologies, Inc. | Bow shaped catheter |
US5906636A (en) | 1996-09-20 | 1999-05-25 | Texas Heart Institute | Heat treatment of inflamed tissue |
US6464697B1 (en) | 1998-02-19 | 2002-10-15 | Curon Medical, Inc. | Stomach and adjoining tissue regions in the esophagus |
US5891027A (en) | 1996-10-21 | 1999-04-06 | Irvine Biomedical, Inc. | Cardiovascular catheter system with an inflatable soft tip |
US6016437A (en) | 1996-10-21 | 2000-01-18 | Irvine Biomedical, Inc. | Catheter probe system with inflatable soft shafts |
WO1998018170A1 (en) | 1996-10-23 | 1998-04-30 | Tdk Corporation | Method for manufacturing electrode for battery |
US5848969A (en) | 1996-10-28 | 1998-12-15 | Ep Technologies, Inc. | Systems and methods for visualizing interior tissue regions using expandable imaging structures |
US5722403A (en) | 1996-10-28 | 1998-03-03 | Ep Technologies, Inc. | Systems and methods using a porous electrode for ablating and visualizing interior tissue regions |
US5779669A (en) | 1996-10-28 | 1998-07-14 | C. R. Bard, Inc. | Steerable catheter with fixed curve |
US5752518A (en) | 1996-10-28 | 1998-05-19 | Ep Technologies, Inc. | Systems and methods for visualizing interior regions of the body |
US5904651A (en) | 1996-10-28 | 1999-05-18 | Ep Technologies, Inc. | Systems and methods for visualizing tissue during diagnostic or therapeutic procedures |
US5908445A (en) | 1996-10-28 | 1999-06-01 | Ep Technologies, Inc. | Systems for visualizing interior tissue regions including an actuator to move imaging element |
WO1998018391A1 (en) | 1996-10-30 | 1998-05-07 | Ekos Corporation | Intraluminal wall drug delivery device |
US5919147A (en) | 1996-11-01 | 1999-07-06 | Jain; Krishna M. | Method and apparatus for measuring the vascular diameter of a vessel |
US6197013B1 (en) | 1996-11-06 | 2001-03-06 | Setagon, Inc. | Method and apparatus for drug and gene delivery |
US6091995A (en) | 1996-11-08 | 2000-07-18 | Surx, Inc. | Devices, methods, and systems for shrinking tissues |
US6480746B1 (en) | 1997-08-13 | 2002-11-12 | Surx, Inc. | Noninvasive devices, methods, and systems for shrinking of tissues |
US5833651A (en) | 1996-11-08 | 1998-11-10 | Medtronic, Inc. | Therapeutic intraluminal stents |
US6081749A (en) | 1997-08-13 | 2000-06-27 | Surx, Inc. | Noninvasive devices, methods, and systems for shrinking of tissues |
US6073052A (en) | 1996-11-15 | 2000-06-06 | Zelickson; Brian D. | Device and method for treatment of gastroesophageal reflux disease |
GB9626960D0 (en) | 1996-12-27 | 1997-02-12 | Glaxo Group Ltd | Valve for aerosol container |
US5730741A (en) | 1997-02-07 | 1998-03-24 | Eclipse Surgical Technologies, Inc. | Guided spiral catheter |
US5873865A (en) | 1997-02-07 | 1999-02-23 | Eclipse Surgical Technologies, Inc. | Spiral catheter with multiple guide holes |
US6056769A (en) | 1997-02-11 | 2000-05-02 | Biointerventional Corporation | Expansile device for use in blood vessels and tracts in the body and tension application device for use therewith and method |
US5882329A (en) | 1997-02-12 | 1999-03-16 | Prolifix Medical, Inc. | Apparatus and method for removing stenotic material from stents |
JP4052690B2 (en) | 1997-02-19 | 2008-02-27 | 株式会社エス・エフ・シー | Shiatsu type water heater |
US7591814B2 (en) * | 1997-02-27 | 2009-09-22 | Cryocath Technologies Inc. | Extended treatment zone catheter |
US5999855A (en) | 1997-02-28 | 1999-12-07 | Dimarco; Anthony F. | Method and apparatus for electrical activation of the expiratory muscles to restore cough |
US5897554A (en) | 1997-03-01 | 1999-04-27 | Irvine Biomedical, Inc. | Steerable catheter having a loop electrode |
US7220257B1 (en) | 2000-07-25 | 2007-05-22 | Scimed Life Systems, Inc. | Cryotreatment device and method |
US6063078A (en) | 1997-03-12 | 2000-05-16 | Medtronic, Inc. | Method and apparatus for tissue ablation |
US5954661A (en) | 1997-03-31 | 1999-09-21 | Thomas Jefferson University | Tissue characterization and treatment using pacing |
US7992572B2 (en) | 1998-06-10 | 2011-08-09 | Asthmatx, Inc. | Methods of evaluating individuals having reversible obstructive pulmonary disease |
US7425212B1 (en) | 1998-06-10 | 2008-09-16 | Asthmatx, Inc. | Devices for modification of airways by transfer of energy |
US6083255A (en) | 1997-04-07 | 2000-07-04 | Broncus Technologies, Inc. | Bronchial stenter |
US6273907B1 (en) | 1997-04-07 | 2001-08-14 | Broncus Technologies, Inc. | Bronchial stenter |
US6411852B1 (en) | 1997-04-07 | 2002-06-25 | Broncus Technologies, Inc. | Modification of airways by application of energy |
US6200333B1 (en) | 1997-04-07 | 2001-03-13 | Broncus Technologies, Inc. | Bronchial stenter |
US5972026A (en) | 1997-04-07 | 1999-10-26 | Broncus Technologies, Inc. | Bronchial stenter having diametrically adjustable electrodes |
US6283988B1 (en) | 1997-04-07 | 2001-09-04 | Broncus Technologies, Inc. | Bronchial stenter having expandable electrodes |
US7027869B2 (en) | 1998-01-07 | 2006-04-11 | Asthmatx, Inc. | Method for treating an asthma attack |
US6488673B1 (en) | 1997-04-07 | 2002-12-03 | Broncus Technologies, Inc. | Method of increasing gas exchange of a lung |
US6634363B1 (en) | 1997-04-07 | 2003-10-21 | Broncus Technologies, Inc. | Methods of treating lungs having reversible obstructive pulmonary disease |
US5876340A (en) | 1997-04-17 | 1999-03-02 | Irvine Biomedical, Inc. | Ablation apparatus with ultrasonic imaging capabilities |
US5861014A (en) | 1997-04-30 | 1999-01-19 | Medtronic, Inc. | Method and apparatus for sensing a stimulating gastrointestinal tract on-demand |
US6012457A (en) | 1997-07-08 | 2000-01-11 | The Regents Of The University Of California | Device and method for forming a circumferential conduction block in a pulmonary vein |
US5971983A (en) | 1997-05-09 | 1999-10-26 | The Regents Of The University Of California | Tissue ablation device and method of use |
US6024740A (en) | 1997-07-08 | 2000-02-15 | The Regents Of The University Of California | Circumferential ablation device assembly |
US6416740B1 (en) | 1997-05-13 | 2002-07-09 | Bristol-Myers Squibb Medical Imaging, Inc. | Acoustically active drug delivery systems |
US6217576B1 (en) | 1997-05-19 | 2001-04-17 | Irvine Biomedical Inc. | Catheter probe for treating focal atrial fibrillation in pulmonary veins |
US6050992A (en) | 1997-05-19 | 2000-04-18 | Radiotherapeutics Corporation | Apparatus and method for treating tissue with multiple electrodes |
US7255693B1 (en) | 1997-05-23 | 2007-08-14 | Csa Medical, Inc. | Heated catheter used in cryotherapy |
US5876399A (en) | 1997-05-28 | 1999-03-02 | Irvine Biomedical, Inc. | Catheter system and methods thereof |
US6201023B1 (en) | 1997-06-10 | 2001-03-13 | Agrogene Ltd. | Methods and compositions to protect crops against plant parasitic nematodes |
EP0998248A4 (en) | 1997-06-13 | 2001-03-21 | Arthrocare Corp | Electrosurgical systems and methods for recanalization of occluded body lumens |
US6251109B1 (en) | 1997-06-27 | 2001-06-26 | Daig Corporation | Process and device for the treatment of atrial arrhythmia |
US5957919A (en) | 1997-07-02 | 1999-09-28 | Laufer; Michael D. | Bleb reducer |
US6117101A (en) | 1997-07-08 | 2000-09-12 | The Regents Of The University Of California | Circumferential ablation device assembly |
US6652515B1 (en) | 1997-07-08 | 2003-11-25 | Atrionix, Inc. | Tissue ablation device assembly and method for electrically isolating a pulmonary vein ostium from an atrial wall |
US6547788B1 (en) | 1997-07-08 | 2003-04-15 | Atrionx, Inc. | Medical device with sensor cooperating with expandable member |
US6500174B1 (en) | 1997-07-08 | 2002-12-31 | Atrionix, Inc. | Circumferential ablation device assembly and methods of use and manufacture providing an ablative circumferential band along an expandable member |
US6139571A (en) | 1997-07-09 | 2000-10-31 | Fuller Research Corporation | Heated fluid surgical instrument |
US6010500A (en) | 1997-07-21 | 2000-01-04 | Cardiac Pathways Corporation | Telescoping apparatus and method for linear lesion ablation |
US6014579A (en) | 1997-07-21 | 2000-01-11 | Cardiac Pathways Corp. | Endocardial mapping catheter with movable electrode |
US6626903B2 (en) | 1997-07-24 | 2003-09-30 | Rex Medical, L.P. | Surgical biopsy device |
AUPO826597A0 (en) | 1997-07-25 | 1997-08-21 | Platt, Harry Louis | Cardiac patient remote monitoring apparatus |
US6711436B1 (en) | 1997-08-08 | 2004-03-23 | Duke University | Compositions, apparatus and methods for facilitating surgical procedures |
WO1999007354A2 (en) | 1997-08-08 | 1999-02-18 | Duke University | Compositions, apparatus and methods for facilitating surgical procedures |
US5891138A (en) | 1997-08-11 | 1999-04-06 | Irvine Biomedical, Inc. | Catheter system having parallel electrodes |
US5916235A (en) | 1997-08-13 | 1999-06-29 | The Regents Of The University Of California | Apparatus and method for the use of detachable coils in vascular aneurysms and body cavities |
US9023031B2 (en) | 1997-08-13 | 2015-05-05 | Verathon Inc. | Noninvasive devices, methods, and systems for modifying tissues |
ATE326913T1 (en) | 1997-08-13 | 2006-06-15 | Solarant Medical Inc | NON-INVASIVE DEVICES AND SYSTEMS FOR SHRINKING TISSUES |
US6479523B1 (en) | 1997-08-26 | 2002-11-12 | Emory University | Pharmacologic drug combination in vagal-induced asystole |
US6063768A (en) | 1997-09-04 | 2000-05-16 | First; Eric R. | Application of botulinum toxin to the management of neurogenic inflammatory disorders |
US5964782A (en) | 1997-09-18 | 1999-10-12 | Scimed Life Systems, Inc. | Closure device and method |
US5954717A (en) | 1997-09-25 | 1999-09-21 | Radiotherapeutics Corporation | Method and system for heating solid tissue |
US6045549A (en) | 1997-09-30 | 2000-04-04 | Somnus Medical Technologies, Inc. | Tissue ablation apparatus and device for use therein and method |
EP0908713A1 (en) | 1997-10-06 | 1999-04-14 | Claud S. Gordon Company | Temperature instrumented semiconductor wafer |
US5893835A (en) | 1997-10-10 | 1999-04-13 | Ethicon Endo-Surgery, Inc. | Ultrasonic clamp coagulator apparatus having dual rotational positioning |
US6645200B1 (en) | 1997-10-10 | 2003-11-11 | Scimed Life Systems, Inc. | Method and apparatus for positioning a diagnostic or therapeutic element within the body and tip electrode for use with same |
US6071281A (en) | 1998-05-05 | 2000-06-06 | Ep Technologies, Inc. | Surgical method and apparatus for positioning a diagnostic or therapeutic element within the body and remote power control unit for use with same |
US5893887A (en) | 1997-10-14 | 1999-04-13 | Iowa-India Investments Company Limited | Stent for positioning at junction of bifurcated blood vessel and method of making |
WO1999027991A1 (en) | 1997-11-28 | 1999-06-10 | Matsura Masayuki | Method of wave therapy and apparatus therefor |
US5971979A (en) | 1997-12-02 | 1999-10-26 | Odyssey Technologies, Inc. | Method for cryogenic inhibition of hyperplasia |
US6917834B2 (en) | 1997-12-03 | 2005-07-12 | Boston Scientific Scimed, Inc. | Devices and methods for creating lesions in endocardial and surrounding tissue to isolate focal arrhythmia substrates |
JP3980140B2 (en) | 1997-12-04 | 2007-09-26 | 村越 寧根 | Therapeutic instrument |
US6464680B1 (en) | 1998-07-29 | 2002-10-15 | Pharmasonics, Inc. | Ultrasonic enhancement of drug injection |
US7921855B2 (en) | 1998-01-07 | 2011-04-12 | Asthmatx, Inc. | Method for treating an asthma attack |
DE69941252D1 (en) | 1998-01-14 | 2009-09-24 | Ams Res Corp | RIBBED ELECTRODES |
US6440128B1 (en) | 1998-01-14 | 2002-08-27 | Curon Medical, Inc. | Actively cooled electrode assemblies for forming lesions to treat dysfunction in sphincters and adjoining tissue regions |
WO1999035988A1 (en) | 1998-01-14 | 1999-07-22 | Conway-Stuart Medical, Inc. | Electrosurgical device for sphincter treatment |
AU2317899A (en) | 1998-01-14 | 1999-08-02 | Conway-Stuart Medical, Inc. | Gerd treatment apparatus and method |
US6200311B1 (en) | 1998-01-20 | 2001-03-13 | Eclipse Surgical Technologies, Inc. | Minimally invasive TMR device |
US6231595B1 (en) | 1998-03-31 | 2001-05-15 | Innercool Therapies, Inc. | Circulating fluid hypothermia method and apparatus |
US6447505B2 (en) | 1998-02-11 | 2002-09-10 | Cosman Company, Inc. | Balloon catheter method for intra-urethral radio-frequency urethral enlargement |
US6273886B1 (en) | 1998-02-19 | 2001-08-14 | Curon Medical, Inc. | Integrated tissue heating and cooling apparatus |
US6358245B1 (en) | 1998-02-19 | 2002-03-19 | Curon Medical, Inc. | Graphical user interface for association with an electrode structure deployed in contact with a tissue region |
US6258087B1 (en) | 1998-02-19 | 2001-07-10 | Curon Medical, Inc. | Expandable electrode assemblies for forming lesions to treat dysfunction in sphincters and adjoining tissue regions |
US7165551B2 (en) | 1998-02-19 | 2007-01-23 | Curon Medical, Inc. | Apparatus to detect and treat aberrant myoelectric activity |
US8906010B2 (en) | 1998-02-19 | 2014-12-09 | Mederi Therapeutics, Inc. | Graphical user interface for association with an electrode structure deployed in contact with a tissue region |
US6402744B2 (en) | 1998-02-19 | 2002-06-11 | Curon Medical, Inc. | Systems and methods for forming composite lesions to treat dysfunction in sphincters and adjoining tissue regions |
US6325798B1 (en) | 1998-02-19 | 2001-12-04 | Curon Medical, Inc. | Vacuum-assisted systems and methods for treating sphincters and adjoining tissue regions |
US6423058B1 (en) | 1998-02-19 | 2002-07-23 | Curon Medical, Inc. | Assemblies to visualize and treat sphincters and adjoining tissue regions |
US6355031B1 (en) | 1998-02-19 | 2002-03-12 | Curon Medical, Inc. | Control systems for multiple electrode arrays to create lesions in tissue regions at or near a sphincter |
CA2319517A1 (en) * | 1998-02-19 | 1999-08-26 | Curon Medical, Inc. | Electrosurgical sphincter treatment apparatus |
US20100114087A1 (en) | 1998-02-19 | 2010-05-06 | Edwards Stuart D | Methods and devices for treating urinary incontinence |
US6142993A (en) | 1998-02-27 | 2000-11-07 | Ep Technologies, Inc. | Collapsible spline structure using a balloon as an expanding actuator |
JP2002505138A (en) | 1998-03-06 | 2002-02-19 | キューロン メディカル,インコーポレイテッド | Instrument for electrosurgically treating the esophageal sphincter |
AU3104999A (en) | 1998-03-19 | 1999-10-11 | Oratec Interventions, Inc. | Catheter for delivery of energy to a surgical site |
US6053909A (en) | 1998-03-27 | 2000-04-25 | Shadduck; John H. | Ionothermal delivery system and technique for medical procedures |
US8128595B2 (en) | 1998-04-21 | 2012-03-06 | Zoll Circulation, Inc. | Method for a central venous line catheter having a temperature control system |
US6338727B1 (en) | 1998-08-13 | 2002-01-15 | Alsius Corporation | Indwelling heat exchange catheter and method of using same |
WO1999055245A1 (en) | 1998-04-30 | 1999-11-04 | Edwards Stuart D | Electrosurgical sphincter treatment apparatus |
US6003517A (en) | 1998-04-30 | 1999-12-21 | Ethicon Endo-Surgery, Inc. | Method for using an electrosurgical device on lung tissue |
US6161047A (en) | 1998-04-30 | 2000-12-12 | Medtronic Inc. | Apparatus and method for expanding a stimulation lead body in situ |
US6045550A (en) | 1998-05-05 | 2000-04-04 | Cardiac Peacemakers, Inc. | Electrode having non-joined thermocouple for providing multiple temperature-sensitive junctions |
US6558378B2 (en) | 1998-05-05 | 2003-05-06 | Cardiac Pacemakers, Inc. | RF ablation system and method having automatic temperature control |
US6493589B1 (en) | 1998-05-07 | 2002-12-10 | Medtronic, Inc. | Methods and apparatus for treatment of pulmonary conditions |
US6001054A (en) | 1998-05-19 | 1999-12-14 | Regulla; D. F. | Method and apparatus for differential energy application for local dose enhancement of ionizing radiation |
US6241727B1 (en) | 1998-05-27 | 2001-06-05 | Irvine Biomedical, Inc. | Ablation catheter system having circular lesion capabilities |
US6599311B1 (en) | 1998-06-05 | 2003-07-29 | Broncus Technologies, Inc. | Method and assembly for lung volume reduction |
US6174323B1 (en) | 1998-06-05 | 2001-01-16 | Broncus Technologies, Inc. | Method and assembly for lung volume reduction |
US6997189B2 (en) | 1998-06-05 | 2006-02-14 | Broncus Technologies, Inc. | Method for lung volume reduction |
US5997534A (en) | 1998-06-08 | 1999-12-07 | Tu; Hosheng | Medical ablation device and methods thereof |
US20070123958A1 (en) | 1998-06-10 | 2007-05-31 | Asthmatx, Inc. | Apparatus for treating airways in the lung |
US8181656B2 (en) | 1998-06-10 | 2012-05-22 | Asthmatx, Inc. | Methods for treating airways |
US7198635B2 (en) | 2000-10-17 | 2007-04-03 | Asthmatx, Inc. | Modification of airways by application of energy |
US20070106348A1 (en) | 1998-06-10 | 2007-05-10 | Asthmatx, Inc. | Method for treating airways in the lung |
US7187973B2 (en) | 1998-06-30 | 2007-03-06 | Endocardial Solutions, Inc. | Congestive heart failure pacing optimization method and device |
US6322559B1 (en) | 1998-07-06 | 2001-11-27 | Vnus Medical Technologies, Inc. | Electrode catheter having coil structure |
US5995873A (en) | 1998-07-07 | 1999-11-30 | Rhodes; Donald A. | Treatment of pain and of the nervous system |
US6029091A (en) | 1998-07-09 | 2000-02-22 | Irvine Biomedical, Inc. | Catheter system having lattice electrodes |
US6296639B1 (en) | 1999-02-12 | 2001-10-02 | Novacept | Apparatuses and methods for interstitial tissue removal |
US6212433B1 (en) | 1998-07-28 | 2001-04-03 | Radiotherapeutics Corporation | Method for treating tumors near the surface of an organ |
US6322584B2 (en) | 1998-07-31 | 2001-11-27 | Surx, Inc. | Temperature sensing devices and methods to shrink tissues |
US6366813B1 (en) | 1998-08-05 | 2002-04-02 | Dilorenzo Daniel J. | Apparatus and method for closed-loop intracranical stimulation for optimal control of neurological disease |
US5992419A (en) | 1998-08-20 | 1999-11-30 | Mmtc, Inc. | Method employing a tissue-heating balloon catheter to produce a "biological stent" in an orifice or vessel of a patient's body |
US6610083B2 (en) | 1998-08-24 | 2003-08-26 | Radiant Medical, Inc. | Multiple lumen heat exchange catheters |
US6673098B1 (en) | 1998-08-24 | 2004-01-06 | Radiant Medical, Inc. | Disposable cassette for intravascular heat exchange catheter |
GB9818548D0 (en) | 1998-08-25 | 1998-10-21 | Microbiological Res Authority | Treatment of mucas hypersecretion |
US5980563A (en) | 1998-08-31 | 1999-11-09 | Tu; Lily Chen | Ablation apparatus and methods for treating atherosclerosis |
US6123702A (en) | 1998-09-10 | 2000-09-26 | Scimed Life Systems, Inc. | Systems and methods for controlling power in an electrosurgical probe |
US6245065B1 (en) | 1998-09-10 | 2001-06-12 | Scimed Life Systems, Inc. | Systems and methods for controlling power in an electrosurgical probe |
US6183468B1 (en) | 1998-09-10 | 2001-02-06 | Scimed Life Systems, Inc. | Systems and methods for controlling power in an electrosurgical probe |
US6123703A (en) | 1998-09-19 | 2000-09-26 | Tu; Lily Chen | Ablation catheter and methods for treating tissues |
US6036689A (en) | 1998-09-24 | 2000-03-14 | Tu; Lily Chen | Ablation device for treating atherosclerotic tissues |
WO2000016684A1 (en) | 1998-09-24 | 2000-03-30 | Super Dimension Ltd. | System and method for determining the location of a catheter during an intra-body medical procedure |
US20040006268A1 (en) | 1998-09-24 | 2004-01-08 | Super Dimension Ltd Was Filed In Parent Case | System and method of recording and displaying in context of an image a location of at least one point-of-interest in a body during an intra-body medical procedure |
US20030074011A1 (en) | 1998-09-24 | 2003-04-17 | Super Dimension Ltd. | System and method of recording and displaying in context of an image a location of at least one point-of-interest in a body during an intra-body medical procedure |
IL126333A0 (en) | 1998-09-24 | 1999-05-09 | Super Dimension Ltd | System and method of recording and displaying in context of an image a location of at least one point-of-interest in body during an intra-body medical procedure |
US20040230252A1 (en) | 1998-10-21 | 2004-11-18 | Saul Kullok | Method and apparatus for affecting the autonomic nervous system |
US7076307B2 (en) | 2002-05-09 | 2006-07-11 | Boveja Birinder R | Method and system for modulating the vagus nerve (10th cranial nerve) with electrical pulses using implanted and external components, to provide therapy neurological and neuropsychiatric disorders |
US6366814B1 (en) | 1998-10-26 | 2002-04-02 | Birinder R. Boveja | External stimulator for adjunct (add-on) treatment for neurological, neuropsychiatric, and urological disorders |
US6123718A (en) | 1998-11-02 | 2000-09-26 | Polymerex Medical Corp. | Balloon catheter |
AU1727400A (en) | 1998-11-16 | 2000-06-05 | United States Surgical Corporation | Apparatus for thermal treatment of tissue |
KR20010040761A (en) | 1998-12-09 | 2001-05-15 | 쿡 인코포레이티드 | Hollow, Curved, Superelastic Medical Needle |
WO2000040281A1 (en) | 1999-01-06 | 2000-07-13 | United States Surgical Corporation | Tissue mapping injection device |
US6269813B1 (en) | 1999-01-15 | 2001-08-07 | Respironics, Inc. | Tracheal gas insufflation bypass and phasic delivery system and method |
US6230052B1 (en) | 1999-01-29 | 2001-05-08 | Andy Wolff | Device and method for stimulating salivation |
US6097985A (en) | 1999-02-09 | 2000-08-01 | Kai Technologies, Inc. | Microwave systems for medical hyperthermia, thermotherapy and diagnosis |
US6293908B1 (en) | 1999-02-12 | 2001-09-25 | Fuji Photo Optical Co., Ltd. | Mouthpiece and insertion assisting device for endoscope |
US6019783A (en) | 1999-03-02 | 2000-02-01 | Alsius Corporation | Cooling system for therapeutic catheter |
US6582427B1 (en) | 1999-03-05 | 2003-06-24 | Gyrus Medical Limited | Electrosurgery system |
US6161049A (en) | 1999-03-26 | 2000-12-12 | Urologix, Inc. | Thermal therapy catheter |
JP2000271235A (en) | 1999-03-26 | 2000-10-03 | Olympus Optical Co Ltd | Prostate-treating apparatus |
US6786889B1 (en) | 1999-03-31 | 2004-09-07 | Scimed Life Systems, Inc | Textured and/or marked balloon for stent delivery |
US6425877B1 (en) | 1999-04-02 | 2002-07-30 | Novasys Medical, Inc. | Treatment of tissue in the digestive circulatory respiratory urinary and reproductive systems |
US6409723B1 (en) | 1999-04-02 | 2002-06-25 | Stuart D. Edwards | Treating body tissue by applying energy and substances |
US6325797B1 (en) | 1999-04-05 | 2001-12-04 | Medtronic, Inc. | Ablation catheter and method for isolating a pulmonary vein |
US6546932B1 (en) | 1999-04-05 | 2003-04-15 | Cryocath Technologies Inc. | Cryogenic method and apparatus for promoting angiogenesis |
US20010007070A1 (en) * | 1999-04-05 | 2001-07-05 | Medtronic, Inc. | Ablation catheter assembly and method for isolating a pulmonary vein |
US6776990B2 (en) | 1999-04-08 | 2004-08-17 | Allergan, Inc. | Methods and compositions for the treatment of pancreatitis |
US6593130B1 (en) | 1999-04-16 | 2003-07-15 | The Regents Of The University Of California | Method and apparatus for ex vivo and in vivo cellular electroporation of gene protein or drug therapy |
US6317615B1 (en) | 1999-04-19 | 2001-11-13 | Cardiac Pacemakers, Inc. | Method and system for reducing arterial restenosis in the presence of an intravascular stent |
US6149647A (en) | 1999-04-19 | 2000-11-21 | Tu; Lily Chen | Apparatus and methods for tissue treatment |
US6939346B2 (en) | 1999-04-21 | 2005-09-06 | Oratec Interventions, Inc. | Method and apparatus for controlling a temperature-controlled probe |
US6270476B1 (en) | 1999-04-23 | 2001-08-07 | Cryocath Technologies, Inc. | Catheter |
US6302870B1 (en) | 1999-04-29 | 2001-10-16 | Precision Vascular Systems, Inc. | Apparatus for injecting fluids into the walls of blood vessels, body cavities, and the like |
US6341236B1 (en) | 1999-04-30 | 2002-01-22 | Ivan Osorio | Vagal nerve stimulation techniques for treatment of epileptic seizures |
WO2000069376A1 (en) | 1999-05-18 | 2000-11-23 | Silhouette Medical Inc. | Surgical weight control device |
US7171263B2 (en) | 1999-06-04 | 2007-01-30 | Impulse Dynamics Nv | Drug delivery device |
DK1185200T3 (en) | 1999-06-05 | 2008-04-07 | Wilson Cook Medical Inc | Characteristics of an endoscopic medical device |
US6235024B1 (en) | 1999-06-21 | 2001-05-22 | Hosheng Tu | Catheters system having dual ablation capability |
EP1281366B1 (en) | 1999-06-23 | 2006-10-11 | Novasys Medical, Inc. | Treatment of sphincters with electrosurgery and active substances |
ATE470414T1 (en) | 1999-06-25 | 2010-06-15 | Vahid Saadat | TISSUE TREATMENT DEVICE |
WO2001000273A1 (en) | 1999-06-25 | 2001-01-04 | Emory University | Devices and methods for vagus nerve stimulation |
RU2164424C1 (en) | 1999-06-28 | 2001-03-27 | Коноплев Сергей Петрович | Method and device for applying low frequency electromagnetic therapy |
US6238392B1 (en) | 1999-06-29 | 2001-05-29 | Ethicon Endo-Surgery, Inc. | Bipolar electrosurgical instrument including a plurality of balloon electrodes |
US6361554B1 (en) | 1999-06-30 | 2002-03-26 | Pharmasonics, Inc. | Methods and apparatus for the subcutaneous delivery of acoustic vibrations |
US6587719B1 (en) | 1999-07-01 | 2003-07-01 | Cyberonics, Inc. | Treatment of obesity by bilateral vagus nerve stimulation |
US6364878B1 (en) | 1999-07-07 | 2002-04-02 | Cardiac Pacemakers, Inc. | Percutaneous transluminal ablation catheter manipulation tool |
US6200332B1 (en) | 1999-07-09 | 2001-03-13 | Ceramoptec Industries, Inc. | Device and method for underskin laser treatments |
US20030070676A1 (en) | 1999-08-05 | 2003-04-17 | Cooper Joel D. | Conduits having distal cage structure for maintaining collateral channels in tissue and related methods |
US20050137715A1 (en) | 1999-08-05 | 2005-06-23 | Broncus Technologies, Inc. | Methods and devices for maintaining patency of surgically created channels in a body organ |
US6749606B2 (en) | 1999-08-05 | 2004-06-15 | Thomas Keast | Devices for creating collateral channels |
US7815590B2 (en) | 1999-08-05 | 2010-10-19 | Broncus Technologies, Inc. | Devices for maintaining patency of surgically created channels in tissue |
US20050060044A1 (en) | 1999-08-05 | 2005-03-17 | Ed Roschak | Methods and devices for maintaining patency of surgically created channels in a body organ |
EP1143864B1 (en) | 1999-08-05 | 2004-02-04 | Broncus Technologies, Inc. | Methods and devices for creating collateral channels in the lungs |
US7462162B2 (en) | 2001-09-04 | 2008-12-09 | Broncus Technologies, Inc. | Antiproliferative devices for maintaining patency of surgically created channels in a body organ |
US20050177144A1 (en) | 1999-08-05 | 2005-08-11 | Broncus Technologies, Inc. | Methods and devices for maintaining patency of surgically created channels in a body organ |
US6712812B2 (en) | 1999-08-05 | 2004-03-30 | Broncus Technologies, Inc. | Devices for creating collateral channels |
US7422563B2 (en) | 1999-08-05 | 2008-09-09 | Broncus Technologies, Inc. | Multifunctional tip catheter for applying energy to tissue and detecting the presence of blood flow |
US20030130657A1 (en) | 1999-08-05 | 2003-07-10 | Tom Curtis P. | Devices for applying energy to tissue |
US7422584B2 (en) | 2002-07-05 | 2008-09-09 | Broncus Technologies, Inc. | Extrapleural airway device and method |
US7022088B2 (en) | 1999-08-05 | 2006-04-04 | Broncus Technologies, Inc. | Devices for applying energy to tissue |
US7175644B2 (en) | 2001-02-14 | 2007-02-13 | Broncus Technologies, Inc. | Devices and methods for maintaining collateral channels in tissue |
US6767544B2 (en) | 2002-04-01 | 2004-07-27 | Allergan, Inc. | Methods for treating cardiovascular diseases with botulinum toxin |
US6315778B1 (en) | 1999-09-10 | 2001-11-13 | C. R. Bard, Inc. | Apparatus for creating a continuous annular lesion |
US6264653B1 (en) | 1999-09-24 | 2001-07-24 | C. R. Band, Inc. | System and method for gauging the amount of electrode-tissue contact using pulsed radio frequency energy |
WO2001022897A1 (en) | 1999-09-28 | 2001-04-05 | Novasys Medical, Inc. | Treatment of tissue by application of energy and drugs |
US6338836B1 (en) | 1999-09-28 | 2002-01-15 | Siemens Aktiengesellschaft | Asthma analysis method employing hyperpolarized gas and magnetic resonance imaging |
US7229469B1 (en) | 1999-10-02 | 2007-06-12 | Quantumcor, Inc. | Methods for treating and repairing mitral valve annulus |
US20030069570A1 (en) | 1999-10-02 | 2003-04-10 | Witzel Thomas H. | Methods for repairing mitral valve annulus percutaneously |
US20040249401A1 (en) | 1999-10-05 | 2004-12-09 | Omnisonics Medical Technologies, Inc. | Apparatus and method for an ultrasonic medical device with a non-compliant balloon |
US6587718B2 (en) | 1999-10-08 | 2003-07-01 | Scimed Life Systems, Inc. | Iontophoretic delivery to heart tissue |
US6265379B1 (en) | 1999-10-13 | 2001-07-24 | Allergan Sales, Inc. | Method for treating otic disorders |
US6287304B1 (en) | 1999-10-15 | 2001-09-11 | Neothermia Corporation | Interstitial cauterization of tissue volumes with electrosurgically deployed electrodes |
US6838429B2 (en) | 1999-10-22 | 2005-01-04 | Paslin David A | Atopic dermatitis treatment method |
DE19952505A1 (en) | 1999-10-29 | 2001-05-03 | Gerd Hausdorf | An expandable balloon for medical use comprises a thin-walled polymer shell coated with radio-opaque material in a pattern and is expandable on introduction of liquid and increasing pressure |
US6303509B1 (en) | 1999-10-29 | 2001-10-16 | Taiwan Semiconductor Manufacturing Company | Method to calibrate the wafer transfer for oxide etcher (with clamp) |
US20040215235A1 (en) | 1999-11-16 | 2004-10-28 | Barrx, Inc. | Methods and systems for determining physiologic characteristics for treatment of the esophagus |
US20040215296A1 (en) | 1999-11-16 | 2004-10-28 | Barrx, Inc. | System and method for treating abnormal epithelium in an esophagus |
US20060095032A1 (en) | 1999-11-16 | 2006-05-04 | Jerome Jackson | Methods and systems for determining physiologic characteristics for treatment of the esophagus |
CA2388861C (en) | 1999-11-16 | 2013-09-03 | Robert A. Ganz | System and method of treating abnormal tissue in the human esophagus |
US6529756B1 (en) | 1999-11-22 | 2003-03-04 | Scimed Life Systems, Inc. | Apparatus for mapping and coagulating soft tissue in or around body orifices |
US6626855B1 (en) | 1999-11-26 | 2003-09-30 | Therus Corpoation | Controlled high efficiency lesion formation using high intensity ultrasound |
US6752765B1 (en) | 1999-12-01 | 2004-06-22 | Medtronic, Inc. | Method and apparatus for monitoring heart rate and abnormal respiration |
US6139845A (en) | 1999-12-07 | 2000-10-31 | Allergan Sales, Inc. | Method for treating cancer with a neurotoxin |
US6719694B2 (en) | 1999-12-23 | 2004-04-13 | Therus Corporation | Ultrasound transducers for imaging and therapy |
US6547776B1 (en) | 2000-01-03 | 2003-04-15 | Curon Medical, Inc. | Systems and methods for treating tissue in the crura |
US7483743B2 (en) | 2000-01-11 | 2009-01-27 | Cedars-Sinai Medical Center | System for detecting, diagnosing, and treating cardiovascular disease |
US6451013B1 (en) * | 2000-01-19 | 2002-09-17 | Medtronic Xomed, Inc. | Methods of tonsil reduction using high intensity focused ultrasound to form an ablated tissue area containing a plurality of lesions |
US6356787B1 (en) | 2000-02-24 | 2002-03-12 | Electro Core Techniques, Llc | Method of treating facial blushing by electrical stimulation of the sympathetic nerve chain |
US6438423B1 (en) | 2000-01-20 | 2002-08-20 | Electrocore Technique, Llc | Method of treating complex regional pain syndromes by electrical stimulation of the sympathetic nerve chain |
US6885888B2 (en) | 2000-01-20 | 2005-04-26 | The Cleveland Clinic Foundation | Electrical stimulation of the sympathetic nerve chain |
US6356786B1 (en) | 2000-01-20 | 2002-03-12 | Electrocore Techniques, Llc | Method of treating palmar hyperhydrosis by electrical stimulation of the sympathetic nervous chain |
US6589235B2 (en) | 2000-01-21 | 2003-07-08 | The Regents Of The University Of California | Method and apparatus for cartilage reshaping by radiofrequency heating |
US20030050591A1 (en) | 2000-02-08 | 2003-03-13 | Patrick Mchale Anthony | Loading system and method for using the same |
US6663622B1 (en) | 2000-02-11 | 2003-12-16 | Iotek, Inc. | Surgical devices and methods for use in tissue ablation procedures |
US6524580B1 (en) | 2000-02-15 | 2003-02-25 | Allergan Sales, Inc. | Method for treating thyroid disorders |
US6773711B2 (en) | 2000-02-15 | 2004-08-10 | Allergan, Inc. | Botulinum toxin therapy for Hashimoto's thyroiditis |
US6649161B1 (en) | 2000-02-22 | 2003-11-18 | Allergan, Inc. | Method for treating hypocalcemia |
US6723091B2 (en) | 2000-02-22 | 2004-04-20 | Gyrus Medical Limited | Tissue resurfacing |
US6708064B2 (en) | 2000-02-24 | 2004-03-16 | Ali R. Rezai | Modulation of the brain to affect psychiatric disorders |
US6551274B2 (en) | 2000-02-29 | 2003-04-22 | Biosense Webster, Inc. | Cryoablation catheter with an expandable cooling chamber |
US6394956B1 (en) | 2000-02-29 | 2002-05-28 | Scimed Life Systems, Inc. | RF ablation and ultrasound catheter for crossing chronic total occlusions |
US6679264B1 (en) | 2000-03-04 | 2004-01-20 | Emphasys Medical, Inc. | Methods and devices for use in performing pulmonary procedures |
US6544226B1 (en) | 2000-03-13 | 2003-04-08 | Curon Medical, Inc. | Operative devices that can be removably fitted on catheter bodies to treat tissue regions in the body |
US6770070B1 (en) | 2000-03-17 | 2004-08-03 | Rita Medical Systems, Inc. | Lung treatment apparatus and method |
US8251070B2 (en) | 2000-03-27 | 2012-08-28 | Asthmatx, Inc. | Methods for treating airways |
US6514290B1 (en) | 2000-03-31 | 2003-02-04 | Broncus Technologies, Inc. | Lung elastic recoil restoring or tissue compressing device and method |
US20010031981A1 (en) | 2000-03-31 | 2001-10-18 | Evans Michael A. | Method and device for locating guidewire and treating chronic total occlusions |
US6673068B1 (en) | 2000-04-12 | 2004-01-06 | Afx, Inc. | Electrode arrangement for use in a medical instrument |
US20060100666A1 (en) | 2000-04-20 | 2006-05-11 | Pulmosonix Pty. Ltd. | Apparatus and method for lung analysis |
AU2001255713A1 (en) | 2000-04-25 | 2001-11-07 | Harumi Naganuma | Noninvasive detection and activation of the lymphatic system in treating diseaseand alleviating pain |
US6652517B1 (en) | 2000-04-25 | 2003-11-25 | Uab Research Foundation | Ablation catheter, system, and method of use thereof |
US20010044596A1 (en) | 2000-05-10 | 2001-11-22 | Ali Jaafar | Apparatus and method for treatment of vascular restenosis by electroporation |
US6599288B2 (en) * | 2000-05-16 | 2003-07-29 | Atrionix, Inc. | Apparatus and method incorporating an ultrasound transducer onto a delivery member |
US8914114B2 (en) | 2000-05-23 | 2014-12-16 | The Feinstein Institute For Medical Research | Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation |
US6610713B2 (en) | 2000-05-23 | 2003-08-26 | North Shore - Long Island Jewish Research Institute | Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation |
US6306423B1 (en) | 2000-06-02 | 2001-10-23 | Allergan Sales, Inc. | Neurotoxin implant |
US6306403B1 (en) | 2000-06-14 | 2001-10-23 | Allergan Sales, Inc. | Method for treating parkinson's disease with a botulinum toxin |
EP1365800B1 (en) | 2000-06-28 | 2013-03-06 | Ira Sanders | Methods for using tetanus toxin for benificial purposes in animals (mammals) |
US6477396B1 (en) | 2000-07-07 | 2002-11-05 | Biosense Webster, Inc. | Mapping and ablation catheter |
EP1299035B1 (en) | 2000-07-13 | 2013-02-13 | ReCor Medical, Inc. | Thermal treatment apparatus with focussed energy application |
EP2430997A3 (en) | 2000-07-13 | 2014-05-07 | ReCor Medical, Inc. | Ultrasonic emitter with reflective interface |
US20030125786A1 (en) | 2000-07-13 | 2003-07-03 | Gliner Bradford Evan | Methods and apparatus for effectuating a lasting change in a neural-function of a patient |
EP1172445A1 (en) | 2000-07-14 | 2002-01-16 | Praenadia GmbH | A method for direct genetic analysis of target cells by using fluorescence probes |
US6903187B1 (en) | 2000-07-21 | 2005-06-07 | Allergan, Inc. | Leucine-based motif and clostridial neurotoxins |
IT1319170B1 (en) | 2000-07-28 | 2003-09-26 | Lorenzo Piccone | APPARATUS ABLE TO MODULATE THE NEUROVEGETATIVE SYSTEM AND INTEGRATE ITS ACTION WITH THAT OF THE CENTRAL NERVOUS SYSTEM: |
JP2002078809A (en) | 2000-09-07 | 2002-03-19 | Shutaro Satake | Balloon catheter for electrically isolating pulmonary vein |
US6640120B1 (en) | 2000-10-05 | 2003-10-28 | Scimed Life Systems, Inc. | Probe assembly for mapping and ablating pulmonary vein tissue and method of using same |
JP2002112946A (en) | 2000-10-11 | 2002-04-16 | Olympus Optical Co Ltd | Hood for endoscope |
PT1292281E (en) | 2000-10-12 | 2004-11-30 | Boehringer Ingelheim Pharma | NEW POSSESSION FOR INHALATION CONTAINING TIOTROPIO |
US6908928B2 (en) | 2000-10-12 | 2005-06-21 | Bi Pharma Kg. | Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions |
UA75375C2 (en) | 2000-10-12 | 2006-04-17 | Boehringer Ingelheim Pharma | Method for producing powdery preparations for inhaling |
US6475160B1 (en) | 2000-10-13 | 2002-11-05 | Nathan Sher | Skin testing device |
CA2426144C (en) | 2000-10-17 | 2010-08-10 | Broncus Technologies, Inc. | Modification of airways by application of energy |
US7104987B2 (en) | 2000-10-17 | 2006-09-12 | Asthmatx, Inc. | Control system and process for application of energy to airway walls and other mediums |
US6549808B1 (en) | 2000-10-19 | 2003-04-15 | Heinz R. Gisel | Devices and methods for the transcutaneous delivery of ions and the electrical stimulation of tissue and cells at targeted areas in the eye |
US6827931B1 (en) | 2000-10-20 | 2004-12-07 | Allergan, Inc. | Method for treating endocrine disorders |
US6601581B1 (en) | 2000-11-01 | 2003-08-05 | Advanced Medical Applications, Inc. | Method and device for ultrasound drug delivery |
US6575623B2 (en) | 2000-11-10 | 2003-06-10 | Cardiostream, Inc. | Guide wire having extendable contact sensors for measuring temperature of vessel walls |
US6847849B2 (en) | 2000-11-15 | 2005-01-25 | Medtronic, Inc. | Minimally invasive apparatus for implanting a sacral stimulation lead |
US20040087936A1 (en) | 2000-11-16 | 2004-05-06 | Barrx, Inc. | System and method for treating abnormal tissue in an organ having a layered tissue structure |
AT5005U1 (en) | 2000-11-21 | 2002-02-25 | Ernst Biegler Ges M B H | ELECTRODESY SYSTEM FOR ELECTRICAL PUNCTUAL STIMULATION THERAPY AND HANDLING TOOL THEREFOR |
US6633779B1 (en) | 2000-11-27 | 2003-10-14 | Science Medicus, Inc. | Treatment of asthma and respiratory disease by means of electrical neuro-receptive waveforms |
US6681136B2 (en) | 2000-12-04 | 2004-01-20 | Science Medicus, Inc. | Device and method to modulate blood pressure by electrical waveforms |
US7785323B2 (en) | 2000-12-04 | 2010-08-31 | Boston Scientific Scimed, Inc. | Loop structure including inflatable therapeutic device |
US6676657B2 (en) | 2000-12-07 | 2004-01-13 | The United States Of America As Represented By The Department Of Health And Human Services | Endoluminal radiofrequency cauterization system |
US20020087151A1 (en) | 2000-12-29 | 2002-07-04 | Afx, Inc. | Tissue ablation apparatus with a sliding ablation instrument and method |
US20020143373A1 (en) | 2001-01-25 | 2002-10-03 | Courtnage Peter A. | System and method for therapeutic application of energy |
US6735475B1 (en) | 2001-01-30 | 2004-05-11 | Advanced Bionics Corporation | Fully implantable miniature neurostimulator for stimulation as a therapy for headache and/or facial pain |
US6989004B2 (en) | 2001-02-28 | 2006-01-24 | Rex Medical, L.P. | Apparatus for delivering ablation fluid to treat lesions |
US7101384B2 (en) | 2001-03-08 | 2006-09-05 | Tru-Light Corporation | Light processing of selected body components |
US6723053B2 (en) | 2001-03-14 | 2004-04-20 | Coopersurgical, Inc. | Esophageal balloon catheter device |
WO2002074385A2 (en) | 2001-03-20 | 2002-09-26 | Bruce R. Gilbert, M.D., Ph.D., P.C. | Device for surface stimulation of acupuncture points |
US6699243B2 (en) | 2001-09-19 | 2004-03-02 | Curon Medical, Inc. | Devices, systems and methods for treating tissue regions of the body |
US20050283197A1 (en) | 2001-04-10 | 2005-12-22 | Daum Douglas R | Systems and methods for hypotension |
US6666858B2 (en) | 2001-04-12 | 2003-12-23 | Scimed Life Systems, Inc. | Cryo balloon for atrial ablation |
US20040243118A1 (en) | 2001-06-01 | 2004-12-02 | Ayers Gregory M. | Device and method for positioning a catheter tip for creating a cryogenic lesion |
US6620159B2 (en) | 2001-06-06 | 2003-09-16 | Scimed Life Systems, Inc. | Conductive expandable electrode body and method of manufacturing the same |
US7127284B2 (en) | 2001-06-11 | 2006-10-24 | Mercator Medsystems, Inc. | Electroporation microneedle and methods for its use |
US20020198574A1 (en) | 2001-06-22 | 2002-12-26 | Ron Gumpert | Automatic sobriety training and reconditioning system |
EP1271384A1 (en) | 2001-06-28 | 2003-01-02 | Boehringer Ingelheim International GmbH | System and method for assisting in diagnosis, therapy and/or monitoring of a funtional lung disease |
JP4602602B2 (en) | 2001-07-19 | 2010-12-22 | オリンパス株式会社 | Medical instruments |
US20060167498A1 (en) | 2001-07-23 | 2006-07-27 | Dilorenzo Daniel J | Method, apparatus, and surgical technique for autonomic neuromodulation for the treatment of disease |
DE50202789D1 (en) | 2001-07-27 | 2005-05-19 | Impella Cardiotech Ag | NEUROSTIMULATION UNIT FOR THE IMMOBILIZATION OF THE HEART DURING CARDIOSURGICAL OPERATIONS |
US6622047B2 (en) | 2001-07-28 | 2003-09-16 | Cyberonics, Inc. | Treatment of neuropsychiatric disorders by near-diaphragmatic nerve stimulation |
HU224941B1 (en) | 2001-08-10 | 2006-04-28 | Bgi Innovacios Kft | Phototerapy apparatus |
US6994706B2 (en) | 2001-08-13 | 2006-02-07 | Minnesota Medical Physics, Llc | Apparatus and method for treatment of benign prostatic hyperplasia |
US6827718B2 (en) | 2001-08-14 | 2004-12-07 | Scimed Life Systems, Inc. | Method of and apparatus for positioning and maintaining the position of endoscopic instruments |
US7734355B2 (en) | 2001-08-31 | 2010-06-08 | Bio Control Medical (B.C.M.) Ltd. | Treatment of disorders by unidirectional nerve stimulation |
US20050060041A1 (en) | 2001-09-04 | 2005-03-17 | Broncus Technologies, Inc. | Methods and devices for maintaining surgically created channels in a body organ |
WO2003020103A2 (en) | 2001-09-04 | 2003-03-13 | Amit Technology Science & Medicine Ltd. | Method of and device for therapeutic illumination of internal organs and tissues |
US20050060042A1 (en) | 2001-09-04 | 2005-03-17 | Broncus Technologies, Inc. | Methods and devices for maintaining surgically created channels in a body organ |
US7708712B2 (en) | 2001-09-04 | 2010-05-04 | Broncus Technologies, Inc. | Methods and devices for maintaining patency of surgically created channels in a body organ |
US20050137611A1 (en) | 2001-09-04 | 2005-06-23 | Broncus Technologies, Inc. | Methods and devices for maintaining surgically created channels in a body organ |
US6802843B2 (en) | 2001-09-13 | 2004-10-12 | Csaba Truckai | Electrosurgical working end with resistive gradient electrodes |
US6623742B2 (en) | 2001-09-17 | 2003-09-23 | Allergan, Inc. | Methods for treating fibromyalgia |
US7187964B2 (en) | 2001-09-27 | 2007-03-06 | Dirar S. Khoury | Cardiac catheter imaging system |
JP3607231B2 (en) | 2001-09-28 | 2005-01-05 | 有限会社日本エレクテル | High frequency heating balloon catheter |
US6635056B2 (en) | 2001-10-09 | 2003-10-21 | Cardiac Pacemakers, Inc. | RF ablation apparatus and method using amplitude control |
US6671533B2 (en) | 2001-10-11 | 2003-12-30 | Irvine Biomedical Inc. | System and method for mapping and ablating body tissue of the interior region of the heart |
US6934583B2 (en) | 2001-10-22 | 2005-08-23 | Pacesetter, Inc. | Implantable lead and method for stimulating the vagus nerve |
US6895267B2 (en) | 2001-10-24 | 2005-05-17 | Scimed Life Systems, Inc. | Systems and methods for guiding and locating functional elements on medical devices positioned in a body |
US6669693B2 (en) | 2001-11-13 | 2003-12-30 | Mayo Foundation For Medical Education And Research | Tissue ablation device and methods of using |
US6692492B2 (en) | 2001-11-28 | 2004-02-17 | Cardiac Pacemaker, Inc. | Dielectric-coated ablation electrode having a non-coated window with thermal sensors |
US7591818B2 (en) | 2001-12-04 | 2009-09-22 | Endoscopic Technologies, Inc. | Cardiac ablation devices and methods |
US6893436B2 (en) | 2002-01-03 | 2005-05-17 | Afx, Inc. | Ablation instrument having a flexible distal portion |
WO2003059336A1 (en) | 2002-01-18 | 2003-07-24 | Tatton Technologies, Llc. | Methods for treating eye disorders |
US7473273B2 (en) | 2002-01-22 | 2009-01-06 | Medtronic Vascular, Inc. | Stent assembly with therapeutic agent exterior banding |
US20080147137A1 (en) | 2002-01-23 | 2008-06-19 | Biocontrol Medical Ltd. | Inhibition of sympathetic nerves |
US20030153905A1 (en) | 2002-01-25 | 2003-08-14 | Edwards Stuart Denzil | Selective ablation system |
US6695761B2 (en) | 2002-01-30 | 2004-02-24 | Biomed Solutions, Llc | Apparatus for assisting a heart |
US6814733B2 (en) * | 2002-01-31 | 2004-11-09 | Biosense, Inc. | Radio frequency pulmonary vein isolation |
AU2003212870A1 (en) | 2002-02-01 | 2003-09-02 | The Cleveland Clinic Foundation | Methods of affecting hypothalamic-related conditions |
AU2003241269A1 (en) | 2002-02-01 | 2003-09-09 | The Cleveland Clinic Foundation | Neurostimulation for affecting sleep disorders |
US7477945B2 (en) | 2002-02-01 | 2009-01-13 | The Cleveland Clinic Foundation | Delivery device for stimulating the sympathetic nerve chain |
US20110306997A9 (en) | 2002-02-21 | 2011-12-15 | Roschak Edmund J | Devices for creating passages and sensing for blood vessels |
US6937896B1 (en) | 2002-02-26 | 2005-08-30 | Pacesetter, Inc. | Sympathetic nerve stimulator and/or pacemaker |
GB0204525D0 (en) | 2002-02-27 | 2002-04-10 | Whale Jon | Medical therapy apparatus |
US20030225443A1 (en) | 2002-03-13 | 2003-12-04 | Kanthi Kiran | Methods and devices for modulating atrial configuration |
US20030187430A1 (en) | 2002-03-15 | 2003-10-02 | Vorisek James C. | System and method for measuring power at tissue during RF ablation |
US7309707B2 (en) | 2002-03-20 | 2007-12-18 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament |
US7689276B2 (en) | 2002-09-13 | 2010-03-30 | Leptos Biomedical, Inc. | Dynamic nerve stimulation for treatment of disorders |
US7239912B2 (en) | 2002-03-22 | 2007-07-03 | Leptos Biomedical, Inc. | Electric modulation of sympathetic nervous system |
US6755849B1 (en) | 2002-03-28 | 2004-06-29 | Board Of Regents, The University Of Texas System | Method for delivering energy to tissue and apparatus |
US6978174B2 (en) | 2002-04-08 | 2005-12-20 | Ardian, Inc. | Methods and devices for renal nerve blocking |
US7620451B2 (en) | 2005-12-29 | 2009-11-17 | Ardian, Inc. | Methods and apparatus for pulsed electric field neuromodulation via an intra-to-extravascular approach |
US20080213331A1 (en) | 2002-04-08 | 2008-09-04 | Ardian, Inc. | Methods and devices for renal nerve blocking |
US8774913B2 (en) | 2002-04-08 | 2014-07-08 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and apparatus for intravasculary-induced neuromodulation |
US7653438B2 (en) | 2002-04-08 | 2010-01-26 | Ardian, Inc. | Methods and apparatus for renal neuromodulation |
US20070129761A1 (en) | 2002-04-08 | 2007-06-07 | Ardian, Inc. | Methods for treating heart arrhythmia |
US8131371B2 (en) | 2002-04-08 | 2012-03-06 | Ardian, Inc. | Methods and apparatus for monopolar renal neuromodulation |
US20070135875A1 (en) | 2002-04-08 | 2007-06-14 | Ardian, Inc. | Methods and apparatus for thermally-induced renal neuromodulation |
US7617005B2 (en) | 2002-04-08 | 2009-11-10 | Ardian, Inc. | Methods and apparatus for thermally-induced renal neuromodulation |
US7853333B2 (en) | 2002-04-08 | 2010-12-14 | Ardian, Inc. | Methods and apparatus for multi-vessel renal neuromodulation |
US8150519B2 (en) | 2002-04-08 | 2012-04-03 | Ardian, Inc. | Methods and apparatus for bilateral renal neuromodulation |
US8150520B2 (en) | 2002-04-08 | 2012-04-03 | Ardian, Inc. | Methods for catheter-based renal denervation |
US7756583B2 (en) | 2002-04-08 | 2010-07-13 | Ardian, Inc. | Methods and apparatus for intravascularly-induced neuromodulation |
US8347891B2 (en) | 2002-04-08 | 2013-01-08 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and apparatus for performing a non-continuous circumferential treatment of a body lumen |
US7162303B2 (en) | 2002-04-08 | 2007-01-09 | Ardian, Inc. | Renal nerve stimulation method and apparatus for treatment of patients |
US8145317B2 (en) | 2002-04-08 | 2012-03-27 | Ardian, Inc. | Methods for renal neuromodulation |
US6953431B2 (en) | 2002-04-11 | 2005-10-11 | University Of South Florida | Eccentric dilation balloons for use with endoscopes |
WO2003088820A2 (en) | 2002-04-19 | 2003-10-30 | Broncus Technologies, Inc. | Devices for maintaining surgically created openings |
US7141041B2 (en) | 2003-03-19 | 2006-11-28 | Mercator Medsystems, Inc. | Catheters having laterally deployable needles |
DE10218894A1 (en) | 2002-04-26 | 2003-11-13 | Storz Endoskop Prod Gmbh | Device for monitoring medical devices |
US7326697B2 (en) | 2002-04-29 | 2008-02-05 | Corcept Therapeutics, Inc. | Methods for increasing the therapeutic response to electroconvulsive therapy |
AU2003222424A1 (en) | 2002-05-02 | 2003-11-17 | Medigus Ltd. | Entry port for endoscopes and laparoscopes |
EP1515775A4 (en) | 2002-05-07 | 2010-03-03 | Oncostim Inc | Method and device for treating concer with electrical therapy in conjunction with chemotherapeutic agents and radiation therapy |
US6921538B2 (en) | 2002-05-10 | 2005-07-26 | Allergan, Inc. | Therapeutic treatments for neuropsychiatric disorders |
AUPS226402A0 (en) | 2002-05-13 | 2002-06-13 | Advanced Metal Coatings Pty Limited | An ablation catheter |
US6898557B2 (en) | 2002-05-17 | 2005-05-24 | Hewlett-Packard Development Company, Lp. | System and method for remote testing of components |
WO2003097095A1 (en) | 2002-05-20 | 2003-11-27 | Chemstop Pty Ltd | Process for the preparation and activation of substances and a means of producing same |
US20040028676A1 (en) | 2002-08-06 | 2004-02-12 | Klein Dean A. | Swallowing system tissue modifier |
US7292890B2 (en) | 2002-06-20 | 2007-11-06 | Advanced Bionics Corporation | Vagus nerve stimulation via unidirectional propagation of action potentials |
US6776991B2 (en) | 2002-06-26 | 2004-08-17 | Allergan, Inc. | Methods for treating priapism |
US6881213B2 (en) | 2002-06-28 | 2005-04-19 | Ethicon, Inc. | Device and method to expand treatment array |
US20040009180A1 (en) | 2002-07-11 | 2004-01-15 | Allergan, Inc. | Transdermal botulinum toxin compositions |
US6866662B2 (en) | 2002-07-23 | 2005-03-15 | Biosense Webster, Inc. | Ablation catheter having stabilizing array |
US6878156B1 (en) | 2002-07-26 | 2005-04-12 | Alsius Corporation | Portable cooler for heat exchange catheter |
US6852110B2 (en) | 2002-08-01 | 2005-02-08 | Solarant Medical, Inc. | Needle deployment for temperature sensing from an electrode |
US7393350B2 (en) | 2002-08-06 | 2008-07-01 | Erbe Elektromedizin Gmbh | Cryo-surgical apparatus and methods |
US6733464B2 (en) | 2002-08-23 | 2004-05-11 | Hewlett-Packard Development Company, L.P. | Multi-function sensor device and methods for its use |
US7328069B2 (en) | 2002-09-06 | 2008-02-05 | Medtronic, Inc. | Method, system and device for treating disorders of the pelvic floor by electrical stimulation of and the delivery of drugs to the left and right pudendal nerves |
US6780183B2 (en) | 2002-09-16 | 2004-08-24 | Biosense Webster, Inc. | Ablation catheter having shape-changing balloon |
WO2004033034A1 (en) | 2002-10-04 | 2004-04-22 | Microchips, Inc. | Medical device for neural stimulation and controlled drug delivery |
US7037319B2 (en) | 2002-10-15 | 2006-05-02 | Scimed Life Systems, Inc. | Nanotube paper-based medical device |
US6755026B2 (en) | 2002-10-24 | 2004-06-29 | Tech Medical Devices Inc. | Thermoelectric system to directly regulate the temperature of intravenous solutions and bodily fluids |
US20040082947A1 (en) | 2002-10-25 | 2004-04-29 | The Regents Of The University Of Michigan | Ablation catheters |
US7066950B2 (en) | 2002-10-31 | 2006-06-27 | Cherokee Products, Inc. | Vapor therapy treatment device and method for generating therapeutic vapor treatment |
US20050222651A1 (en) | 2002-10-31 | 2005-10-06 | Cherokee Products, Inc | Therapeutic device and method |
US7536339B1 (en) | 2002-10-31 | 2009-05-19 | Trading Technologies International, Inc. | Method and system for quantity entry |
US7238357B2 (en) | 2002-11-05 | 2007-07-03 | Allergan, Inc. | Methods for treating ulcers and gastroesophageal reflux disease |
US20040153056A1 (en) | 2002-11-11 | 2004-08-05 | Berchtold Holding Gmbh, A German Corporation | Probe |
US20040106954A1 (en) | 2002-11-15 | 2004-06-03 | Whitehurst Todd K. | Treatment of congestive heart failure |
US7142917B2 (en) | 2002-12-04 | 2006-11-28 | Terumo Kabushiki Kaisha | Heart treatment equipment and method for preventing fatal arrhythmia |
US7986994B2 (en) | 2002-12-04 | 2011-07-26 | Medtronic, Inc. | Method and apparatus for detecting change in intrathoracic electrical impedance |
US7065409B2 (en) | 2002-12-13 | 2006-06-20 | Cardiac Pacemakers, Inc. | Device communications of an implantable medical device and an external system |
NZ540425A (en) | 2002-12-20 | 2009-03-31 | Botulinum Toxin Res Ass Inc | Pharmaceutical botulinum toxin compositions |
US7131445B2 (en) | 2002-12-23 | 2006-11-07 | Gyrus Medical Limited | Electrosurgical method and apparatus |
US7395117B2 (en) | 2002-12-23 | 2008-07-01 | Cardiac Pacemakers, Inc. | Implantable medical device having long-term wireless capabilities |
US7127300B2 (en) | 2002-12-23 | 2006-10-24 | Cardiac Pacemakers, Inc. | Method and apparatus for enabling data communication between an implantable medical device and a patient management system |
US6978182B2 (en) | 2002-12-27 | 2005-12-20 | Cardiac Pacemakers, Inc. | Advanced patient management system including interrogator/transceiver unit |
US7278984B2 (en) | 2002-12-31 | 2007-10-09 | Alsius Corporation | System and method for controlling rate of heat exchange with patient |
US20050059153A1 (en) | 2003-01-22 | 2005-03-17 | George Frank R. | Electromagnetic activation of gene expression and cell growth |
JP4067976B2 (en) | 2003-01-24 | 2008-03-26 | 有限会社日本エレクテル | High frequency heating balloon catheter |
US20040147988A1 (en) | 2003-01-29 | 2004-07-29 | Stephens Willard M. | Method of treatment using one or more of a group of the "THERMA-KLOTH" products |
US7613515B2 (en) | 2003-02-03 | 2009-11-03 | Enteromedics Inc. | High frequency vagal blockage therapy |
US7844338B2 (en) | 2003-02-03 | 2010-11-30 | Enteromedics Inc. | High frequency obesity treatment |
US20040172084A1 (en) | 2003-02-03 | 2004-09-02 | Knudson Mark B. | Method and apparatus for treatment of gastro-esophageal reflux disease (GERD) |
DE10305553B4 (en) | 2003-02-10 | 2005-11-03 | Lothar Dr.med. Göbel | Device for tamponade of body cavities |
US20040158237A1 (en) | 2003-02-11 | 2004-08-12 | Marwan Abboud | Multi-energy ablation station |
US6913616B2 (en) | 2003-02-14 | 2005-07-05 | Laser Cleanse | Laser ionization therapy system and method |
AU2004213010A1 (en) | 2003-02-18 | 2004-09-02 | Neurosignal Technologies, Inc. | Regulation of blood pressure by coded nerve signals |
US7837676B2 (en) | 2003-02-20 | 2010-11-23 | Recor Medical, Inc. | Cardiac ablation devices |
US6923808B2 (en) | 2003-02-24 | 2005-08-02 | Boston Scientific Scimed, Inc. | Probes having helical and loop shaped inflatable therapeutic elements |
US7559890B2 (en) | 2003-02-26 | 2009-07-14 | Ikona Medical Corporation | Endoscopic imaging of an organ system |
US8071550B2 (en) | 2003-03-03 | 2011-12-06 | Allergan, Inc. | Methods for treating uterine disorders |
IL154801A0 (en) | 2003-03-06 | 2003-10-31 | Karotix Internat Ltd | Multi-channel and multi-dimensional system and method |
US7551957B2 (en) | 2003-03-06 | 2009-06-23 | Bioelectronics Corp. | Electromagnetic therapy device and methods |
US20060015151A1 (en) | 2003-03-14 | 2006-01-19 | Aldrich William N | Method of using endoscopic truncal vagoscopy with gastric bypass, gastric banding and other procedures |
US7684865B2 (en) | 2003-03-14 | 2010-03-23 | Endovx, Inc. | Methods and apparatus for treatment of obesity |
US7783358B2 (en) | 2003-03-14 | 2010-08-24 | Endovx, Inc. | Methods and apparatus for treatment of obesity with an ultrasound device movable in two or three axes |
US7430449B2 (en) | 2003-03-14 | 2008-09-30 | Endovx, Inc. | Methods and apparatus for testing disruption of a vagal nerve |
US7252677B2 (en) | 2003-03-14 | 2007-08-07 | Light Sciences Oncology, Inc. | Light generating device to intravascular use |
US7394976B2 (en) | 2003-03-25 | 2008-07-01 | Arizant Healthcare Inc. | Fluid warming cassette and system capable of operation under negative pressure |
US7186251B2 (en) | 2003-03-27 | 2007-03-06 | Cierra, Inc. | Energy based devices and methods for treatment of patent foramen ovale |
KR100466866B1 (en) | 2003-04-24 | 2005-01-24 | 전명기 | Electrode for radiofrequency tissue ablation |
US7390496B2 (en) | 2003-04-25 | 2008-06-24 | Allergan, Inc. | Therapeutic treatments for repetitive hand washing |
US7396535B2 (en) | 2003-04-25 | 2008-07-08 | Ackerman Alan H | Therapy for obsessive compulsive head banging |
US7101387B2 (en) | 2003-04-30 | 2006-09-05 | Scimed Life Systems, Inc. | Radio frequency ablation cooling shield |
US7221979B2 (en) | 2003-04-30 | 2007-05-22 | Medtronic, Inc. | Methods and apparatus for the regulation of hormone release |
US6838434B2 (en) | 2003-05-02 | 2005-01-04 | Allergan, Inc. | Methods for treating sinus headache |
US20040226556A1 (en) | 2003-05-13 | 2004-11-18 | Deem Mark E. | Apparatus for treating asthma using neurotoxin |
WO2004103459A2 (en) | 2003-05-16 | 2004-12-02 | Science Medicus, Inc. | Respiratory control by means of neuro-electrical coded signals |
US20060111755A1 (en) | 2003-05-16 | 2006-05-25 | Stone Robert T | Method and system to control respiration by means of neuro-electrical coded signals |
US20050261747A1 (en) | 2003-05-16 | 2005-11-24 | Schuler Eleanor L | Method and system to control respiration by means of neuro-electrical coded signals |
US20060287679A1 (en) | 2003-05-16 | 2006-12-21 | Stone Robert T | Method and system to control respiration by means of confounding neuro-electrical signals |
WO2004111074A2 (en) | 2003-05-30 | 2004-12-23 | The Cleveland Clinic Foundation | In vivo production of a clostridial neurotoxin light chain peptide |
US7149574B2 (en) | 2003-06-09 | 2006-12-12 | Palo Alto Investors | Treatment of conditions through electrical modulation of the autonomic nervous system |
US7738952B2 (en) | 2003-06-09 | 2010-06-15 | Palo Alto Investors | Treatment of conditions through modulation of the autonomic nervous system |
US20040253274A1 (en) | 2003-06-11 | 2004-12-16 | Allergan, Inc. | Use of a clostridial toxin to reduce appetite |
EP1648558A4 (en) | 2003-06-13 | 2015-05-27 | Biocontrol Medical B C M Ltd | Applications of vagal stimulation |
US7186220B2 (en) | 2003-07-02 | 2007-03-06 | Cardiac Pacemakers, Inc. | Implantable devices and methods using frequency-domain analysis of thoracic signal |
US8002740B2 (en) | 2003-07-18 | 2011-08-23 | Broncus Technologies, Inc. | Devices for maintaining patency of surgically created channels in tissue |
WO2005006964A2 (en) | 2003-07-18 | 2005-01-27 | Broncus Technologies, Inc. | Devices for maintaining patency of surgically created channels in tissue |
US8308682B2 (en) | 2003-07-18 | 2012-11-13 | Broncus Medical Inc. | Devices for maintaining patency of surgically created channels in tissue |
US6974224B2 (en) | 2003-07-30 | 2005-12-13 | Tru-Light Corporation | Modularized light processing of body components |
US7662101B2 (en) | 2003-09-18 | 2010-02-16 | Cardiac Pacemakers, Inc. | Therapy control based on cardiopulmonary status |
US7610094B2 (en) | 2003-09-18 | 2009-10-27 | Cardiac Pacemakers, Inc. | Synergistic use of medical devices for detecting medical disorders |
US7757690B2 (en) | 2003-09-18 | 2010-07-20 | Cardiac Pacemakers, Inc. | System and method for moderating a therapy delivered during sleep using physiologic data acquired during non-sleep |
US7156843B2 (en) * | 2003-09-08 | 2007-01-02 | Medtronic, Inc. | Irrigated focal ablation tip |
US20050065584A1 (en) | 2003-09-09 | 2005-03-24 | Schiff Jonathan D. | System and method for cooling internal tissue |
DE202004021943U1 (en) | 2003-09-12 | 2013-05-13 | Vessix Vascular, Inc. | Selectable eccentric remodeling and / or ablation of atherosclerotic material |
JP2007505658A (en) | 2003-09-15 | 2007-03-15 | アトリウム メディカル コーポレーション | Application of therapeutic substances to tissue sites using expandable medical devices |
US20050090722A1 (en) | 2003-09-17 | 2005-04-28 | Thomas Perez | Method and apparatus for providing UV light to blood |
US20050255317A1 (en) | 2003-09-22 | 2005-11-17 | Advanced Cardiovascular Systems, Inc. | Polymeric marker with high radiopacity for use in medical devices |
US20050153885A1 (en) | 2003-10-08 | 2005-07-14 | Yun Anthony J. | Treatment of conditions through modulation of the autonomic nervous system |
US7435252B2 (en) | 2003-10-15 | 2008-10-14 | Valam Corporation | Control of microorganisms in the sino-nasal tract |
US20050171396A1 (en) | 2003-10-20 | 2005-08-04 | Cyberheart, Inc. | Method for non-invasive lung treatment |
US7266414B2 (en) | 2003-10-24 | 2007-09-04 | Syntach, Ag | Methods and devices for creating electrical block at specific sites in cardiac tissue with targeted tissue ablation |
US20050096644A1 (en) | 2003-10-30 | 2005-05-05 | Hall Jeffrey A. | Energy delivery optimization for RF duty cycle for lesion creation |
WO2005062823A2 (en) | 2003-12-19 | 2005-07-14 | Savacor, Inc. | Digital electrode for cardiac rhythm management |
JP4391221B2 (en) | 2003-12-22 | 2009-12-24 | 有限会社日本エレクテル | High frequency heating balloon catheter |
US7676269B2 (en) | 2003-12-29 | 2010-03-09 | Palo Alto Investors | Treatment of female fertility conditions through modulation of the autonomic nervous system |
US7422555B2 (en) | 2003-12-30 | 2008-09-09 | Jacob Zabara | Systems and methods for therapeutically treating neuro-psychiatric disorders and other illnesses |
US7150745B2 (en) | 2004-01-09 | 2006-12-19 | Barrx Medical, Inc. | Devices and methods for treatment of luminal tissue |
US7371231B2 (en) | 2004-02-02 | 2008-05-13 | Boston Scientific Scimed, Inc. | System and method for performing ablation using a balloon |
US8007495B2 (en) | 2004-03-31 | 2011-08-30 | Biosense Webster, Inc. | Catheter for circumferential ablation at or near a pulmonary vein |
US20050222635A1 (en) | 2004-03-31 | 2005-10-06 | Krakovsky Alexander A | Potency package two |
US20050222628A1 (en) | 2004-03-31 | 2005-10-06 | Krakousky Alexander A | Implantable device for pain control and other medical treatments |
EP2893955A1 (en) | 2004-04-12 | 2015-07-15 | Zoll Medical Corporation | Automated pediatric defibrillator |
KR101193709B1 (en) | 2004-04-19 | 2012-10-23 | 프로리듬, 인크. | Ablation devices with sensor structures |
US7410480B2 (en) | 2004-04-21 | 2008-08-12 | Acclarent, Inc. | Devices and methods for delivering therapeutic substances for the treatment of sinusitis and other disorders |
US7377918B2 (en) | 2004-04-28 | 2008-05-27 | Gyrus Medical Limited | Electrosurgical method and apparatus |
US7324850B2 (en) | 2004-04-29 | 2008-01-29 | Cardiac Pacemakers, Inc. | Method and apparatus for communication between a handheld programmer and an implantable medical device |
WO2006007048A2 (en) | 2004-05-04 | 2006-01-19 | The Cleveland Clinic Foundation | Methods of treating medical conditions by neuromodulation of the sympathetic nervous system |
US7706878B2 (en) | 2004-05-07 | 2010-04-27 | Zoll Medical Corporation | Automated caregiving device with prompting based on caregiver progress |
US7899527B2 (en) | 2004-05-13 | 2011-03-01 | Palo Alto Investors | Treatment of conditions through modulation of the autonomic nervous system during at least one predetermined menstrual cycle phase |
WO2006007284A2 (en) | 2004-06-21 | 2006-01-19 | Curon Medical, Inc. | Systems and methods for treating tissue regions of the body |
US8409167B2 (en) | 2004-07-19 | 2013-04-02 | Broncus Medical Inc | Devices for delivering substances through an extra-anatomic opening created in an airway |
CA2591543A1 (en) | 2004-07-19 | 2006-02-09 | Broncus Technologies, Inc. | Methods and devices for maintaining patency of surgically created channels in a body organ |
US8396548B2 (en) | 2008-11-14 | 2013-03-12 | Vessix Vascular, Inc. | Selective drug delivery in a lumen |
WO2006031902A2 (en) | 2004-09-10 | 2006-03-23 | The Cleveland Clinic Foundation | Methods and systems of achieving hemodynamic control through neuromodulation |
US7906124B2 (en) | 2004-09-18 | 2011-03-15 | Asthmatx, Inc. | Inactivation of smooth muscle tissue |
US7553309B2 (en) | 2004-10-08 | 2009-06-30 | Covidien Ag | Electrosurgical system employing multiple electrodes and method thereof |
US7402172B2 (en) | 2004-10-13 | 2008-07-22 | Boston Scientific Scimed, Inc. | Intraluminal therapeutic patch |
JP4792467B2 (en) | 2004-10-14 | 2011-10-12 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | Ablation apparatus and method with ultrasound imaging |
US20060089637A1 (en) | 2004-10-14 | 2006-04-27 | Werneth Randell L | Ablation catheter |
US7553307B2 (en) | 2004-10-15 | 2009-06-30 | Baxano, Inc. | Devices and methods for tissue modification |
US8221397B2 (en) | 2004-10-15 | 2012-07-17 | Baxano, Inc. | Devices and methods for tissue modification |
US7524318B2 (en) | 2004-10-28 | 2009-04-28 | Boston Scientific Scimed, Inc. | Ablation probe with flared electrodes |
US7937143B2 (en) | 2004-11-02 | 2011-05-03 | Ardian, Inc. | Methods and apparatus for inducing controlled renal neuromodulation |
US20070083239A1 (en) | 2005-09-23 | 2007-04-12 | Denise Demarais | Methods and apparatus for inducing, monitoring and controlling renal neuromodulation |
US7949407B2 (en) | 2004-11-05 | 2011-05-24 | Asthmatx, Inc. | Energy delivery devices and methods |
US7200445B1 (en) | 2005-10-21 | 2007-04-03 | Asthmatx, Inc. | Energy delivery devices and methods |
WO2006052940A2 (en) | 2004-11-05 | 2006-05-18 | Asthmatx, Inc. | Medical device with procedure improvement features |
US20070093802A1 (en) | 2005-10-21 | 2007-04-26 | Danek Christopher J | Energy delivery devices and methods |
WO2006053308A2 (en) | 2004-11-12 | 2006-05-18 | Asthmatx, Inc. | Improved energy delivery devices and methods |
WO2006053309A2 (en) | 2004-11-12 | 2006-05-18 | Asthmatx, Inc. | Improved energy delivery devices and methods |
MX2007005937A (en) | 2004-11-16 | 2007-09-11 | Robert L Barry | Device and method for lung treatment. |
US8332047B2 (en) | 2004-11-18 | 2012-12-11 | Cardiac Pacemakers, Inc. | System and method for closed-loop neural stimulation |
US20060118127A1 (en) | 2004-12-06 | 2006-06-08 | Chinn Douglas O | Tissue protective system and method for thermoablative therapies |
US20060135953A1 (en) | 2004-12-22 | 2006-06-22 | Wlodzimierz Kania | Tissue ablation system including guidewire with sensing element |
US11207518B2 (en) | 2004-12-27 | 2021-12-28 | The Feinstein Institutes For Medical Research | Treating inflammatory disorders by stimulation of the cholinergic anti-inflammatory pathway |
CN101124012B (en) | 2004-12-27 | 2012-09-05 | 范因斯坦医学研究院 | Device for treating inflammatory disorders by electrical vagus nerve stimulation |
US20080021274A1 (en) | 2005-01-05 | 2008-01-24 | Avantis Medical Systems, Inc. | Endoscopic medical device with locking mechanism and method |
US7722538B2 (en) | 2005-02-10 | 2010-05-25 | Dirar S. Khoury | Conductance-imaging catheter and determination of cavitary volume |
US20070060954A1 (en) | 2005-02-25 | 2007-03-15 | Tracy Cameron | Method of using spinal cord stimulation to treat neurological disorders or conditions |
EP3045110B1 (en) | 2005-03-28 | 2019-07-31 | Vessix Vascular, Inc. | Intraluminal electrical tissue characterization and tuned rf energy for selective treatment of atheroma and other target tissues |
US20060241523A1 (en) | 2005-04-12 | 2006-10-26 | Prorhythm, Inc. | Ultrasound generating method, apparatus and probe |
EP2727547B1 (en) | 2005-04-21 | 2020-11-18 | Boston Scientific Scimed, Inc. | Devices for energy delivery |
US8052668B2 (en) | 2005-05-13 | 2011-11-08 | Cardiac Pacemakers, Inc. | Neurotoxic agents and devices to treat atrial fibrillation |
WO2006130873A2 (en) | 2005-06-01 | 2006-12-07 | Broncus Technologies, Inc. | Methods and devices for maintaining surgically created channels in a body organ |
US7621890B2 (en) | 2005-06-09 | 2009-11-24 | Endocare, Inc. | Heat exchange catheter with multi-lumen tube having a fluid return passageway |
CA2612679A1 (en) | 2005-06-20 | 2007-01-04 | Richardo D. Roman | Ablation catheter |
DE102005030861A1 (en) | 2005-07-01 | 2007-01-04 | Invendo Medical Gmbh | Cooling device for electronic components, preferably an endoscope |
US7608275B2 (en) | 2005-07-22 | 2009-10-27 | The Foundry, Llc | Systems and methods for delivery of a therapeutic agent |
US9511210B2 (en) | 2006-05-19 | 2016-12-06 | The Foundry, Llc | Apparatus for toxin delivery to the nasal cavity |
US20070021803A1 (en) | 2005-07-22 | 2007-01-25 | The Foundry Inc. | Systems and methods for neuromodulation for treatment of pain and other disorders associated with nerve conduction |
US8660647B2 (en) | 2005-07-28 | 2014-02-25 | Cyberonics, Inc. | Stimulating cranial nerve to treat pulmonary disorder |
US20070043342A1 (en) | 2005-08-16 | 2007-02-22 | Galil Medical Ltd. | Cryoprobe with reduced adhesion to frozen tissue, and cryosurgical methods utilizing same |
US7628789B2 (en) | 2005-08-17 | 2009-12-08 | Pulmonx Corporation | Selective lung tissue ablation |
EP1933787A1 (en) | 2005-08-19 | 2008-06-25 | Werner Francois De Neve | Device and method for assisting heat ablation treatment of the heart |
US20070055328A1 (en) | 2005-09-02 | 2007-03-08 | Mayse Martin L | Device and method for esophageal cooling |
US9486274B2 (en) | 2005-09-07 | 2016-11-08 | Ulthera, Inc. | Dissection handpiece and method for reducing the appearance of cellulite |
US9037247B2 (en) | 2005-11-10 | 2015-05-19 | ElectroCore, LLC | Non-invasive treatment of bronchial constriction |
US20070106337A1 (en) | 2005-11-10 | 2007-05-10 | Electrocore, Inc. | Methods And Apparatus For Treating Disorders Through Neurological And/Or Muscular Intervention |
US9119953B2 (en) | 2005-11-10 | 2015-09-01 | ElectroCore, LLC | Non-invasive treatment of a medical condition by vagus nerve stimulation |
US8676324B2 (en) | 2005-11-10 | 2014-03-18 | ElectroCore, LLC | Electrical and magnetic stimulators used to treat migraine/sinus headache, rhinitis, sinusitis, rhinosinusitis, and comorbid disorders |
US20110125203A1 (en) | 2009-03-20 | 2011-05-26 | ElectroCore, LLC. | Magnetic Stimulation Devices and Methods of Therapy |
US8868177B2 (en) | 2009-03-20 | 2014-10-21 | ElectroCore, LLC | Non-invasive treatment of neurodegenerative diseases |
US8874205B2 (en) | 2009-03-20 | 2014-10-28 | ElectroCore, LLC | Device and methods for non-invasive electrical stimulation and their use for vagal nerve stimulation |
US8812112B2 (en) | 2005-11-10 | 2014-08-19 | ElectroCore, LLC | Electrical treatment of bronchial constriction |
US9089719B2 (en) | 2009-03-20 | 2015-07-28 | ElectroCore, LLC | Non-invasive methods and devices for inducing euphoria in a patient and their therapeutic application |
US8041428B2 (en) | 2006-02-10 | 2011-10-18 | Electrocore Llc | Electrical stimulation treatment of hypotension |
US9174066B2 (en) | 2009-03-20 | 2015-11-03 | ElectroCore, LLC | Devices and methods for non-invasive capacitive electrical stimulation and their use for vagus nerve stimulation on the neck of a patient |
US8676330B2 (en) | 2009-03-20 | 2014-03-18 | ElectroCore, LLC | Electrical and magnetic stimulators used to treat migraine/sinus headache and comorbid disorders |
US7747324B2 (en) | 2005-11-10 | 2010-06-29 | Electrocore Llc | Electrical stimulation treatment of bronchial constriction |
US20070106338A1 (en) | 2005-11-10 | 2007-05-10 | Electrocore, Inc. | Direct and Indirect Control of Muscle for the Treatment of Pathologies |
US8874227B2 (en) | 2009-03-20 | 2014-10-28 | ElectroCore, LLC | Devices and methods for non-invasive capacitive electrical stimulation and their use for vagus nerve stimulation on the neck of a patient |
WO2007061982A1 (en) | 2005-11-22 | 2007-05-31 | Mayo Foundation For Medical Education And Research | Detecting and treating nervous system disorders |
US7997278B2 (en) | 2005-11-23 | 2011-08-16 | Barrx Medical, Inc. | Precision ablating method |
US8190238B2 (en) | 2005-12-09 | 2012-05-29 | Hansen Medical, Inc. | Robotic catheter system and methods |
US20070149959A1 (en) | 2005-12-23 | 2007-06-28 | Sanarus Medical, Inc. | Cryoprobe for low pressure systems |
JP2009525806A (en) | 2006-02-10 | 2009-07-16 | エレクトロコア、インコーポレイテッド | Electrical stimulation treatment for hypotension |
AU2006337679A1 (en) | 2006-02-10 | 2007-08-16 | Electrocore, Inc. | Methods and apparatus for treating anaphylaxis using electrical modulation |
US20070239256A1 (en) | 2006-03-22 | 2007-10-11 | Jan Weber | Medical devices having electrical circuits with multilayer regions |
US20100174340A1 (en) | 2006-04-18 | 2010-07-08 | Electrocore, Inc. | Methods and Apparatus for Applying Energy to Patients |
US20100057178A1 (en) | 2006-04-18 | 2010-03-04 | Electrocore, Inc. | Methods and apparatus for spinal cord stimulation using expandable electrode |
US8209034B2 (en) | 2008-12-18 | 2012-06-26 | Electrocore Llc | Methods and apparatus for electrical stimulation treatment using esophageal balloon and electrode |
US8401650B2 (en) | 2008-04-10 | 2013-03-19 | Electrocore Llc | Methods and apparatus for electrical treatment using balloon and electrode |
US20100241188A1 (en) | 2009-03-20 | 2010-09-23 | Electrocore, Inc. | Percutaneous Electrical Treatment Of Tissue |
US20070255270A1 (en) | 2006-04-27 | 2007-11-01 | Medtronic Vascular, Inc. | Intraluminal guidance system using bioelectric impedance |
EP2020914B1 (en) | 2006-05-10 | 2017-03-01 | Regents of the University of Minnesota | Methods and apparatus of three dimensional cardiac electrophysiological imaging |
WO2007136566A2 (en) | 2006-05-19 | 2007-11-29 | Prorhythm, Inc. | Ablation device with optimized input power profile and method of using the same |
GB0610637D0 (en) | 2006-05-23 | 2006-07-05 | Emcision Ltd | Apparatus and method for treating tissue such as tumours |
US20080004596A1 (en) | 2006-05-25 | 2008-01-03 | Palo Alto Institute | Delivery of agents by microneedle catheter |
EP2032059A4 (en) | 2006-06-05 | 2009-09-16 | Broncus Tech Inc | Devices for creating passages and sensing blood vessels |
ES2378956T5 (en) | 2006-06-28 | 2019-10-09 | Medtronic Ardian Luxembourg | Systems for thermally induced renal neuromodulation |
US7517320B2 (en) | 2006-06-30 | 2009-04-14 | Broncus Technologies, Inc. | Airway bypass site selection and treatment planning |
EP2067447B1 (en) | 2006-06-30 | 2012-08-15 | Bernard Alfons Lucie B. Cambier | Steerable catheter device for the chemoembolization and/or embolization of vascular structures, tumours and/or organs |
US7425211B2 (en) | 2006-08-03 | 2008-09-16 | Arbel Medical Ltd. | Cryogenic probe for treating enlarged volume of tissue |
US7588549B2 (en) | 2006-08-03 | 2009-09-15 | Terumo Cardiovascular Systems Corporation | Thermoelectric temperature control for extracorporeal blood circuit |
US8177829B2 (en) | 2006-08-23 | 2012-05-15 | Boston Scientific Scimed, Inc. | Auxiliary balloon catheter |
US8103341B2 (en) | 2006-08-25 | 2012-01-24 | Cardiac Pacemakers, Inc. | System for abating neural stimulation side effects |
WO2008049087A2 (en) | 2006-10-18 | 2008-04-24 | Minnow Medical, Inc. | System for inducing desirable temperature effects on body tissue |
ES2560006T3 (en) | 2006-10-18 | 2016-02-17 | Vessix Vascular, Inc. | Induction of desirable temperature effects on body tissue |
WO2008049084A2 (en) | 2006-10-18 | 2008-04-24 | Minnow Medical, Inc. | Tuned rf energy and electrical tissue characterization for selective treatment of target tissues |
US7931647B2 (en) | 2006-10-20 | 2011-04-26 | Asthmatx, Inc. | Method of delivering energy to a lung airway using markers |
EP2091439B1 (en) | 2006-11-22 | 2012-10-24 | Broncus Technologies, Inc. | Devices for creating passages and sensing for blood vessels |
GB0624658D0 (en) | 2006-12-11 | 2007-01-17 | Medical Device Innovations Ltd | Electrosurgical ablation apparatus and a method of ablating biological tissue |
CN100574719C (en) | 2006-12-26 | 2009-12-30 | 上海导向医疗系统有限公司 | Gas throttling cooling type radio frequency ablation electrode |
US20080208305A1 (en) | 2007-01-17 | 2008-08-28 | The Cleveland Clinic Foundation | Apparatus and methods for treating pulmonary conditions |
WO2008109760A2 (en) | 2007-03-06 | 2008-09-12 | Broncus Technologies, Inc. | Blood vessel sensing catheter having working lumen for medical appliances |
CN101292897A (en) | 2007-04-25 | 2008-10-29 | 中国科学院理化技术研究所 | Cold and hot probe treatment system |
US8641711B2 (en) | 2007-05-04 | 2014-02-04 | Covidien Lp | Method and apparatus for gastrointestinal tract ablation for treatment of obesity |
US8983609B2 (en) | 2007-05-30 | 2015-03-17 | The Cleveland Clinic Foundation | Apparatus and method for treating pulmonary conditions |
EP2170458A1 (en) | 2007-06-13 | 2010-04-07 | E- Pacing, Inc. | Implantable devices and methods for stimulation of cardiac or other tissues |
US20080312543A1 (en) | 2007-06-18 | 2008-12-18 | Broncus Technologies, Inc. | Measurement of pulmonary hypertension from within the airways |
US8784338B2 (en) | 2007-06-22 | 2014-07-22 | Covidien Lp | Electrical means to normalize ablational energy transmission to a luminal tissue surface of varying size |
US8251992B2 (en) | 2007-07-06 | 2012-08-28 | Tyco Healthcare Group Lp | Method and apparatus for gastrointestinal tract ablation to achieve loss of persistent and/or recurrent excess body weight following a weight-loss operation |
WO2009006748A2 (en) | 2007-07-09 | 2009-01-15 | Sis-Medical Ag | Method and system to detect neointima coverage of a stent |
US8235983B2 (en) | 2007-07-12 | 2012-08-07 | Asthmatx, Inc. | Systems and methods for delivering energy to passageways in a patient |
US20090177192A1 (en) | 2007-07-13 | 2009-07-09 | Scimed Life Systems, Inc. | Method for ablating tissue to facilitate implantation and apparatus and kit for use therewith |
JP4967875B2 (en) | 2007-07-17 | 2012-07-04 | 三菱電機株式会社 | Semiconductor light emitting device and manufacturing method thereof |
JP5436423B2 (en) | 2007-07-24 | 2014-03-05 | アスマティックス,インコーポレイテッド | System and method for power control based on impedance detection such as power control for tissue treatment device |
US20090043301A1 (en) * | 2007-08-09 | 2009-02-12 | Asthmatx, Inc. | Monopolar energy delivery devices and methods for controlling current density in tissue |
US20090076491A1 (en) | 2007-09-19 | 2009-03-19 | Broncus Technologies, Inc. | Methods for maintaining the patency of collateral channels in the lungs using cryo-energy |
AU2008310656A1 (en) | 2007-10-12 | 2009-04-16 | Conmed Corporation | Apparatus and methods for the measurement of cardiac output |
CN101411645A (en) * | 2007-10-19 | 2009-04-22 | 上海导向医疗系统有限公司 | The uniform radio-frequency ablation electrode of surface temperature |
US8906011B2 (en) | 2007-11-16 | 2014-12-09 | Kardium Inc. | Medical device for use in bodily lumens, for example an atrium |
US8323202B2 (en) | 2007-11-16 | 2012-12-04 | Pneumrx, Inc. | Method and system for measuring pulmonary artery circulation information |
US20090192505A1 (en) | 2007-12-05 | 2009-07-30 | Reset Medical, Inc. | Method for cryospray ablation |
US8155744B2 (en) | 2007-12-13 | 2012-04-10 | The Cleveland Clinic Foundation | Neuromodulatory methods for treating pulmonary disorders |
US20090204005A1 (en) | 2008-02-07 | 2009-08-13 | Broncus Technologies, Inc. | Puncture resistant catheter for sensing vessels and for creating passages in tissue |
EP2249900A4 (en) | 2008-02-08 | 2013-11-06 | Terumo Corp | Device for local intraluminal transport of a biologically and physiologically active agent |
US8483831B1 (en) | 2008-02-15 | 2013-07-09 | Holaira, Inc. | System and method for bronchial dilation |
US20090248011A1 (en) | 2008-02-28 | 2009-10-01 | Hlavka Edwin J | Chronic venous insufficiency treatment |
EP2265316B1 (en) | 2008-03-06 | 2016-01-13 | Boston Scientific Scimed, Inc. | Triggered drug release |
US8470337B2 (en) | 2008-03-13 | 2013-06-25 | Allergan, Inc. | Therapeutic treatments using botulinum neurotoxin |
US20090254142A1 (en) | 2008-04-08 | 2009-10-08 | Silhouette Medical, Usa | Treating Medical Conditions of Hollow Organs |
EP2265204B1 (en) | 2008-04-10 | 2017-12-06 | ElectroCore LLC | Device comprising an enclosure and an interior electrode for delivering energy to a mammal |
US8543211B2 (en) | 2008-04-10 | 2013-09-24 | ElectroCore, LLC | Methods and apparatus for deep brain stimulation |
US8682449B2 (en) | 2008-04-10 | 2014-03-25 | ElectroCore, LLC | Methods and apparatus for transcranial stimulation |
EP2662046B1 (en) | 2008-05-09 | 2023-03-15 | Nuvaira, Inc. | Systems and assemblies for treating a bronchial tree |
US8128617B2 (en) | 2008-05-27 | 2012-03-06 | Boston Scientific Scimed, Inc. | Electrical mapping and cryo ablating with a balloon catheter |
US9101382B2 (en) | 2009-02-18 | 2015-08-11 | Hotspur Technologies, Inc. | Apparatus and methods for treating obstructions within body lumens |
US9089700B2 (en) | 2008-08-11 | 2015-07-28 | Cibiem, Inc. | Systems and methods for treating dyspnea, including via electrical afferent signal blocking |
US9211155B2 (en) | 2008-08-20 | 2015-12-15 | Prostacare Pty Ltd. | Non-thermal ablation system for treating BPH and other growths |
EP2328650B1 (en) | 2008-08-26 | 2016-04-06 | Cook Medical Technologies LLC | Balloon catheters having a plurality of needles for the injection of one or more therapeutic agents |
US20110306904A1 (en) | 2008-08-26 | 2011-12-15 | Northwestern University | Ablation devices and related methods thereof |
US8303581B2 (en) | 2008-09-02 | 2012-11-06 | Covidien Lp | Catheter with remotely extendible instruments |
US20100076518A1 (en) | 2008-09-18 | 2010-03-25 | Conceptx Medical, Inc. | Systems and methods for relieving dyspnea |
ES2440751T3 (en) | 2008-10-07 | 2014-01-30 | Boston Scientific Scimed, Inc. | Medical devices for administration of therapeutic agents to body lumens |
CN104068933B (en) | 2008-11-11 | 2017-03-15 | 施菲姆德控股有限责任公司 | The electrode assemblie of little profile |
US8734502B2 (en) | 2008-12-17 | 2014-05-27 | Cook Medical Technologies Llc | Tapered stent and flexible prosthesis |
US20100160906A1 (en) | 2008-12-23 | 2010-06-24 | Asthmatx, Inc. | Expandable energy delivery devices having flexible conductive elements and associated systems and methods |
EP2376011B1 (en) | 2009-01-09 | 2019-07-03 | ReCor Medical, Inc. | Apparatus for treatment of mitral valve insufficiency |
US9174045B2 (en) | 2009-03-20 | 2015-11-03 | ElectroCore, LLC | Non-invasive electrical and magnetic nerve stimulators used to treat overactive bladder and urinary incontinence |
US10252074B2 (en) | 2009-03-20 | 2019-04-09 | ElectroCore, LLC | Nerve stimulation methods for averting imminent onset or episode of a disease |
US8914122B2 (en) | 2009-03-20 | 2014-12-16 | ElectroCore, LLC | Devices and methods for non-invasive capacitive electrical stimulation and their use for vagus nerve stimulation on the neck of a patient |
US10286212B2 (en) | 2009-03-20 | 2019-05-14 | Electrocore, Inc. | Nerve stimulation methods for averting imminent onset or episode of a disease |
WO2010110785A1 (en) | 2009-03-24 | 2010-09-30 | Electrocore, Inc. | Electrical treatment of bronchial constriction |
US20100256629A1 (en) | 2009-04-06 | 2010-10-07 | Voyage Medical, Inc. | Methods and devices for treatment of the ostium |
US20100256630A1 (en) | 2009-04-07 | 2010-10-07 | Angiodynamics, Inc. | Irreversible electroporation (ire) for esophageal disease |
EP2243501A1 (en) | 2009-04-24 | 2010-10-27 | Eurocor Gmbh | Shellac and paclitaxel coated catheter balloons |
US8788034B2 (en) | 2011-05-09 | 2014-07-22 | Setpoint Medical Corporation | Single-pulse activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation |
CN201431510Y (en) * | 2009-05-08 | 2010-03-31 | 上海理工大学 | Gas-cooling and perfusion combined-type radio-frequency ablation probe electrode device for intervertebral disc |
US8551096B2 (en) | 2009-05-13 | 2013-10-08 | Boston Scientific Scimed, Inc. | Directional delivery of energy and bioactives |
EP2253337A1 (en) | 2009-05-18 | 2010-11-24 | Encapson B.V. | Balloon catheter comprising pressure sensitive microcapsules. |
US8483832B2 (en) | 2009-05-20 | 2013-07-09 | ElectroCore, LLC | Systems and methods for selectively applying electrical energy to tissue |
EP2440262A2 (en) | 2009-06-10 | 2012-04-18 | Boston Scientific Scimed, Inc. | Electrochemical therapeutic agent delivery device |
JP2012531270A (en) | 2009-06-24 | 2012-12-10 | シファメド・ホールディングス・エルエルシー | Operable medical delivery device and method of use |
AU2010281644A1 (en) | 2009-08-05 | 2012-02-23 | Ndi Medical, Llc | Systems and methods for maintaining airway patency |
US8371303B2 (en) | 2009-08-05 | 2013-02-12 | Anesthetech Inc. | System and method for imaging endotracheal tube placement and measuring airway occlusion cuff pressure |
WO2011021948A1 (en) | 2009-08-21 | 2011-02-24 | Auckland Uniservices Limited | System and method for mapping gastro-intestinal electrical activity |
US8233987B2 (en) | 2009-09-10 | 2012-07-31 | Respicardia, Inc. | Respiratory rectification |
CN107049479B (en) | 2009-10-27 | 2020-10-16 | 努瓦拉公司 | Delivery device with coolable energy emitting assembly |
CN102596320B (en) | 2009-10-30 | 2016-09-07 | 瑞蔻医药有限公司 | Method and apparatus by percutaneous ultrasound ripple Renal denervation treatment hypertension |
WO2011053772A1 (en) | 2009-10-30 | 2011-05-05 | Sound Interventions, Inc. | Method and apparatus for non-invasive treatment of hypertension through ultrasound renal denervation |
US20110112400A1 (en) | 2009-11-06 | 2011-05-12 | Ardian, Inc. | High intensity focused ultrasound catheter apparatuses, systems, and methods for renal neuromodulation |
US20120302909A1 (en) | 2009-11-11 | 2012-11-29 | Mayse Martin L | Methods and systems for screening subjects |
US8911439B2 (en) | 2009-11-11 | 2014-12-16 | Holaira, Inc. | Non-invasive and minimally invasive denervation methods and systems for performing the same |
EP2842510B1 (en) | 2009-11-11 | 2022-08-24 | Nuvaira, Inc. | Device for treating tissue and controlling stenosis |
US20110137284A1 (en) | 2009-12-03 | 2011-06-09 | Northwestern University | Devices for material delivery, electroporation, and monitoring electrophysiological activity |
US20110245756A1 (en) | 2009-12-03 | 2011-10-06 | Rishi Arora | Devices for material delivery, electroporation, sonoporation, and/or monitoring electrophysiological activity |
US20110144630A1 (en) | 2009-12-10 | 2011-06-16 | Loeb Marvin P | Fiber optic device with controlled reuse |
WO2011088399A1 (en) | 2010-01-18 | 2011-07-21 | Stanford University | Method and apparatus for radioablation of regular targets such as sympathetic nerves |
US9993625B2 (en) | 2010-01-29 | 2018-06-12 | Mirus Llc | Biodegradable protrusions on inflatable device |
WO2011119857A2 (en) | 2010-03-24 | 2011-09-29 | Shifamed, Llc | Intravascular tissue disruption |
US10575893B2 (en) | 2010-04-06 | 2020-03-03 | Nuvaira, Inc. | System and method for pulmonary treatment |
EP3482709B1 (en) | 2010-04-06 | 2021-07-07 | Nuvaira, Inc. | System for pulmonary treatment |
CN102933169B (en) | 2010-04-14 | 2016-03-16 | 波士顿科学西美德公司 | Adopt the renal artery denervation art apparatus of spiral forming device |
US9237961B2 (en) | 2010-04-23 | 2016-01-19 | Medtronic Vascular, Inc. | Stent delivery system for detecting wall apposition of the stent during deployment |
CA2797130A1 (en) | 2010-05-12 | 2011-11-17 | Shifamed Holdings, Llc | Low profile electrode assembly |
EP2568900B1 (en) | 2010-05-14 | 2017-09-27 | Neuraxis, LLC | Device for cooling spinal tissue |
EP2593029A4 (en) | 2010-07-13 | 2015-03-04 | Sandhill Scient Inc | Apparatus and method for detecting and measuring condition of esophageal mucosa and indications of gastroesophageal reflux disease |
US9295663B2 (en) | 2010-07-14 | 2016-03-29 | Abbott Cardiovascular Systems Inc. | Drug coated balloon with in-situ formed drug containing microspheres |
US20120029512A1 (en) | 2010-07-30 | 2012-02-02 | Willard Martin R | Balloon with surface electrodes and integral cooling for renal nerve ablation |
US9155589B2 (en) | 2010-07-30 | 2015-10-13 | Boston Scientific Scimed, Inc. | Sequential activation RF electrode set for renal nerve ablation |
US9095320B2 (en) | 2010-09-27 | 2015-08-04 | CyroMedix, LLC | Cryo-induced renal neuromodulation devices and methods |
CN202478392U (en) | 2010-10-20 | 2012-10-10 | 美敦力阿迪安卢森堡有限责任公司 | Associated system of catheter device |
US9192435B2 (en) * | 2010-11-22 | 2015-11-24 | Boston Scientific Scimed, Inc. | Renal denervation catheter with cooled RF electrode |
US8998893B2 (en) | 2010-12-07 | 2015-04-07 | Boaz Avitall | Catheter systems for cardiac arrhythmia ablation |
US11246653B2 (en) | 2010-12-07 | 2022-02-15 | Boaz Avitall | Catheter systems for cardiac arrhythmia ablation |
EP3132827B1 (en) | 2010-12-28 | 2019-04-03 | Cibiem, Inc. | Endovascular carotid body ablation catheter for sympathetic rebalancing of patient |
US9095262B2 (en) | 2011-01-05 | 2015-08-04 | Mehdi Razavi | Guided ablation devices, systems, and methods |
US20120191080A1 (en) | 2011-01-25 | 2012-07-26 | Medtronic, Inc. | Method and Apparatus for Regulating the Formation of Ice On A Catheter |
US20120191081A1 (en) | 2011-01-25 | 2012-07-26 | Medtronic, Inc. | Method and Apparatus for Regulating The Formation Of Ice On A Catheter |
WO2012103157A1 (en) | 2011-01-28 | 2012-08-02 | Medtronc Vascular Inc. | Ablation catheter equipped with a shape memory material |
US20120203067A1 (en) | 2011-02-04 | 2012-08-09 | The Penn State Research Foundation | Method and device for determining the location of an endoscope |
EP3275390B1 (en) | 2011-02-10 | 2019-06-19 | Corvia Medical, Inc. | Apparatus to create and maintain an intra-atrial pressure relief opening |
US8579800B2 (en) | 2011-03-22 | 2013-11-12 | Fabian Emura | Systematic chromoendoscopy and chromocolonoscopy as a novel systematic method to examine organs with endoscopic techniques |
WO2013106054A2 (en) | 2011-04-08 | 2013-07-18 | Vivant Medical, Inc. | Flexible microwave catheters for natural or artificial lumens |
EP2694150A1 (en) | 2011-04-08 | 2014-02-12 | Covidien LP | Iontophoresis drug delivery system and method for denervation of the renal sympathetic nerve and iontophoretic drug delivery |
WO2012148966A2 (en) | 2011-04-25 | 2012-11-01 | Brian Kelly | Apparatus and methods related to selective thermal insulation of cryogenic balloons for limited cryogenic ablation of vessel walls |
EP2701623B1 (en) | 2011-04-25 | 2016-08-17 | Medtronic Ardian Luxembourg S.à.r.l. | Apparatus related to constrained deployment of cryogenic balloons for limited cryogenic ablation of vessel walls |
US20140316398A1 (en) | 2011-04-29 | 2014-10-23 | Brian Kelly | Systems and methods related to selective heating of cryogenic balloons for targeted cryogenic neuromodulation |
US8909316B2 (en) | 2011-05-18 | 2014-12-09 | St. Jude Medical, Cardiology Division, Inc. | Apparatus and method of assessing transvascular denervation |
US8702619B2 (en) | 2011-08-26 | 2014-04-22 | Symap Holding Limited | Mapping sympathetic nerve distribution for renal ablation and catheters for same |
WO2013052501A1 (en) | 2011-10-05 | 2013-04-11 | Innovative Pulmonary Solutions, Inc. | Apparatus for injuring nerve tissue |
US20130310822A1 (en) | 2012-05-18 | 2013-11-21 | Holaira, Inc. | Compact delivery pulmonary treatment systems and methods for improving pulmonary function |
US9398933B2 (en) | 2012-12-27 | 2016-07-26 | Holaira, Inc. | Methods for improving drug efficacy including a combination of drug administration and nerve modulation |
EP4410338A3 (en) | 2013-03-13 | 2024-10-16 | Nuvaira, Inc. | Fluid delivery system and method for treatment |
WO2014143898A1 (en) | 2013-03-15 | 2014-09-18 | Holaira, Inc. | Systems, devices, and methods for treating a pulmonary disorder with an agent |
WO2015038886A1 (en) | 2013-09-12 | 2015-03-19 | Holaira, Inc. | Systems, devices, and methods for treating a pulmonary disease with ultrasound energy |
WO2015089377A1 (en) | 2013-12-12 | 2015-06-18 | Holaira, Inc. | Catheter and handle assembly, systems, and methods |
EP3468495B1 (en) | 2016-06-09 | 2024-02-28 | Nuvaira, Inc. | Systems for improved delivery of expandable catheter assemblies into body lumens |
EP3551109A4 (en) | 2016-12-07 | 2020-07-22 | Nuvaira, Inc. | Method and systems for reducing treatment variability and increasing treatment efficacy and durability |
-
2010
- 2010-11-11 EP EP14188819.8A patent/EP2842510B1/en active Active
- 2010-11-11 CN CN201080060627.6A patent/CN102711645B/en active Active
- 2010-11-11 EP EP10779422.4A patent/EP2498705B1/en active Active
- 2010-11-11 CN CN201611095404.9A patent/CN106618731B/en active Active
- 2010-11-11 AU AU2010319477A patent/AU2010319477A1/en not_active Abandoned
- 2010-11-11 KR KR1020127013100A patent/KR101820542B1/en active IP Right Grant
- 2010-11-11 JP JP2012538992A patent/JP6000851B2/en active Active
- 2010-11-11 US US13/509,581 patent/US9149328B2/en active Active
- 2010-11-11 CA CA2780608A patent/CA2780608C/en active Active
- 2010-11-11 WO PCT/US2010/056424 patent/WO2011060200A1/en active Application Filing
- 2010-11-11 EP EP22191688.5A patent/EP4111995A1/en active Pending
-
2012
- 2012-05-06 IL IL219605A patent/IL219605A0/en unknown
-
2015
- 2015-10-01 US US14/872,212 patent/US9662171B2/en active Active
-
2016
- 2016-03-16 JP JP2016051983A patent/JP6734082B2/en active Active
-
2017
- 2017-05-30 US US15/607,918 patent/US10363091B2/en active Active
-
2018
- 2018-06-26 JP JP2018120822A patent/JP2018187407A/en active Pending
-
2019
- 2019-07-29 US US16/524,971 patent/US11389233B2/en active Active
-
2022
- 2022-07-18 US US17/813,297 patent/US20220370123A1/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997025917A1 (en) * | 1996-01-19 | 1997-07-24 | Ep Technologies, Inc. | Multi-function electrode structures for electrically analyzing and heating body tissue |
US20090131928A1 (en) * | 1998-01-14 | 2009-05-21 | Respiratory Diagnostic, Inc. | GERD treatment apparatus and method |
WO1999042047A1 (en) * | 1998-02-19 | 1999-08-26 | Conway-Stuart Medical, Inc. | Method for electrosurgically treating a sphincter |
WO2000066017A1 (en) * | 1999-05-04 | 2000-11-09 | Curon Medical, Inc. | Electrodes for creating lesions in tissue regions at or near a sphincter |
US20080262489A1 (en) * | 2007-04-23 | 2008-10-23 | Minnow Medical, Llc | Thrombus removal |
Cited By (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103860258A (en) * | 2012-12-12 | 2014-06-18 | 北京中孵友信医药科技股份有限公司 | Self-adaptive annular positioning endovascular catheter |
CN105555220A (en) * | 2013-07-22 | 2016-05-04 | 波士顿科学国际有限公司 | Medical devices for renal nerve ablation |
CN105555220B (en) * | 2013-07-22 | 2019-05-17 | 波士顿科学国际有限公司 | Medical instrument for renal nerve ablation |
CN105636538B (en) * | 2013-10-18 | 2019-01-15 | 波士顿科学国际有限公司 | Foley's tube with flexible wire and its correlation technique for using and manufacturing |
CN105636538A (en) * | 2013-10-18 | 2016-06-01 | 波士顿科学国际有限公司 | Balloon catheters with flexible conducting wires and related methods of use and manufacture |
CN110575244A (en) * | 2013-11-19 | 2019-12-17 | 伊西康公司 | Thoracoscopic method for treating bronchial diseases |
CN105744907A (en) * | 2013-11-19 | 2016-07-06 | 伊西康公司 | Thoracoscopic methods for treatment of bronchial disease |
CN103735307B (en) * | 2014-01-14 | 2016-06-08 | 沈诚亮 | Bronchus hot forming conduit |
CN103735307A (en) * | 2014-01-14 | 2014-04-23 | 沈诚亮 | Bronchial thermoplasty catheter |
US11083400B2 (en) | 2014-11-20 | 2021-08-10 | Biosense Webster (Israel) Ltd. | Catheter with high density electrode spine array |
US12089940B2 (en) | 2014-11-20 | 2024-09-17 | Biosense Webster (Israel) Ltd. | Catheter with high density electrode spine array |
US11039772B2 (en) | 2015-06-29 | 2021-06-22 | Biosense Webster (Israel) Ltd. | Catheter with stacked spine electrode assembly |
CN106264715B (en) * | 2015-06-29 | 2020-11-06 | 韦伯斯特生物官能(以色列)有限公司 | Catheter having closed loop array with in-plane linear electrode portions |
US10966623B2 (en) | 2015-06-29 | 2021-04-06 | Biosense Webster (Israel) Ltd. | Catheter having closed loop array with in-plane linear electrode portion |
CN106264715A (en) * | 2015-06-29 | 2017-01-04 | 韦伯斯特生物官能(以色列)有限公司 | There is the conduit of closed loop array with plane internal linear electrode part |
US11690552B2 (en) | 2015-06-29 | 2023-07-04 | Biosense Webster (Israel) Ltd. | Catheter with stacked spine electrode assembly |
US12097034B2 (en) | 2015-06-29 | 2024-09-24 | Biosense Webster (Israel) Ltd. | Catheter with stacked spine electrode assembly |
US11116436B2 (en) | 2015-06-30 | 2021-09-14 | Biosense Webster (Israel) Ltd. | Catheter having closed electrode assembly with spines of uniform length |
US11723574B2 (en) | 2015-06-30 | 2023-08-15 | Biosense Webster (Israel) Ltd. | Catheter having closed electrode assembly with spines of uniform length |
CN106880400A (en) * | 2015-12-16 | 2017-06-23 | 上海微创电生理医疗科技有限公司 | Electrophysiologicalcatheter catheter and radio frequency ablation system |
CN110944581A (en) * | 2017-07-28 | 2020-03-31 | 美敦力公司 | Expandable element for delivery of electric fields |
CN110944581B (en) * | 2017-07-28 | 2023-09-12 | 美敦力公司 | Expandable element for delivery of an electric field |
US12144629B2 (en) | 2023-06-20 | 2024-11-19 | Biosense Webster (Israel) Ltd. | Catheter having closed electrode assembly with spines of uniform length |
Also Published As
Publication number | Publication date |
---|---|
JP6000851B2 (en) | 2016-10-05 |
US9149328B2 (en) | 2015-10-06 |
JP6734082B2 (en) | 2020-08-05 |
US10363091B2 (en) | 2019-07-30 |
US11389233B2 (en) | 2022-07-19 |
KR101820542B1 (en) | 2018-01-19 |
CN106618731B (en) | 2020-08-07 |
EP2498705B1 (en) | 2014-10-15 |
CN106618731A (en) | 2017-05-10 |
CA2780608C (en) | 2019-02-26 |
US20120310233A1 (en) | 2012-12-06 |
CA2780608A1 (en) | 2011-05-19 |
CN102711645B (en) | 2016-12-28 |
KR20120101007A (en) | 2012-09-12 |
EP2842510A1 (en) | 2015-03-04 |
EP2842510B1 (en) | 2022-08-24 |
US20200085495A1 (en) | 2020-03-19 |
US9662171B2 (en) | 2017-05-30 |
EP2498705A1 (en) | 2012-09-19 |
IL219605A0 (en) | 2012-07-31 |
JP2018187407A (en) | 2018-11-29 |
US20220370123A1 (en) | 2022-11-24 |
US20160192981A1 (en) | 2016-07-07 |
US20180042668A1 (en) | 2018-02-15 |
JP2013510676A (en) | 2013-03-28 |
AU2010319477A1 (en) | 2012-05-24 |
WO2011060200A1 (en) | 2011-05-19 |
EP4111995A1 (en) | 2023-01-04 |
JP2016152926A (en) | 2016-08-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102711645B (en) | For processing tissue and controlling narrow system and device | |
JP6859393B2 (en) | Systems, assemblies, and methods for the treatment of bronchial trees | |
CN104042322B (en) | Delivery apparatus with coolable energy transmitting device |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent of invention or patent application | ||
CB02 | Change of applicant information |
Address after: American Minnesota Applicant after: Heler Corp. Address before: Washington State Applicant before: Innovative Pulmonary Solutions, Inc. |
|
COR | Change of bibliographic data |
Free format text: CORRECT: APPLICANT; FROM: INNOVATIVE PULMONARY SOLUTIONS, INC. TO: HELER CORP. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP01 | Change in the name or title of a patent holder |
Address after: American Minnesota Patentee after: Nouarra company Address before: American Minnesota Patentee before: Heler Corp. |
|
CP01 | Change in the name or title of a patent holder |